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 Foreword
The International Laboratory for Research on Animal Diseases (ILRAD) has recently
developed interests in several areas of cell biology and biochemistry that are relevant to
trypanosomiasis and theileriosis (East Coast fever [ECF]). The reasons for this interest stem
from a perceived difficulty of tackling trypanosomiasis by conventional vaccination procedures
due to the tremendous antigenic variation that trypanosomes can undergo. Thus, approaches
other than a purely immunological one are now being explored. As a part of this new
emphasis, a four-day workshop was held at ILRAD to review the current state of knowledge in
the field of protein traffic and catabolism and to attempt to address these issues, with
particular reference to parasitic diseases. The topics covered included such areas as protein
targeting, protein assembly, protein degradation, endocytosis and lysosomal activity. There
were 20 speakers from Europe and America and 8 from ILRAD, as well as approximately 40
observers from ILRAD and other research organizations in Africa. The organizers of this
workshop would like to thank the United Nations Development Program (UNDP) for their
financial support, and the distinguished visitors for their most valuable scientific contributions,
which helped to make the meeting a success.
C. Redman (New York Blood Center) gave an elegant exposition on how a relatively simple
procedure such as SDS-polyacrylamide gel electrophoresis (SDS-PAGE) can be used to
delineate the steps involved in such complex tasks as protein macromolecular assembly and
disulphide cross-linking. The role of disulphide bond formation in protein assembly and
targeting was also addressed by T. Morrison (University of Massachusetts Medical School)
who showed that, while virion associated protein was exclusively in disulphide-linked
oligomers, not all haemoglobin-nitrogen (HN) protein (in the Newcastle disease virus) was in
this form during processing from the endoplasmic reticulum (ER). The importance of
understanding such assembly process was exemplified by W. Fish (ILRAD), who showed that
the immunological exposure of the species cross-reactive epitope, called the cross-reacting
determinant (CRD), of the variant specific glycoprotein (VSG) of Trypanosoma congolense
could be dissected into several distinct enzymatic and non-enzymatic (disulphide-bond
reduction) steps. Apparently the enzymatic removal from VSG of the proposed membrane
anchor, dimeristoylphosphatidyl-inositol, is not a pre-requisite for CRD exposure as formerly
believed. Indeed, D. Grab (ILRAD) provided evidence that a phospholipase-C, which had
been proposed to mediate the release of the surface coat from the parasite, was probably an
intracellular enzyme, thus also raising doubts as to the proposed physiological role of the
enzyme as a mediator for the release of VSG from the surface of the parasite.
The importance of correctly folded proteins was further explored by A. Goldberg (Harvard),
who described the role of cytosolic proteases that degrade abnormally synthesized proteins
and proteins that have been damaged by other processes such as the action of free radicals.
Free radicals and their reaction products have long been recognized as agents capable of
reacting with lipids and carbohydrates, but only recently was evidence found to show that
proteins may also be affected. Interestingly, R. Dean (Brunei) showed that the bloodstream
forms of African trypanosomes, which contain the thick VSG coating, are apparently more
susceptible to free radical damage than are the same parasites from which the coat has been
removed enzymatically, or those that have lost it (procyclic forms) in the normal course of the
parasite life cycle! Such observations emphasize the importance of ascertaining the role of
free radical damage to cellular proteins.
The purification and characterization of lysosomal enzymes from Entamoeaba histolytica (A.
Barrett, Strangeways), and African trypanosomes (J. Lonsdale-Eccles, ILRAD) were described
and their biochemical properties shown to be distinct from mammalian thiol-dependent
cathepsins. The possibility that such differences between mammalian and parasite enzymes
may be exploitable was addressed by E. Shaw (Freidrich Miescher Institute, Basel), who
described a variety of peptidyl derivatives that acted as specific affinity-labelling inactivators of
cysteine and serine proteinases. By appropriately tailoring the inhibitor, he was able to
demonstrate the intracellular inhibition of different lysosomal enzymes as well as the blockage
of intracellular processes such as antigen presentation or proinsulin processing. Interestingly,
the trypanolytic activity of human serum could be blocked by lysosomotropic agents such as
chloroquine (B. Betschart, Swiss Tropical Institute). J. Kay (University College, Cardiff) also
described a modulation of intracellular antigen processing using an inhibitor that had a
specificity against aspartyl proteases such as cathepsin E.
R. Kelly (University of California) described how sorting signals, which appear to be conserved
in different cells, are involved in deflecting proteins from an otherwise default secretory
pathway. K. Simons (European Molecular Biology Laboratory) addressed how such sorting
can occur in polarized cells (e.g., Madin-Darby canine kidney cells, which can be infected by
vesicular stomatitus virus only on the basolateral side and hepatitus A virus only on the apical
side). He eliminated carbohydrate as a possible signal and showed that the lipid/glycolipid
gradient from one side to the other is affected by a gate at the tight junctions between cells.
By a novel technique (of decapitating the cells!) he was able to show that it is possible to
dissect some of the biochemical events that are involved in such sorting. Whether
trypanosomes, which are also polarized cells, will be amenable to such studies remains to be
determined.
The biological importance of the lysosomal system was beautifully shown by E. Harms
(Universitaets-Kinderklinik). He demonstrated the importance of several of the lysosomal
enzymes using hereditary deficiencies of the enzymes to show their roles in the maintenance
of the viability of the individual. A. Fok and R. Allen (Hawaii) gave detailed descriptions of the
endocytotic pathways of Paramecium, whose endocytotic system is the best studied of the
protozoans. Their digestive process appears to undergo a rapid, complex series of maturation
events (approximately 30 minutes from internalization to defecation) that involves fusion of
acidic vesicles and ultimate secretion of lysosomal contents. M. Moore (Plymouth, UK)
described how lysosomes become destabilized when cells have been in contact with
xenobiotics. This increased lysosome fragility is associated with enhanced catabolic activity.
Destabilization of the lysosomal membranes can occur with a wide variety of perturbations,
including pH. Indeed, using such properties, L. Huang (University of Tennessee) described the
use of a pH-dependent drug delivery system that has been successfully employed in
transfection and in other studies. Specific targeting of the liposomes is achieved by
incorporating appropriate target antibodies in the surface of the liposome.
However, the use of immuno-liposomes will require a detailed knowledge of the intracellular
compartments and sorting mechanisms. J. Slot (University of Utrecht), for example, has been
studying how the lysosome membrane differs from that of the plasma membrane (he has
proposed that sorting may be a consequence of changes in surface area within the
organelles). A. Helenius (Yale University) has taken this one step further and suggested that
there are two cycling systems, with early lysosomes and late lysosomes recycling their
membranes in separate cycles. In the case of trypanosomes, progress in understanding
sorting has been made by P. Webster (ILRAD). He has shown that there appears to be
several sorting systems that may be effective according to either the chemical structure or the
size of the respective compounds that are subject to sorting. This sorting appears to occur in a
complex network of interconnected tubules or cisternae rather than in discete vesicles. In
contrast, F. Maxfield (Columbia University) has shown that in mammalian CHO cells, 80% of a
2-macroglobulin goes to lysosomes whereas 90% of transferrin goes to the surface. Each
appears to be in different-sized vesicles that are subject to different pH values in the different
endocytic pathways. These endosomes fuse actively for several minutes after the initial
internalization with a concomitant large increase in the number of non-recycling components
but no increase in the recycled components (analogous to fractional distillation). To dissect the
endocytotic steps, R. Anderson (University of Texas) has begun an ambitious project to study
coated pit assembly in vitro. Initial studies suggest that he is able to prepare, in vitro, clathrin-
coated pits that have properties similar to the in vivo ones.
During the blood-infective stage of their life cycle, T. brucei can undergo a morphologic
differentiation that is accompanied by changes in several protein kinase substrates (Aboage-
Kwarteng, ILRAD). These proteins are phosphorylated by cytosolic casein kinase-II-like
enzymes that differ from mammalian casein kinase-II. Whereas the kinases from the African
trypanosome appear to be involved in the switch from dividing to non-dividing cells, protein
kinases in Theileria may act as growth signal transducers in the Theileria-induced-cell
proliferation (O. ole-MoiYoi, ILRAD). The Theileria protozoan parasites are unusual in that
they induce lymphoblastogenesis and clonal expansion of otherwise quiescent cells. A
definitive role for the kinases in this transformation process has yet to be found. Although not
causing transformation, plasmodial infection of cells causes morphologic changes in host
structure. Some of these, M. Aikawa (Case Western Reserve University) reports, are to allow
for the traffic of parasite protein to the host cell surface.
 
  
Opening address
A.R. GRAY
Director General
International Laboratory for Research on Animal Diseases
P O Box 30709, Nairobi, Kenya
The International Laboratory for Research on Animal Diseases (ILRAD) was established in
1973 to undertake programs of research and training aimed at the improved control of
livestock diseases. From the outset the emphasis of the Laboratory has been improved control
of the forms of animal trypanosomiasis and theileriosis that continue to plague the livestock
industries of many countries in Africa.
Much of our work has been concerned with the antigenicity of the causative organisms and
immunological aspects of infection with the aim of developing methods of immunization.
However, both disease complexes are caused by pathogenic protozoa, and as you all know,
effective vaccines against protozoa are hard to find. In recognition of this, our research
programs are broadly based and we take a fairly wide view of the epidemiology, biochemistry
and pathology of infections, as well as of immunity.
This week, with your help, we will be concentrating on aspects of the problem presented by
tsetse-transmitted trypanosomiasis. This is of particular interest to us and is being tackled at
ILRAD in several ways, namely by:
1. The development of improved techniques to diagnose infections, the
identification of causal organisms, assessment of their sensitivity to trypanocidal
drugs and improvement of therapeutic treatment regimes.
2. Basic research studies on the biology of trypanosomes, particularly their
antigenicity, metabolic processes and pathways, and control of differentiation
processes.
3. Examination of non-specific and specific resistance to infection, particularly the
responses of trypanotolerant livestock.
4. Research on selected aspects of the pathogenesis of infection, particularly the
development of anaemia and certain reproductive and endocrine disorders.
Our objective at ILRAD is to identify ways in which we can significantly improve the control of
trypanosomiasis as a result of work on the parasites in one or several of these research areas.
Other organisations are giving their attention primarily to aspects of tsetse control. During the
coming week we will be concerned mainly with work on various aspects of trypanosomal
metabolism, especially metabolic and synthetic pathways.
The move to convene this workshop came from two sources, ILRAD and United Nations
Development Program (UNDP). It has been ILRAD's practice for some years to organise
reviews of aspects of ILRAD's research programs, with contributions from ILRAD scientists
and scientists working in the same field at other Laboratories. Three years ago we reviewed
bovine immune responses, last year the bovine major histocompatability complex and
trypanotolerance in African livestock. On this occasion the theme is Protein Traffic in Parasites
and Mammalian Cells.
Enthusiasm at ILRAD for this theme received a special boost late last year from UNDP. For
ten years ILRAD has received financial support for the research and training program on
African trypanosomiasis from the UNDP global and interregional development program. Late
last year, UNDP offered additional support to enable ILRAD to organise workshops to
examine recent advances in aspects of cellular and molecular biology of parasitic protozoa
that are pathogens of both humans and livestock. The UNDP wish to stimulate dialogue
among people interested in medical and veterinary aspects of research on trypanosomiasis
and fruitful collaboration between ILRAD and leading centres of excellence around the world.
The theme of this week's activities is therefore very appropriate. Protein traffic in parasites has
many features in common with corresponding processes in mammalian cells. Such processes
are vital to the survival and multiplication of the parasites and thus may offer potential targets
for immunological and chemical attack. We have therefore invited you here as scientists
distinguished in cell biology to interact with ILRAD staff members and scientists from other
organisations who are working on pathogenic trypanosomes and to ensure that current
concepts and findings from mammalian cell biology are available to those working towards
improved control of parasites. Specifically, therefore, the objectives of the workshop are:
1. To review findings from research on the biology and biochemistry of mammalian
cells and other organisms for their possible relevance and application to research
programs on trypanosomiasis and other parasitic diseases.
2. To review research in progress at ILRAD and elsewhere on aspects of the
biochemistry and cell biology of pathogenic trypanosomes for its quality and
relevance to the potential control of human and animal trypanosomiasis.
3. To identify research areas where new ideas and new findings offer possibilities
for developing new research approaches.
4. To encourage and strengthen links among scientists at ILRAD and elsewhere
working on topics of interest and relevance to ILRAD's research programs on cell
biology and biochemistry.
At the end of the workshop I trust it will be possible to put together a summary of the
presentations and discussions in a report for use at both ILRAD and UNDP. It is also
desirable that new personal associations and research activities develop in view of the urgent
need to alleviate the continuing burden of trypanosomiasis and other protozoan diseases on
the livestock and peoples of Africa. I wish you all a most successful and productive meeting.
  
  
Protein Phosphorylation in Trypanosoma brucei
T. ABOAGYE-KWARTENG, O.K. ole-MOIYOI and
J.D. LONSDALE-ECCLES
International Laboratory for Research on Animal Diseases
P.O. Box 30709, Nairobi, Kenya
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In the life cycle of African trypanosomes, the parasites differentiate through several morphologically
and biochemically distinct forms. In the bloodstream of the mammalian host, Trypanosoma brucei
differentiates from a rapidly dividing slender form to a non-dividing stumpy form. While it is clear that
this differentiation is important to the life cycle and survival of the parasite, the factors that control the
processes have not been identified.
The role of protein phosphorylation in both differentiation and transformation of eukaryotic cells is
well established. In Saccharomyces cerevisiae, cAMP-dependent protein phosphorylation is required
for cell cycle initiation.¹ In the fission yeast Schizosaccharomyces pombe, the cdc2 gene, whose
transcription is required at the start of the cell cycle and probably later in mitosis, encodes a
phosphoprotein with protein kinase activity.² Our objective in this study is to identify differentially
phosphorylated proteins in bloodstream Trypanosoma brucei and to determine their roles in the
differentiation from slender to stumpy form parasites. The basis of an experimental approach with a
phosphoprotein of unknown function was nicely formulated by Robinson, who said that: "One enters
the story in the middle by first targetting a phosphoprotein as a 'band on a gel' and then proceeding
both backwards (what protein kinase is responsible for its labelling?) and forwards (what is the
protein's function?)". This report describes the identification of two differentially phosphorylated
proteins and a partial characterization of the protein kinase(s) that phosphorylate them.
Methods
Preparation of trypanosome cytosolic fraction
Trypanosoma brucei brucei ILTat 1.1 was used in this study. The infection produced in laboratory
rodents is sufficiently synchronous to allow 100% slender and greater than 90% stumpy
trypomastigotes to be isolated on days 4 and 7, respectively, after infection. Trypanosomes were
grown in lethally irradiated rats and the percentage of stumpy forms on different days after infection
determined according to Ormerod.4 When the desired stage of parasitaemia was attained, the
trypanosomes were purified from blood elements by isopycnic Percoll gradient centrifugation5 and
DEAE-cellulose chromatography.6 The purified trypanosomes (5 x 1010) were suspended in 25 mM
Hepes, pH 7.0, 250 mM sucrose, 2 mM EDTA, 10 mM EGTA and 2 mM DTT with 40 m g/mL each of
the protease inhibitors leupeptin, antipain and E-64 and disrupted in a French Press at a pressure of
2,500 psi. The homogenate was centrifuged at 100,000 g for 60 minutes to give a cytosolic fraction
(HSS) and pellet (HSP).
Protein kinase assay
Assays were carried out in a total volume of 150 m l with the following components: 50 mM Tris-HCl
32
pH 7.2, 150 mM KCl, 10 mM MgCl2, 5 m M ATP, 10 m Ci [ P]ATP (5000 Ci/mmol), 150 m g of
protein and enzyme source (usually stumpy HSS). The reaction was carried out on ice for 10 minutes
and stopped by the addition of 50 m l 4 x SDS sample buffer (200 mM Tris-HCl pH 6.8,8% SDS,
40% glycerol and 4% 2-mercaptoethanol) and boiling for 5 minutes.
Electrophoresis
The phosphorylated proteins were separated by SDS polyacrylamide gel electrophoresis (SDS-
PAGE) according to Laemmli,7 using 7.5-15% polyacrylamide gradient gels. The gels were stained
with Coomassie blue, destained and dried. Radioactive protein bands were detected by
autoradiography. Quantitative measurement of phosphate incorporation into individual bands were
made by counting, in aquasol, the respective regions excised from the gel.
The phosphorylated amino acids recovered from protein bands of approximate Mr 42 and 37, which
had been electroeluted from SDS-PAGE gels, were determined using electrophoresis on cellulose
thin-layer plates.8
Results
Clear differences were observed in the profiles of the cytosoluble (HSS) phosphoproteins of
trypanosomes isolated between 4 and 7 days after infection (Figure 1). There is decreased
phosphorylation of a protein with Mr 80 kDa (pp80) with the change from the slender to stumpy form
parasite. However, all the work described in this paper is on the two proteins, with Mr of about 42
kDa (pp42) and 37 kDa (pp37), which show increased phosphorylation with the differentiation of the
slender to the stumpy parasite. Protein kinase assays of the nonsoluble fractions (HSP) show a
much lower level of phosphorylation of both pp42 and pp37, which suggests that both proteins are
predominantly cytosolic.
Trypanosome protein kinases are able to use both ATP and GTP as phosphoryl donors. Heparin,
which inhibits casein kinase II but not casein kinase I,9 inhibits the phosphorylation of pp42 but has
little effect on pp37 phosphorylation. Suramin, a trypanocidal polysulphated naphthylamine, was also
found to inhibit the activity of trypanosome protein kinases (50% inhibition at about 25 m M).
The metal ion requirements for the phosphorylation of both proteins suggest the presence of more
than one protein kinase in T. b. brucei.10 The optimum Mg2+ concentration for the phosphorylation of
pp42 is 10 mM. For pp37, however, the optimal Mg2+ concentration is 100 mM. The trypanosome
protein kinases can use Mn2+ at approximately five-fold lower concentrations than those required for
Mg2+.
Assays with enzymatic amounts of D7 HSS and a variety of substrates showed that the trypanosome
protein kinases can phosphorylate the acidic proteins casein and phosvitin but not the basic histones
or protamin (Figure 2). Analysis showed that both pp37 and pp42 are phosphorylated on serine and
threonine residues.
Discussion
Protein phosphorylation has emerged as a mechanism involved in the hormonal control of
metabolism in mature cells11 and in the changes in cellular activity associated with cellular
proliferation and differentiation.12 The work presented above demonstrates the coincidental
increased phosphorylation of two proteins (pp42 and pp37) with the differentiation of slender
bloodstream forms of T. b. brucei into the stumpy forms. Previous studies of T. b. gambiense have
shown the presence of multiple cAMP-independent protein kinases, which can phosphorylate
phosvitin, protamine and histones However, no endogenous protein substrates of these kinases were
determined.13 Our work has identified two differentially phosphorylated endogenous proteins in T. b.
brucei.
Our studies on the effects of metal ions on the phosphorylation of pp42 and pp37 suggest that the
two proteins are phosphorylated by different enzymes. This is in agreement with studies of T. b.
gambiense that have demonstrated the presence of multiple protein kinases.11
It has been shown that phosphorylation on both serine and threonine residues differentiates casein
kinase II activity from casein kinase I, which only phosphorylates serine residues. Casein kinase II is
also distinguished from casein kinase I in its ability to use both ATP and GTP as phosphoryl donors
in phosphotransferase reactions.9 Our studies with effectors are independent of cyclic-nucleotides,
calcium/calmodulin, and calcium/phospholipid. Phosphoamino acid studies on pp42 and pp37
showed that the amino acid residues phosphorylated were serine and threonine, thus implicating the
involvement of casein kinase II-like enzymes in these phosphorylations and eliminating the
involvement of tyrosine kinases. Further studies established the trypanosome protein kinases as
casein kinase II-like because of their ability to phosphorylate casein and phosvitin and their
stimulation by KC1.
Sensitivity to heparin inhibition has been used to differentiate casein kinase II from casein kinase I.9
We observed that while the phosphorylation of pp42 was sensitive to inhibition by heparin, the
phosphorylation of pp35 was relatively unaffected. However, recent studies in Xenopus laevis
oocytes10 and yeast14 have identified heparin-insensitive casein kinase II enzymes. Thus the validity
of using susceptibility to heparin inhibition as a criterion for distinguishing of casein kinase II from the
type I enzyme is questionable.
The polyamine spermine has been shown to activate casein kinase II.9 In contrast, we found that the
phosphorylation of pp42 was inhibited by spermine while pp37 phosphorylation was largely
unaffected. This further suggests that the two proteins are phosphorylated by different enzymes.
Another difference between the casein kinase II-like activity of trypanosomes and the enzyme
described from mammalian sources is the effect of polylysine and polyarginine. While the classical
mammalian enzymes are activated by these effectors, the low-density-lipoprotein-receptor kinase15
and the trypanosome enzymes are inhibited by them. Thus the inhibition studies show that the
protein phosphorylation in trypanosomes is inhibited by large negatively and positively charged
molecules.
In conclusion, we have identified two differentially phosphorylated proteins in T. b. brucei. The
proteins with Mr 42 and 37 kDa on SDS-PAGE are more heavily phosphorylated in the stumpy
parasite than in the slender. The activities of the enzymes that phosphorylate the proteins are
independent of cyclic-nucleotides, calcium/calmodulin or calcium/phospholipids. The trypanosome
protein kinases are casein kinase II-like but show some significant differences from the classical
mammalian casein kinases.
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Figure 1. Protein phosphorylation of the cytosoluble fraction (HSS) of trypanosomes isolated
4-7 days after infection. The proportions of stumpy-form parasites in the trypanosomes
isolated on days 4, 5, 6 and 7 were approximately 0, 10, 70 and 95%, respectively. Three
proteins were differentially phosphorylated: a protein with Mr of 80 kDa (pp80) decreased in
phosphorylation with increasing proportion of stumpy-form parasites, whereas the other two
proteins, with Mr 42 kDa (pp42) and 37 kDa (pp37), showed increasing phosphorylation with
an increasing percentage of stumpy parasites.
Figure 2. Trypanosome protein kinases can phosphorylate the acidic proteins casein and
phosvitin. The lanes show kinase assays done with 5 m g D7 HSS alone (1), 150 m g D7 HSS
(2) and 5 m g D7 HSS + 5 mg/mL casein (3), phosvitin (4), protamine (5), histone 2A (6) and
histone VS (7).
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Morphological and functional changes occur in erythrocytes infected with malarial parasites.
These erythrocyte alterations appear to relate to the capability of malarial parasites to change
the properties of the erythrocyte and its membrane in order to export malarial proteins from the
parasite to the host erythrocyte membrane. Although the significance of these changes are not
clear, they appear to be involved in the development of malaria-related complications in the
host.
In my presentation, the host cell alterations induced by primate parasites, including
Plasmodium falciparum, P. brasilianum, P. vivax and P. malariae infections, will be discussed
and the trafficking of these malarial proteins from the parasite to the erythrocyte membrane will
be described.
Erythrocyte Changes Induced by P. falciparum
Plasmodium falciparum infection induces morphological changes in erythrocytes that include
(1) knob-like protrusions of the erythrocyte membrane, (2) clefts in the erythrocyte cytoplasm
and (3) electron dense material (EDM) in the erythrocyte cytoplasm. 3,8
Electron dense material and clefts appear to be associated with the formation of knobs. EDM
is seen associated with the plasma membrane of intracellular parasites and is also associated
with unit membrane-bounded Maurer's clefts. This EDM has the same density and
appearance as the material located under knobs at the erythrocyte membrane.4
Immunoelectron microscopy has demonstrated that EDM and knobs contain P. falciparum
antigens. Thus, the parasite-derived EDM appears to be transported from the parasite
plasmalemma to the erythrocyte membrane via clefts in the erythrocyte cytoplasm.
At least four malarial proteins (HRP1, HRP2, EMP1 and EMP2) have been identified in the
surface of P. falciparum-infected erythrocytes. Three of these proteins - HRP1, EMP1 and
EMP2 - are localized in knobs as demonstrated by immunoelectron microscopy. The presence
of histidine-rich proteins in HRP1 is an important factor in knob formation,9 and a histidine
analogue, 2-fluoro-L-histidine, reduces the formation of knobs and increases the amount and
density of EDM.5 This indicates that this histidine analogue blocks export of EDM from the
parasite to knobs, thereby inhibiting knob formation.
The knobs have cytoadherence activity to the endothelial cells11 and are responsible for
sequestration of infected erythrocytes in organs such as the spleen, pancreas, heart and brain.
Host cell molecules such as OKM56 and thrombospondin 12 have been suggested as
endothelial cell surface receptors for the knobs of P. falciparum-infected erythrocytes. By
acting independently or together, these proteins could play a role in cytoadherence of knobs in
vitro.1
Movement of the P. falciparum Protein to the Erythrocyte Membrane
Resulting in Lysis of the Erythrocyte and Release of Gametes
During erythrocyte invasion by merozoites, a molecule (Pf155/RESA) is injected by the
parasite into the erythrocyte membrane and the entire membrane becomes covered with
Pf155/RESA.14 During differentiation of the parasite to the trophozoite stage, the antigens, as
detected by immuno-gold labelling, are no longer detectable on the erythrocyte membrane,
while gold particles become more numerous within the parasite and in the erythrocyte
cytoplasm adjacent to the parasite. As the parasites develop into schizonts, more antigen
appears within the parasite and some of it appears to diffuse into the erythrocyte cytoplasm.
At the segmented schizont stage, many intraparasitic gold particles are associated with
rhoptries and micronemes of developing merozoites.14
In addition, Pf155/RESA appeared to be associated with gametocytes. Therefore, using a MAb
to Pf155/RESA and rabbit sera to two different repeat peptides of Pf155/RESA, we studied the
location of Pf155/RESA after induction of gametogenesis. Five minutes after gametogenesis
was triggered, the parasitophorous membrane no longer surrounded the parasites, bringing
the parasite membrane in contact with erythrocyte cytoplasm. Clear spaces appeared
throughout the haemoglobin-rich host cytoplasm. Pf155/RESA was now localized in the
haemoglobin directly surrounding the spaces. No membrane existed between the spaces and
the haemoglobin. The spaces with surrounding malarial protein extended to the erythrocyte
membrane. After lysis of the erythrocyte membrane, the antigen was distributed along the
erythrocyte membrane and throughout the space between the gamete and the erythrocyte
membrane.
Our study, therefore, indicates that Pf155/RESA antigen is responsible for disrupting the red
blood cell cytoplasm and lysing the erythrocyte plasma membrane, thereby allowing release of
P. falciparum gametes from their host cells.
Erythrocyte Changes Induced by P. brasilianum Infection
Plasmodium brasilianum is a quartan malarial parasite of New World monkeys. A close
evolutionary relationship between P. brasilianum and the human malaria parasite, P. malariae,
is suggested by analogies in their morphology and course of their development in primate
hosts.
Erythrocyte changes include the formation of knobs on the infected erythrocyte membrane and
clefts in the erthrocyte cytoplasm.7 The knobs are similar to those seen in P. falciparum-
infected erthrocytes. The cytoplasmic clefts can be divided into three morphological types,
namely, short, long and circular clefts. Recently a series of monoclonal antibodies (MAbs)
against blood stages of P. brasilianum has been developed that reacts with knobs and clefts
as detected by immunoelectron microscopy.
MAbs that recognize an antigen of 38 kDa molecular weight reacted with short clefts.
Immuno-gold particles appeared over short clefts and were not associated with long clefts,
reflecting the specificity of binding of these MAbs to short cleft antigen.7 MAbs that recognize
an antigen of 16 kDa molecular weight reacted with long clefts and also with the
parasitophorous vacuole membrane (PVM). The long clefts appear to be continuous with both
PVM and IRBC membranes. Immunoelectron microscopy identified the presence of 14, 16 and
19 kDa malarial proteins in knobs.
The difference in antigenic composition between short and long clefts has not been reported
for any plasmodial species. That the long cleft antigen was associated with the PVM and the
short cleft antigen was not suggests that different mechanisms incorporate the two antigens
into their respective clefts.7 The clefts have been suggested to function in the transport of
knob materials, as demonstrated in P. falciparum-infected erythrocytes. However, cleft and
knob antigens of P. brasilianum are immunologically distinct. It is possible that the nature of
antigens being transported via clefts varies with the stage of parasite development and that
early in the parasite life cycle, knob proteins are principally transported. At a later stage of
development, the antigenic composition of the clefts might change.
The relationship between knob proteins of P. brasilianum and P. falciparum remains unclear.
Although the knobs of P. falciparum-infected erythrocytes have cytoadherent activity, those on
P. brasilianum-infected erythrocytes do not appear to possess cytoadherent functions. Further
studies may be required to determine the function of the knobs that appear on the membrane
of erythrocytes infected with P. brasilianum.
Erythrocyte Changes Induced by P. vivax
Erythrocytes infected with vivax-type malaria parasites are characterized by Schuffner's dots,
which appear as multiple small brick-red dots in Giemsa-stained thin films. Electron
microscopy demonstrated that Schuffner's dots are composed of caveola-vesicle complexes
(CVC).2 This structure consists of caveolae to which vesicles are attached in an alveolar
fashion. Another host cell alteration observed within the infected erythrocyte cytoplasm is
cytoplasmic clefts.
Recently investigators produced a series of MAbs against various antigens of erythrocytic
stages of P. vivax. Among them, MAbs that identified a 95 kDa 35 S-methionine-labelled P.
vivax protein produced a stippled pattern similar to Schuffner's dots in P. vivax-infected
erythrocytes. Other MAbs that reacted with a 28 kDa 35S-methionine-labelled protein gave a
linear pattern by immunofluorescent microscopy.10
To identify the precise location of P. vivax antigens that react with these MAbs, we perfommed
post-embedding immunoelectron microscopy. MAbs against a 95 kDa 35S-methionine-labelled
protein gave a pattern similar to that of Schuffner's dots by the immunofluorescence test (IFA).
Immunoelectron microscopically specific label was found by immunoelectron microscopy to be
associated with vesicles of the CVC, whereas only a few gold particles were associated with
the caveolae. Vesicles scattered throughout the erythrocyte cytoplasm were also labelled with
gold particles.
Other MAbs that react with a 28 kDa parasite protein gave a linear pattern in the cytoplasm of
infected erythrocytes by IFA. Immunoelectron microscopy clearly revealed that the target
antigen of these MAbs was located along the cytoplasmic clefts of infected erythrocytes.
Immunoreactivity was also observed in association with vesicles scattered in the erythrocyte
cytoplasm and vesicles of the CVC.
A double-labelling technique was applied to localize the 28 kDa and 95 kDa antigens in the
same erythrocyte. The small gold particles identified the 95 kDa antigenic sites, while the large
gold particles identified the 28 kDa antigenic sites. Immunoelectron microscopy demonstrated
that small gold particles were associated only with vesicles and most of the large gold
particles were seen in clefts. Some large particles, however, were found in association with
vesicles together with small particles. Thus, double-labelling confirmed that the vesicles
contained predominantly the 95 kDa antigen and some of the 28 kDa antigen, whereas clefts
were associated only with the 28 kDa antigen.
The presence of P. vivax antigens in clefts and CVC indicates that these structures are related
to trafficking of P. vivax antigen from the parasites to the erythrocyte surface membrane.
Some P. vivax proteins, at least the 28 kDa protein, are transported from the parasite to the
parasitophorous vacuole and to the clefts. The proteins are then transported along clefts and
transferred to vesicles. The proteins moved toward the erythrocyte surface and into the
caveola space. The proteins are then released from the caveola extracellulary. The vesicles
might be formed by budding from the tips of lamellate clefts, similar to Golgi vesicles that are
pinched off from the Golgi stack. On the other hand, a 95 kDa protein is present only within
the vesicles and not in the clefts. This could indicate that the vesicles containing a 95 kDa
protein may originate directly from the parasitophorous vacuole membrane. These
observations indicate that host cell changes induced by P. vivax are involved in trafficking of
P. vivax antigens to the erythrocyte membrane.
Conclusions
Host cell alterations induced by P. falciparum-, P. brasilianum- and P. vivax-infections were
described by electron microscopy and post-embedding immunoelectron microscopy.
Plasmodium falciparum infection induces knobs, electron dense material and clefts in the
erythrocyte. Clefts are involved in exporting P. falciparum antigen from the parasite to the
erythrocyte membrane. P. falciparum antigen is present in knobs that adhere to endothelial
cells, causing the blockage of capillaries. Pf155/RESA, one of P. falciparum antigens, appears
to lyse the erythrocyte cytoplasm and to assist in the release of gametes from the erythrocyte.
Plasmodium brasilianum infection induces knobs, short and long clefts and electron dense
material, which are engaged in trafficking of P. brasilianum protein from the parasite to the
erythrocyte surface. P. vivax infection induces caveola-vesicle complexes and clefts in the
erthrocyte. They are also involved in trafficking of P. vivax protein from the parasite to the
erythrocyte membrane. Our studies, therefore, indicate that host cell changes occurring in
various species of malarial parasites facilitate the transport of malaria antigens to the host cell
membrane.
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Membranes are in constant flux with their surroundings. They exchange molecules with other membranes and
receive or give up additional molecules in tune with the cell's physiological requirements. Some membranes
can suddenly grow larger or retract in area. To alter membranes, the cell sometimes replaces an existing
membrane with relatively large areas of preformed membrane while the putative original membrane is being
removed as small vesicles. Thus, the cell has the capacity to modify its membranes to fit immediate as well as
ongoing requirements.
As a hypothesis, we are proceeding in our research on the assumption that a given membrane can be
modified in situ to provide for changing roles. The well-documented receptor clustering into coated pits, and
the sorting out and return of the receptors to the plasma membrane following ligand release in some types of
receptor-mediated endocytosis,1,2,3 involves modifications of this type, albeit on a more limited scale than we
envision possible. To test for broader possibilities of this hypothesis, we are investigating the membranes of
the system of the free-living protozoan Paramecium. These membranes are ideally suited to such a study
because of the numerous functions they must assume in the life of a vacuole and their well-documented
highly plastic nature.
Phagosome-lysosome membranes perform a range of critical functions for the cell. (1) The phagosome
membrane encloses entering food and particulate matter and maintains an unbroken hydrophobic barrier
between these potentially harmful substances and the cell's cytosol. (2) The mature phagosome membrane
encloses a highly acid environment during the process of prey killing and digestion and probably contains the
mechanism for the acidification of the phagosome. (3) These membranes protect the cytosol from digestive
enzymes. (4) These membranes facilitate the movement of the products of digestion into the cytosol
subsequent to the selective entry of acid hydrolases into the phagosome. (5) Finally, the various membranes
of the phagosome-lysosome system have the capacity to recognize other membranes in a time-dependent
preprogrammed manner.
The intent of this short review will be to illustrate the way the fine structure of one membrane is modified in
synchrony with the changing state of the space enclosed by the membrane and to explain how this
modification is brought about. Figure 1 provides a guide to the structures and membranes discussed in this
paper.
Membranes Belonging to the Phagosome-Lysosome System
We have recently been able to determine with some certainty the total range of membranous vesicles and
structures in Paramecium that can be considered part of the phagosome-lysosome system.4 Using the lectin
wheat germ agglutinin (WGA), all membranes previously known to be related to this system were labelled.
These included not only those membranes around the discoidal vesicles, digestive vacuoles of undetermined
stage, Lysosomes (shown by Lüthe and Plattner to bind to WGA-gold on Lowicry 1 K4M sections), but also the
acidosomes, the trans cisterna of the Golgi stack, a reticulum of membranes answering the description of the
trans-Golgi network and a continuum of vesicles ranging from 70 nm to 500 nm or more.4 Using WGA-gold on
frozen-thin sections of cells, which had been serially pulse-fed with latex beads of a different size for each
pulse and with the pulses interspersed with appropriate chase times allowing the labelled vacuoles to reach
predetermined stages, we have shown conclusively that all vacuole stages label with WGA. Because the
labelling with WGA is completely inhibited by triacetylchitotriose and because Paramecium seems to lack sialic
acid,6 we conclude that these membranes may be distinguished from other membranes by having in common
a glycocalyx containing either b -(1-4) oligomers of N-acetyl-glucosamine (b -(1-4) GlcNAc) or a very high
content of GlcNAc. No label was found on the plasma membrane or coated pits at the cell surface. However,
the membranes of crystal-containing compartments were heavily labelled, suggesting that these structures are
related to the phagosome-lysosome system.
Having determined the full range of membrane-bound compartments associated with the phagosome-
lysosome system, we can now look at the characteristics of its subdivisions.
Characteristics of the Cytopharynx and Nascent Phagosome Membrane
Freeze-fracture images7 as well as deep-etch, rotary shadowing (unpublished observations) show the
membrane of the cytopharynx to have a highly particulate E-fracture face unlike the plasma membrane with
which it is continuous. Discoidal vesicles have an identical E-fracture face. These two membranes also bear a
glycocalyx of identical appearance and thickness (10 nm).8 In addition, their similarities to each other and
dissimilarities from other membranes of the phagosome-lysosome system are shown by the existence of a
monoclonal antibody9 that binds only to epitopes found on these two membranes.10 These similarities, along
with the morphological evidence of discoidal vesicles that have fused with the cytopharynx11, indicate that
nascent phagosomes obtain their membrane from the pool of discoidal vesicles.
Evidence for in Situ Membrane Modification
Again, freeze-fracture evidence has shown that the membrane of the early phagosome (also termed DV-I
stage) is very quickly and dramatically altered so that by 15 sec to 1 min after pinching off from the
cytopharynx its membrane no longer contains the high number of intramembrane particles (IMPs) on its E-
fracture face but now is almost entirely devoid of IMPs.7 These particles are not simply transferred to the P-
fracture face because the IMP number on this face remains about the same. The phagosomes at this stage
are termed DV-II. The glycocalyx of the membrane of these DV-II phagosomes are also altered by being
reduced to a slightly uneven 7 to 10 min in thickness.8
This membrane is identical in freeze-fracture12 and glycocalyx8 appearance to a set of fairly large vesicles
that bind to the nascent phagosome and travel with the phagosome to the cell's posterior pole. At the pole the
vesicles are seen to fuse with the phagosome.13 Studies with weak bases such as neutral red and acridine
orange show that these vesicles are acidic and, furthermore, the phagosome becomes acidic after, but not
before, these vesicles have fused with the phagosome.14 Prevention of fusion by the application of
cytochalasin B inhibits phagosome acidification. Thus, we have termed these vesicles acidosomes.14
Acidosome and acidified-phagosome (DV-II) membranes have equal concentrations of prominent particles on
their P-fracture faces 7,12 which is quite different from the P-fracture face of the DV-I.7 The relationship
between DV-II and acidosomes is further demonstrated by the unique presence of epitopes for a second
monoclonal antibody,9 which reacts with no other DVs.10 These epitopes are also found in the crystal-
containing compartments (unpublished observation). We have always been impressed by the fact that the
contents of acidosomes resemble the contents of the extracellular space in freeze-fractured replicas. This
resemblance is even more pronounced in deep-etched images (unpublished observation). In NH4Cl studies
we see that these acidosomes are sometimes labelled with horseradish peroxidase within a very short time,
as short as 1 sec, following exposure of the cells to this enzyme marker (unpublished observation). Yet we
have so far been unable to determine the origin of these acidosomes. Using deep-etch techniques following
rapid freezing of living cells, we have recently observed a previously unrecognized set of small vesicles
aligned along the same microtubules at the cytopharynx to which discoidal vesicles are attached (unpublished
observations). Though not yet studied in detail, their proximity to the site at which acidosomes bind to
phagosomes suggests a possible role for these vesicles in the formation of acidosomes should they coalesce
to form the larger vesicles.
Our evidence thus suggests that shortly after they are formed phagosomes undergo a radical membrane
replacement12 during which the original membrane is removed by vesiculation and the membrane remaining in
the DV-II is, for the most part, derived from that of the acidosomes. The timing of this change corresponds to
the time when the phagosome becomes acid, beginning at about 1 min and reaching a maximum acidity at
about 5 min into the digestive cycle. 12
At this time Lysosomes can approach and bind to the DV-II. Lysosome membranes have a moderate number
of very prominent IMPs on their E-fracture faces7 and an extensive 30 nm thick glycocalyx lining their luminal
surface.8 Lysosomes also bear epitopes not shared by discoidal vesicles, acidosomes or the phagosomes.10
However, the membranes of phagolysosomes (DV-III) resemble Lysosomes in IMP number and distribution,7
appearance of their glycocalyxes8 and in monoclonal antibody specificity.10 Thus, the vacuole membrane has
undergone another substantial modification, which occurs concomitant with fusion of Lysosomes beginning 8
minutes into the cycle.15
The DV-III now contains acid phosphatase activity for the first time.l6 The pH then rises dramatically.15 By the
time the pH has returned to 6 or 7, digestion is presumably completed and a final membrane modification
begins. Portions of the planar membrane are remolded into long tubules of a diameter of 45 nm, which contain
acid phosphatase activity.l7 These tubules expand at their distal ends into vesicles that resemble Lysosomes
in all ways, IMP appearance,17 glycocalyx appearance,l7 acid phosphatase activity17 and the presence of
epitopes for the lysosome-specific monoclonal antibody (unpublished observation).
Vacuoles become defecation competent, under the axenic growth conditions we routinely use, at around 20
min.15 However, defecation of the labelled vacuoles in a population of cells follows an exponential pattern. The
rate of defecation depends to a marked extent on the rate of vacuole formation.18 The membranes of these
spent vacuoles (DV-IV), which are now acid phosphatase-negative,16 have not been studied extensively but
they are probably quantitatively rather than qualitatively different from membranes of the DV-III
phagolysosomes.
Fates of the Different Pools of Membrane Incorporated into the Membrane of
Phagosomes or Phagolysosomes
At this stage in our story, solid evidence becomes scarce. Discoidal vesicle membrane seems for the most
part to be retrieved soon after phagosomes are formed. Only one or two phagosomes per cell react with
monoclonal antibodies specific for the discoidal vesicle and nascent phagosome membranes.9 We presume
this membrane can be recycled to the cytopharynx for new phagosome formation but we have no hard
evidence for this. The second group of monoclonal antibodies that are specific for acidosomes also bind
strongly to a few vacuoles near the cytopharynx,9 but these epitopes seem to be diluted out of the vacuole
membrane with time. However, even spent DV-IV contain some epitopes for the latter group of monoclonal
antibodies.9 Lysosome membrane is retrieved from the older DV-III. Whether this retrieval is in bulk or is
composed of only certain components of the Lysosomes is not known. Thus the spent vacuole membrane may
be composed of a mixture of phospholipids derived from the three vesicle populations and may contain an
assortment of glycoproteins and proteins retained in the vacuole membrane that were not sorted out and
retrieved at earlier stages. Spent vacuole membrane apparently does not bear epitopes for discoidal vesicles,
only a low level of epitopes for acidosomes, and few, if any, epitopes for Lysosomes. Spent vacuole
membrane like other vacuole membranes is, however, highly reactive for WGA.4
Once the vacuole is defecated, the DV-IV membrane is retrieved as tubules and vesicles of different shapes.19
At least some of these vesicles become discoidal, attach to microtubular ribbons and move toward the
cytopharynx.20 This portion of the spent vacuole membrane is recycled as discoidal vesicles. With our new
evidence for another set of small spherical vesicles, we will need to see if these arise also from the cytoproct.
Horseradish peroxidase is inactivated below pH 5,21 so we will need to use another marker to be certain we
do not miss vesicles that might have a very acid lumen.
Discussion and Conclusions
Morphological and monoclonal antibody studies provide conclusive evidence for the extensive in situ
modification of an existing membrane that follows the changing physiology of the space that it surrounds.
These changes can be explained for the most part by the insertion and retrieval of vesicular membrane of
different vesicle populations. Whether slower membrane changes can occur by intercalation of individual
molecules of proteins and phospholipids is not known.
Membrane modifications such as those reported here can be very fast and can involve large amounts of
membrane surface area. To carry out such a rapid change, the cell sequesters preformed membrane around
the membrane to be modified. This sequestered membrane is poised to fuse with only a limited subset of the
vacuole population of the cell. Specific recognition factors must be present on the cytosolic side of the
membrane of this subset of vacuoles to provide binding sites for only one specific set of vesicles. The nature
of these recognition factors is completely unknown. Nor is anything known about the triggers that cause the
vesicles to fuse.
The putative recognition factors presented on the cytosolic vacuole surface must be replaced with time since
acidosomes and, later, Lysosomes bind to the same vacuole. This replacement of recognition factors may be
brought about by the addition to the vacuole membrane of vesicular membrane bearing the required
recognition sites. Yet the answer is probably not this simple. In the case of lysosome binding, recognition sites
for Lysosomes could be added to the vacuole during acidosome fusion, but Lysosomes do not bind directly to
vesicular acidosomes free in the cytoplasm. Other factors must be active in the proper presentation of the
putative recognition factors in a form that can be recognized by the vesicles.
Those aspects of membrane traffic in the phagosome-lysosome system in Paramecium remaining to be
worked out include the origins of acidosomes and the identification of all sources of discoidal vesicles, that is,
do these vesicles have any origin than that from the membrane itself. The ultimate origin of the lysosome
membrane appears to be from the trans-Golgi network and the Golgi stacks.4 This membrane may represent
the source of new membrane entering the system. Of immediate concern is the determination of the amount of
intermixing of membrane components from separate sources and the determination if the cell has the capacity
to sort and retrieve, as a package, those components that comprise uniquely acidosome, discoidal vesicle and
lysosome membrane components. These questions are being studied using both morphological and
biochemical techniques.
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Figure 1. Schematic drawings of membrane flow and modifications in the phagosome-lysosome
system of Paramecium. A. View of Paramecium from the dorsal surface. The anterior end (A) is to the
left and the right side (R) is at the top. The buccal cavity (BC) is in a mid-ventral location and is
continuous with the cytopharynx (CYX), where nascent phagosomes (NDV) form. Ribbons of
microtubules fan out from the cytopharynx, directing discoidal vesicles (DCV) to this region.
Acidosomes (AC) bind to the NDV as it forms and travel with the phagosome (DV-I) as it moves along
the postoral bundles of microtubules (POM) toward the cell's posterior pole. Fusion of the
acidosomes and retrieval of DV-I membrane results in a smaller and acidified DV-II which binds to
lysosomes (LY). Fusion of the lysosomes with the DV-II leads to a DV-III or phagolysosome. After
digestion, lysosome components are retrieved, mix with primary lysosomes (pLY), which bud from the
Golgi stack (GS) and/or the trans-Golgi network (TGN), and eventually bind to another DV-II. The spent
vacuole (DV-IV), from which lysosome membrane components and acid phosphatase are removed,
passes to the cytoproct (CYT), where it is defecated. Spent vacuole membrane is retrieved as tubular
vesicles, some of which become discoidal vesicles. B. Membrane especially on the E-fracture face (E)
but also on the P- fracture face (P). Another modification occurs in the appearance of the glycocalyx
(gly) lining the luminal side of vesicle and vacuole membranes. The cytosolic (cyto) side of the
membranes has not been studied but must bear recognition factors. In addition, different populations
of vesicles have different antigenic binding sites, which are indicated here as circles, squares and
rectangles on the luminal sides of the membranes. The precise location of these antigenic sites is not
known.
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Cells constantly sample their environment by internalizing portions of the extracellular fluid and
carrying the fluid in membrane-bound vacuoles to various intracellular targets. The efficiency
of this process is increased when receptors for extracellular molecules are located at sites of
internalization, a process called receptor-mediated endocytosis.¹ For nearly 24 years the
clathrin-coated pit has been implicated as the major site of internalization for receptor-bound
ligands.1,2
There are two components to coated pit function. First, the polygonal lattice of clathrin or the
clathrin associated proteins control the shape of the membrane leading to the formation of a
coated vesicle. Second, molecular elements in coated pits cause certain membrane receptors
to cluster so that when a ligand binds it is rapidly internalized.2 The goal of current research
efforts, therefore, is to understand at the molecular level how invagination and receptor
clustering are achieved.
The evidence that coated pits mediate the internalization of receptor-bound molecules is
almost entirely derived from microscopic studies. The first description of this specialized region
of surface membrane provided a confusing picture of its possible function;3 some researchers
even thought coated pits were an artifact of tissue preservation. The observation that the
number of coated pits is increased in oocytes that are internalizing yolk proteins,4 as well as
the finding that ferritin binding sites are located over coated pits of reticulocytes,5 were two
findings that suggested a function for this region of membrane. Beginning with the discovery of
the low-density lipoprotein (LDL) receptor in coated pits,6 there are now some 20-25
molecules or macromolecular complexes that have been found to enter cells by this route.2
The list will undoubtedly grow; however, in each case the identification of the route of entry will
depend upon microscopic techniques.
While progress has been made in identifying the receptors that use this internalization
mechanism, researchers have made rapid progress in isolating coated vesicles, identifying
and characterizing coated vesicle proteins, and delineating the architecture of the polygonal
coat.7,8 Although many of the coat proteins have been identified and it is now possible to use
them to assemble coated vesicles7 as well as coated pits9 in vitro, we know nothing about
how coated pits function.
Inhibitors of Coated Pit Function
Despite the widespread morphologic documentation that certain ligands enter cells by coated
pits, it is possible that static electron microscopic images do not reveal the true pathway of
internalization. For this reason, many investigators have searched for drugs or culture
conditions that would affect the function of coated pits in some informative way. Whereas
there is no drug or chemical that specifically interferes with coated pit function, there are at
least three culture conditions or treatments that profoundly affect coated pit function: depletion
of intracellular potassium,10 incubation of cells in a hypertonic medium11,12 and acidification of
the cell cytoplasm.13 Each treatment affects coated pits in a different way, which gives clues
about the role of the clathrin lattice in endocytosis.
Larkin et al., 10 were the first to describe a method for inhibiting receptor mediated
endocytosis. Using 125 I-labelled low density lipoprotein (LDL) as an endocytic marker, they
found that when the level of intracellular potassium was lowered in cultured human fibroblasts
below 40% of normal, the internalization of LDL was inhibited. Moreover, under conditions of
maximal inhibition, these cells had a reduced number of coated pits on the cell surface;
greater than 80% of the coated pits were missing. Daukas and Zigmond2 reported that the
receptor mediated internalization of chemotactic peptide was inhibited in cultured
polymorphonuclear leukocytes that had been incubated in a hypertonic medium. Hypertonic
medium affects the endocytosis of LDL11 as well as bulk phase markers. 11 As judged by
immunofluorescence and electron microscopic evaluation of the inner surface of rapid-freeze,
deep-etched membranes, cells incubated in a hypertonic media have a markedly reduced
number of coated pits.11 Finally, Sandvig et al.,13 found that when intracellular pH was
lowered below pH 6.0, there was a dramatic and specific inhibition of endocytosis through
coated pits. Unlike potassium depletion and hypertonic treatment, cells that are treated in this
manner have normal numbers of coated pits; however, these pits appear to be paralyzed and
unable to internalize ligand.
These studies imply that when clathrin lattices are absent from the surface membrane, a cell is
unable to internalize receptor-bound molecules. Moreover, they indicate that the clathrin lattice
has some direct role to play in the endocytic event because in acidified cells the lattice is still
present but apparently unable to function. The exact reason for the effects of these agents on
coated pit structure and function are not known. Therefore, these studies have failed to identify
the active components that account for receptor clustering and invagination.
More than likely, the development of additional inhibitory treatments will not have sufficient
molecular resolution to elucidate how coated pits achieve their endocytic function in cells. For
this reason, there has been widespread interest in the development of in vitro methods for
studying endocytosis.14,15,16 Our laboratory has focused on developing a method for preparing
isolated plasma membranes that are capable of reproducing part or all of the endocytic cycle
in vitro.
Reconstitution of the Endocytic Cycle in Vitro
The endocytic cycle in intact cells has several components:2 (a) receptor clustering over
coated pits; (b) invagination of the coated pit to form a coated vesicle; (c) removal of the coat
from the vesicle to form an endosome; (d) the sorting of receptor from ligand in an early
endosome compartment; (e) the return of the receptor in a transport vesicle to the cell surface;
(f) the movement of the ligand to a specific intracellular target such as the lysosome; and (g)
the formation of a new coated pit at the cell surface. Our goal has been to develop the
methodology needed for studying each step in vitro.
To accomplish this goal, we reasoned that we needed large numbers of isolated plasma
membranes attached to a solid substratum by the extracellular surface.9 In these membranes,
the numerous coated pits would be available for experimental manipulation. The method we
chose relied upon the ability of cells to attach to a poly-L-lysine coated surface. The bulk of
the cell can easily be removed by gentle sonication, leaving behind the plasma membrane.
Since the membranes can be prepared on a variety of different surfaces, it is possible to
analyse coated pits using carbon platinum replicas, indirect immunofluorescence or
radioimmunoassay. With appropriate monoclonal antibodies, clathrin as well as important
receptor molecules such as the LDL receptor can be easily detected by both visual and
quantitative techniques.
Thus far our main focus has been on using these membranes to study coated pit assembly.
The endogenous coated pits can be removed by brief treatment with a high pH buffer. This
leaves behind sites on the membrane that are capable of initiating the formation of coated pits
when suitable coat proteins are available. Cytoplasm prepared from tissues or cells can serve
as a source of clathrin and clathrin associated proteins.9 Some of the important conclusions
from these studies include: (1) clathrin and clathrin associated proteins are recruited from the
cytoplasm to the surface of the cells and form normal appearing coated pits; (2) the
membranes contain a limited number of assembly sites; (3) assembly occurs equally well at 4
°C and 3 °C with a half time of assembly of approximately 5 mini (4) assembly seems not to
require a source of ATP; (5) when assembly is carried out at 37 °C, after initial assembly there
is a rapid disappearance of the clathrin from the membrane, and this disappearance is
inhibited by the ATP-destroying enzyme apyrase.
We have used this system to determine whether it is possible to assemble a coated pit from
coat proteins that have been extracted from isolated coated vesicles.17 These coat proteins
will form normal coated pits and the assembly reaction shares many of the properties
described above.
This membrane preparation has also afforded us the opportunity to investigate whether the
assembly sites have specific ultrastructural features as viewed in carbon platinum replicas of
rapid-freeze, deep-etched membranes. The stripping procedure always leaves behind 20-30%
of the clathrin that was originally on the membrane.9 The replicas reveal that this clathrin is in
the form of incomplete polygons that are occasionally seen on the membrane. More
importantly, these incomplete polygons are associated with well-defined particles that are
arranged into clusters the size of a coated pit. These particles account for the fact that in
stereo images, the flat lattices on unstripped membranes appear to be raised above the
surface of the membrane; in other words, there's a definite molecular linkage between the
clathrin lattice and the membrane. At least one component of the particles making up the
assembly site most likely is the 100-50 Kd assembly complex identified by several laboratories
as involved in coated vesicle assembly.18 19
More recently, we have turned our attention to investigating whether the coated pits that are
on these membranes are capable of rounding up and pinching off to form a vesicle. Although
we have yet to prove definitively that endocytic vesicles can form from these membranes, we
have found that the clathrin lattices will spontaneously round up when the temperature is
shifted from 4 to 37 °C and that attendant with the rounding up process is the loss of clathrin
from the membrane. The loss of clathrin is inhibited at pH below pH 6.0 and by treatment of
the membranes with apyrase. Therefore, the behaviour of the clathrin coated pits in these
isolated membranes is what one would predict based on the extensive morphologic studies
carried out on a variety of cell systems.
Future Directions
To understand the molecular basis of coated pit function, it will be necessary to exploit an in
vitro system such as the one we have developed. There is much to learn about the assembly
phase. For example, we would like to know the nature of the assembly sites and whether or
not their activity depends upon the assembly protein complex. More importantly, we would like
to identify the membrane determinants that specify where and when a coated pit will form.
We are also optimistic that we will be able to use this system to study the invagination phase
of endocytosis. If we can recreate this event and find conditions that lead to endocytosis, then
there are innumerable studies that will be possible, ranging from the use of recombinant
clathrin to the study of mutations that effect endocytosis. Ultimately, we would like to
understand coated pits as dynamic cellular structures.
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I shall review the ability of two particular proteinases to degrade extracellular connective tissue
matrix components. Such activity is an essential aspect of the invasion of the tissues of the
mammalian organism either by tumours or by parasites. Other pathophysiological situations in
which such degradation is important include the remodelling of tissue structures in
development and wound healing. The enzymes I shall consider are two cysteine
endopeptidases.
The terms "endopeptidase" and "proteinase" are completely synonymous; "proteinase" is more
familiar to most people, but "endopeptidase" is more rational, and is the term that we should
use in the future.1 Biochemists divide endopeptidases into four classes on the basis of the
chemical groups responsible for their catalytic activity: these are the serine, cysteine, aspartic
and metallo-endopeptidases.² It happens that representatives of all four groups are involved to
a greater or lesser extent in the degradation of extracellular matrix components. Much recent
work has emphasized the role of metallo-endopeptidases such as collagenase and serine
proteinases such as leukocyte elastase. These enzymes have neutral pH optima, which
obviously suit them well to extracellular activity, but the cysteine and aspartic endopeptidases
have their part to play also.
One of the cysteine endopeptidases that I shall deal with is one from the Lysosomes of human
cells, cathepsin L, and another is from the parasitic protozoan, Entamoeba histolytica, that we
have called histolysin. I shall also mention the endogenous inhibitors that control the activities
of these enzymes in the human body.
Cathepsin L
Human cathepsin L was first purified from liver, by Dr Rob Mason, in our laboratory.³ The
amino acid sequence of the N-terminal part of the molecule shows a close evolutionary
relationship with papain.4
One of the first natural substrates of cathepsin L to be discovered was Type I collagen.5 Much
more recently we have discovered that cathepsin L also degrades elastin.6 Perhaps still more
relevant to the issue of tissue invasion is the finding that cathepsin L is active on basement
membrane collagen.7 There is good reason to think that the ability to penetrate basement
membranes is an important property in invasion.
I have broached the subject of the activity of cathepsin L against extracellular proteins without
considering the question of whether the enzyme appears outside cells. Although usually
considered an intracellular enzyme, cathepsin has been shown to be secreted from cells
under conditions in which the degradation of matrix components occurs. Cells particularly
active in the secretion of this and other Lysosomal enzymes include macrophages and
osteoclasts. These cells are also known to create pericellular regions of acidic pH that are well
suited for the extracellular action of the enzymes. It is therefore our view that cathepsin L is
one of the battery of enzymes that play a part in the remodelling of connective tissue elements
in a variety of pathophysiological processes.
Histolysin
Because of our interest in the contribution of enzymes such as cathepsin L to the breakdown
of connective tissue elements, we were interested to read about a cysteine proteinase of
Entamoeba histolytica that was thought to act in the same way. Entamoeba histolytica is the
organism that causes amoebic dysentry, but it does not always confine its activities to the
intestinal lumen. Sometimes it causes ulceration of the intestinal wall, invades the circulation
and metastasises to other organs such as the liver, where it is able to set up secondary foci or
infection. The escape from the intestine involves the disruption of the tissue structure, or
"histolysis" - hence the specific name of the organism. It has been believed for a long time that
endopeptidases secreted by E. histolytica play an important part in this process, but there has
been little agreement on the properties of these enzymes. We were therefore delighted when a
Cuban scientist, Alfredo Luaces, was able to join us for a year to do some work on the
cysteine proteinase of E. histolytica.
Luaces grew the trophozoites of the axenic HM 1 strain of E. histolytica in culture and found
that both the organisms and the culture medium contained cysteine endopeptidase activity.
The activity was greatest in the organisms, so these formed the source used for the
purification of the enzyme. We were fortunate to discover a method for affinity chromatography
of the enzyme that led to a virtual one-step purification.8 There was not much of the purified
enzyme to spare, but we got a single automated sequencing run on the N terminus. A high
proportion of the residues that were identified were identical with the corresponding residues
in papain and cathepsin L, showing that all three enzymes are closely related in evolution.
We used the pure enzyme to study its catalytic activity. Like cathepsin L, histolysin has
maximal activity on several protein substrates at acidic pH, but it differs in being stable at
neutral and alkaline pH values, which would facilitate its extracellular activity. We tested it
against matrix components at neutral pH. Contrary to some previous reports, we did not find
that the enzyme was active on native Type I collagen; it is very active on denatured collagen,
but that is probably not of much physiological significance. More importantly, the enzyme was
active on the Type IV collagen of glomerular basement membrane, which could well help the
organism escape from the intestine.
Equally important for invasion could be the ability to dissociate cells, so disrupting tissue
architecture. Human skin fibroblasts in culture were transferred into serum-free medium and
treated with 0.5 m a/ml of histolysin overnight. The cells rounded up, but they remained viable;
this was not a cytotoxic effect, as has been claimed previously, but only cell detachment.
Presumably this is due to degradation of some of the "sticky" proteins that cells produce, such
as fibronectin.
Inhibitors of Cysteine Proteinases
I have spoken about two endopeptidases that have the potential to break down tissue
structure by action on extracellular components. Before we can come to any sound
understanding of whether such processes are significant in vivo, however, we need to
understand the systems that exist to control them. For cysteine endopeptidases, we
specifically need to know about the cysteine endopeptidase inhibitor systems.
The first recognized inhibitor of cysteine endopeptidases in the human body was µ -
macroglobulin. This remarkable protein inhibits endopeptidases of all four catalytic classes by
physically trapping the enzyme molecule within its own molecule. It is a very large molecule
with a molecular weight of about 725,000. It exists in the plasma and to some extent in
extravascular fluids.9
The second class of inhibitors relevant to cathepsin L and histolysin comprises the cystatins.
About 1980 we followed up earlier reports of the existence of a cysteine proteinase inhibitor in
chicken egg white by isolating the inhibitor by affinity chromatography. We named it "cystatin",
because of the way it stopped the activities of cysteine proteinase. We then developed the
same type of purification procedure to deal with the more difficult task of isolating similar
inhibitors from human liver. As a result of work in several laboratories, we now have a large
family, technically a superfamily, of related cystatins. 10,11 Cystatins present in the human body
are powerful inhibitors of both cathepsin L and histolysin. They would be likely to prevent such
enzymes from causing any large-scale destruction of the tissues, but might be overwhelmed in
the immediate vicinity of cells actively synthesizing and secreting the enzymes. One of the
cystatins, human cystatin A, is located specifically in polymorphonuclear leucocytes and
epithelial cells, suggesting that it may play a protective role.12
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Among the African trypanosomes, the Trypanosoma brucei group is subdivided into the three
subspecies T. b. brucei, T. b. rhodesiense and T. b. gambiense. The latter two are the
causative agents of human sleeping sickness. Trypanosoma b. brucei and T. b. rhodesiense
are practically indistinguishable using either morphological or biochemical criteria. However,
the two subspecies can be differentiated on the basis of their sensitivity to the lytic action of
normal human serum (NHS).
The phenomenon of the trypanolytic action of NHS has been known for more than 80 years,
when Laveran1 was able to cure mice temporarily infected with T. b. brucei by injecting small
quantities of NHS. Many attempts were made to identify and characterize the serum factor,
before Rifkin² identified a high-density lipoprotein (HDL) fraction as containing the trypanocidal
activity. She also proposed later a model whereby the factor leads, via its interaction with the
trypanosome surface, to an alteration of the cell membrane permeability and a subsequent
damage of the cell by osmotic shock.³
A few years ago we decided to study the mechanism of this cytotoxic action of NHS more
closely. Encountering difficulties in the isolation of a trypanolytic HDL fraction, an alternative
method of isolating the factor had to be designed. In parallel, we looked for ways to analyse
the lytic mechanism in more detail. Assuming that the trypanolytic activity (TLA) might occur
intracellularly, acidotropic agents were used and their modifying effects on the lysis process
studied.
Effects of Weak Bases on the Trypanolytic Action
5 × 106 freshly isolated bloodstream forms of either the human serum-sensitive T. b. brucei
strain STIB 345-A or the human serum resistant stock T. b. rhodesiense STIB 704 BABC were
resuspended in 1 ml of MEM with 40% horse serum or 10% horse serum and 30% NHS. The
extent of lysis was determined by taking aliquots of the cell suspensions incubated at 37 °C
and counting the motile cells in a haemocytometer every hour. The percentage of lysis was
calculated by taking the initial cell number as 100%. Under these conditions 100% of T. b.
brucei are lysed within 6 hours, whereas T. b. rhodesiense showed no signs of lysis.
Supplementing the medium with different chloroquine concentrations in the range of 10-25 mM
resulted in a complete inhibition of the lytic action. Higher concentrations were toxic for both T.
b. brucei and T. b. rhodesiense. Similar effects were found with other weak bases (Table 1).
The concentrations of the weak bases needed to inhibit the trypanolytic activity were in similar
ranges to the concentrations reported to affect a variety of different intracellular processes
associated with acidic compartments.4,5
To test whether a preconditioning of trypanosomes with the weak bases would render them
more resistant to the Lytic activity of NHS, T. b. brucei were preincubated for 3, 2 and 1 hours
in media containing either 30% horse serum or 30% NHS, both supplemented with 10 mM
chloroquine. As a control, trypanosomes were incubated only in media with 30% horse serum
alone. After the preincubation period, all trypanosomes were pelleted and resuspended in 30%
NHS without chloroquine. No significant inhibition of Lysis was observed in any of the
samples. On the contrary, a slight enhancement of Lysis was observed with the cells
preincubated in NHS and chloroquine for 2-3 hours. These data seem to indicate that the
trypanolytic activity can be efficiently inhibited only when the weak bases are continuously
present in the medium. To prove that the weak bases were taken up, T. b. brucei and T. b.
rhodesiense were incubated in the presence of different concentrations of chloroquine for
three hours, washed once in PBS and kept frozen until chloroquine was determined with a
quantitative high-precision thin-layer chromatographic method.6 It could be shown that the
trypanosomes accumulated chloroquine (approximately 50-100 fold accumulation), but no
concentration dependent uptake was found in the range of 0.5 to 20 mM. This can probably be
explained by the fact that after three hours an uptake plateau is reached. Chloroquine
determinations at much earlier time points might well show a concentration dependence.
Attempts to cultivate T. b. brucei in NHS for longer time periods in the presence of chloroquine
on a Microtus montanus feeder layer failed.7 All trypanosomes died. Chloroquine probably
accumulated intracellularly to toxic levels, as has been shown by others.8 In contrast, it was
possible to maintain T. b. brucei in 20 mM ammonium chloride for more than four days in the
presence of normal human serum. The cells did not show any sign of lysis.
Characteristics of the Trypanolytic Factor
The trypanolytic activity in more detail it was necessary to isolate the trypanolytic factor. A new
method to isolate the trypanolytic factor not involving ultracentrifugal flotation was established
(Figure 1) using affinity chromatography of whole human serum on Blue Sepharose, followed
by two anion-exchange steps and a final purification on Superose.9
The known characteristics of the factor are summarized in Table 2. The factor consists of a
macromolecular complex with a molecular weight over 1,000,000. Under non-reducing
conditions a single polypeptide is found, which is separated into 3 4 peptides under reducing
conditions. The isolated active factor was shown to be different from typical high density
lipoproteins.
Conclusions
The trypanolytic activity of human serum can be inhibited by coincubation of bloodstream
forms of T. b. brucei with weak bases. It is proposed that the Lytic activity is mediated via a
receptor-ligand interaction leading to endocytosis and a perturbation of the normal intracellular
processing of receptor-ligand complexes. The perturbation of the processing of the receptor-
ligand complexes might be prevented by the uptake of weak bases. Electron microscopic data
indicate that significant structural changes occur in the presence of normal human serum in the
region between the flagellar pocket and the nucleus, where endosomes and Lysosomes and
the Golgi complex are known to be localized. For a detailed analysis of the cellular
biochemistry of serum-resistant and susceptible trypanosomes, it is now necessary to find out
precisely to which class of proteins the isolated trypanolytic factor belongs.
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Table 1. Optimal concentration ranges of different weak bases to inhibit the trypanolytic
activity
Compound Inhibitory concentrations (m M)
Chloroquine 10-30
Amantadine 50-500
Tributylamine 1-10
Ammonium sulphate 3-10
Ammonium chloride 5-50
Table 2. Properties of the isolated trypanolytic factor from human serum
· a complex of high molecular mass (>1000 kd) determined using gel filtration
· a single molecule under non-reducing conditions
· the factor is separated into three to four peptides under reducing conditions
· the major peptide has a molecular mass of » 80 kd
· the factor is present in human serum at a concentration of » 50 mg/l
· the isolated factor is not identical with high-density lipoprotein
Figure 1. Isolation of the trypanocidal factor from human serum.
Normal human serum
¯
Blue Sepharose (albumin depletion)
¯
Q-Sepharose anion-exchange
¯
Mono-Q anion exchange (FPLC)
¯
Polishing on Superose 6 (FPLC)
¯
ACTIVE TRYPANOCIDAL FACTOR
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Trypanosoma brucei brucei, a causative agent of trypanosomiasis in domestic livestock, and
T. b. rhodesiense and T. b. gambiense, the causative agents of human sleeping sickness, are
tsetse-transmitted flagellated protozoa that multiply extracellularly in infected mammalian
hosts. Variation of the surface glycoprotein (VSG) of T. brucei organisms1 prevents most hosts
from clearing the parasites and leads to chronic and often debilitating infections. The
pathologic consequences of trypanosomiasis caused by T. brucei and other pathogenic
African trypanosomes are manifold, including: anaemia, raised Ig levels, immune complex
disease, progressive destruction of lymphoid organs and other tissues, reduced fertility,
cachexia and neurologic disorders. The severity of these disease symptoms varies among
hosts, which, by this definition, are referred to as more trypano-resistant or more trypano-
susceptible.
Immunity to T. brucei organisms is VSG-specific and is mediated by antibodies that react with
exposed-epitopes on parasite VSG.² It has been observed in model studies that prolonged
infection with African trypanosomes leads to a general inability to mount humoral immune
responses to trypanosomes and third-party antigens.³ A widely held view arising from these
observations is that the level of susceptibility of a given host to infections with African
trypanosomes is likely to reflect the rapidity of development and severity of parasite-induced
immunodepression. In this formulation of the host susceptibility problem, the interaction
between trypanosomes and the humoral limb of the immune system assumes centre stage
and the attention of the audience/investigator is focused on parasite products that drive or
disengage the circuits underlying immune responses.
Recent studies provide reasonable grounds to doubt the above concept.4 An extensive
analysis of plasma-cell responses has been performed in resistant mice, which mount
serologically detectable VSG-specific antibody responses and cause clearance of the first T.
brucei parasitaemic wave, and in susceptible mice, which do not. In both strains of mice
plasma cells arose with the same kinetics, reached similar numbers in all lymphoid organs
examined and synthesized and secreted similar amounts of antibodies of the same Ig classes,
including antibodies specific for exposed VSG-epitopes on the infecting organisms.4
It was shown that the 2.5- to 10-fold higher peak levels of parasitaemia reached in the infected
susceptible, as compared to the resistant, mice could result in the removal by the
trypanosomes of large amounts of antibody. Hence it was inferred that there was less antibody
bound per trypanosome, leading to failure of the susceptible mice to clear parasites from the
bloodstream. VSG-specific antibody absorbed by trypanosomes is endocytosed and degraded
(D. Russo, P. Webster and S. Black, unpublished). Failure to clear trypanosomes from the
bloodstream leads to a prolonged parasitaemic wave, rapid destruction of lymphoid organ
architecture and concomitant loss of ability to mount efficient humoral immune responses.
Accessory studies showed that the higher levels of parasitaemia reached in infected
susceptible, as opposed to resistant, mice correlated with slower parasite differentiation to
committed non-dividing trypanosomes in the bloodstream,5 an event that is probably
controlled by antibody-independent host responses. The rate of parasite differentiation to
committed non-dividing T. brucei in the bloodstream of infected mice can be accelerated by
treatment of mice with Propionibacterium acnes.6 Biological mediators induced by P. acnes
have no direct effect on the parasites in vitro.6 The mediators examined include IL-1, IL-2,
TNF, INF, PGE1, PGE2, PGF2, mitogen-induced mixtures of mediators derived from T cells,
B cells, macrophages and mixed populations of cells (early or late after stimulation), fibroblast
growth factors, endothelial cell growth factors, nerve growth factors, platelet-derived growth
factor, insulin and insulin-like growth factors, tumor-derived growth factors and tumor-
promoting factors6 (S. Black and J. Newson, unpublished). The observations led to the idea
that regulation of trypanosome multiplication and commitment to non-dividing forms might be
mediated by secondary physiological effects of immune mediators that regulated the
availability or nature of host-supplied growth nutrients/growth inhibitors.
Axenic culture systems7 were exploited to identify host-derived macromolecules required for
the multiplication of T. brucei. Two different serodemes of T. brucei were adapted to grow
under axenic culture conditions and the adapted parasites grew equally well in both in vivo
and in vitro environments. No major biochemical adaptations were thus required to transit
between the two environments and hence the in vivo and in vitro T. brucei growth nutrient
requirements were similar.8 The trypanosomes multiplied under axenic culture conditions in
medium supplemented with 10% foetal bovine serum (FBS). In contrast, lipoprotein-depleted-
FBS (LPD-FBS; density 1.25 gm/ml) did not support parasite multiplication unless
supplemented with FBS lipoproteins (density 1.21 gm/ml). High-density lipoproteins (HDL;
density 1.06-1.21 gm/ml) and low-density lipoproteins (LDL; density 1.006-1.06 gm/ml),
prepared by sequential flotation ultracentrifugation, were equally able to supplement LPD-FBS
to support T. brucei multiplication. Chylomicrons (density 0.96 gm/ml) and very low-density
lipoproteins (VLDL; density 0.96-1.006 gm/ml) were unable to support T. brucei multiplication.
Removal of HDL or LDL-lipids by alcohol/ether extraction abrogated the ability of the
lipoproteins to support T. brucei multiplication. Both HDL and LDL from a number of different
species, including cattle, African buffalo, eland, rabbits and rats, were as able as FBS-HDL or
FBS-LDL to support T. brucei multiplication.8 The observations fit well with the published
requirement of bloodstream T. brucei for exogenous lipids9 and suggest the presence of a
lipid scavenging mechanism suited to a parasite with a wide host range.
Foetal bovine serum (FBS), rabbit and rat HDL and LDL were labelled with 125I on the
apolipoprotein content, or with ³H cholesterol, ³H cholesteryl linoleate or ³H dipalmitoyl
phosphatidyl choline, or with combinations of 125I and ³H labels. It was shown that both
culture-adapted T. brucei 8 and T. brucei isolated from the blood of infected mice (including
organisms that had not been culture-adapted) (V. Vandeweerd and S. Black, unpublished)
took up lipoprotein-lipids without talking up or degrading apolipoproteins. Uptake of the
lipoprotein-lipids occurred at 37 °C but not at 0 °C to 4 °C, was saturable and was several
thousand times more efficient than uptake expected to occur by fluid endocytosis. The uptake
process did not discriminate between HDL and LDL, was independent of exogenous divalent
ions and was not influenced by exogenous weak bases (20 mM ammonium chloride, 20 m M
chloroquine8). The uptake mechanism was thus utterly different from receptor-mediated
endocytosis of LDL as practised by mammalian cells. 10
Uptake by T. brucei, X63 mouse myeloma cells and normal mouse spleen cells of lipoprotein-
associated ³H cholesterol occurred to a similar extent. It resulted from desorption of the ³H
cholesterol from the lipoproteins and its diffusion into the plasma membranes of the target
cells. In contrast, uptake of lipoprotein-associated ³H dipalmitoyl phosphatidyl choline and ³H
cholesteryl linoleate differed markedly among the three cell types. Trypansoma brucei
obtained these lipids from both HDL and LDL. X63 obtained the lipids from LDL only and
normal mouse spleen cells did not take up the lipids.8
Uptake by T. brucei of lipoprotein-associated ³H dipalmitoyl phosphatidyl choline was inhibited
by including LPD-FBS in the incubation mixture. The active ingredient in the LPD-FBS was
likely to be albumin. LPD-FBS stimulated rather than inhibited the uptake by T. brucei of
lipoprotein-associated ³H cholesterol linoleate. This observation suggests that lipoprotein-
derived phospholipids and cholesterol esters might enter T. brucei by different processes and
that the phospholipid ³H dipalmitoyl phosphatidyl choline) is free of the carrier lipoprotein prior
to entry into T. brucei.
In contrast, bile acids and conjugated and unconjugated bile salts inhibited the uptake by
culture-adapted and normal bloodstream T. brucei of lipoprotein-associated ³H cholesteryl
linoleate but not lipoprotein-associated ³H dipalmitoyl phosphatidyl choline. Different
cholesterol conversion products had differing efficiencies to inhibit T. brucei lipoprotein-
cholesterol ester uptake. The observed order, derived from inhibition of HDL-associated ³H
cholesterol linoleate uptake using culture-adapted T. brucei as: lithocholic acid >
chenodeoxycholic acid > deoxycholic acid > cholic acid = glycochenodeoxycholic acid >
taurochenodeoxycholic acid (V. Vandeweerd and S. Black, unpublished).
Two possibilities present themselves. The cholesterol conversion products might prevent the
uptake by T. brucei of lipoprotein-associated cholesterol ester by inhibiting cleavage to
cholesterol that can readily diffuse across the cell membrane. Alternatively, the cholesterol
conversion products might compete with an interaction between lipoprotein-associated
cholesterol ester and a T. brucei cholesterol ester binding molecule. To examine these
possibilities, purified lipoproteins were labelled with ³H cholesterol ether ³H cholesterol oleoyl
ether) and incubated with culture-adapted T. brucei in the presence or absence of an
inhibitory concentration of chenodeoxycholic acid. In the absence of the bile acid, the T. brucei
took up ³H cholesterol ether by a process that was similar in all respects to uptake of ³H
cholesterol ester, e.g., uptake occurred only at 37 °C, was saturable, was inhibited by
unlabelled lipoproteins and was enhanced by LPD-FBS. Uptake of the cholesterol ether was
inhibited by the bile acid (Vandeweerd and Black, unpublished). Because cholesterol
esterases are unable to cleave the ether bond11 and because cholesterol ether cannot diffuse
through cell membranes, we conclude that T. brucei have a cholesterol ester/ether binding
molecule that is blocked by cholesterol conversion products.
Both chylomicrons and VLDL contain phospholipids and cholesterol ester yet do not support
T. brucei multiplication and do not inhibit the capacity of LDL or HDL to support T. brucei
multiplication in vitro.
8. It therefore seems possible that size constraints prevent interactions
between the largest lipoprotein molecules and the T. brucei. This conclusion leads to the idea
that lipoprotein/T. brucei interactions occur in the T. brucei flagellar pocket, from which the
larger lipoproteins might be excluded. Alternatively, cholesterol esters and phospholipids might
be sequestered in chylomicrons and VLDL in such a way that they cannot interact with T.
brucei organisms. As a preliminary step to distinguishing between these possibilities, it is of
some importance to define the maximum size of molecules that can enter the T. brucei
flagellar pocket.
Uptake by T. brucei of HDL-associated ³H cholesteryl linoleate is inhibited by including
puromycin or cycloheximide (20 m g/ml medium) in the incubation mixture. In contrast, uptake
by T. brucei of HDL-associated ³H dipalmitoyl phosphatidyl choline is not inhibited by including
puromycin or cycloheximide in the incubation mixture. We therefore consider it likely that
uptake of the 3H cholesteryl linoleate is mediated by binding to a protein, whereas uptake of
3H dipalmitoyl phosphatidyl choline is not. Based on these observations and the ability of LPD-
FBS (albumin) to prevent uptake by T. brucei of lipoprotein-associated ³H dipalmitoyl
phosphatidyl choline, we speculate that the ³H phospholipid is released from the lipoprotein
particle by a process that does not require protein synthesis by the parasite and thereafter
diffuses into the parasite membrane. It is tempting to suggest that release of the lipoprotein-
associated phospholipid occurs in the T. brucei flagellar pocket as a result of mechanical
disruption of the lipoprotein particle. The uptake by T. brucei of lipoprotein-associated
cholesterol occurs as a result of simple desorption; uptake of phospholipid possibly occurs by
mechanically induced release and diffusion. Uptake by T. brucei of lipoprotein-associated
cholesterol ester may therefore be the only component of the parasite lipid scavenging
mechanism amenable to specific chemotherapeutic or immunological attack.
Concentrations of bile acids (5 to 15 m M), and conjugated and unconjugated bile salts (50 to
100 m M), which inhibit uptake by T. brucei of lipoprotein-associated cholesterol ester/ether in
the absence of LPD-FBS, are close to toxic concentrations. Although the inclusion of LPD-
FBS in the incubation mixture reduces the short-term toxicity of cholesterol conversion
products, it does not completely abrogate their effects. Concentrations of bile acids (100 m M)
can be chosen that prevent multiplication of T. brucei in long-term cultures supplemented with
10% FBS. Because conjugated bile salts and bile acids are found in normal plasma, it is an
attractive idea that these molecules might have a role to play in protection against African
trypanosomes. Clearly, quantitative data are required on the bile acid, and conjugated and
unconjugated bile salt concentrations in the plasma and interstitial fluids of normal and
infected trypano-susceptible and trypano-resistant hosts. Equally clearly, quantitative data are
required on the sensitivity of different trypanosome clones, serodemes and species to the toxic
effects of cholesterol conversion products in the presence or absence of blood.
We hope that the above overview will stimulate further studies on trypanosome nutrient
uptake, on the host/trypanosome interface as manifested in the T. brucei flagellar pocket and
on the mechanisms used by infected hosts to control parasite growth.
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Free radicals are produced inevitably during cellular metabolism, such as by electron leakage
from electron transport chains and redox enzymes. In addition, leukocytes, and perhaps some
lymphocytes, can produce a triggered extracellular flux of free radicals by means of a
specialized electron transport chain assembled on the cell surface and involving a low-
potential cytochrome, cytochrome b-245.
1,2 This triggered radical flux is probably important in
defence against foreign organisms, and may also have a positive role in the normal function of
the cells. The primary radical produced in biological systems is the superoxide radical, but this
may undergo conversion into many other radicals, including the extremely reactive hydroxyl
radical. Reactions with lipids and possibly proteins may also deposit relatively stable
hydroperoxides, analogous to hydrogen peroxide (the dismutation product of superoxide
radicals). All these peroxides are important in that they represent a further source of radical
generation after cleavage reactions involving transition metals. Table 1 gives a crude
summary of the nature and actions of the biologically important radicals occuring in normoxic
conditions.
Studies on the mechanisms of action of such free radicals initially concentrated on lipids and
DNA as targets. More recently it has become apparent that proteins are at least as important
as targets. I will outline our studies on protein damage by radicals, and indicate some of its
consequences for functional activity, proteolysis and cytolysis. I will start with the exterior of
cells, move to intracellular proteins and then discuss proteins at the interface, the plasma
membrane and their involvement in cytolysis.
Extracellular proteins are catabolized mainly intracellularly after endocytosis. However, limited
extracellular fragmentation of proteins may be a necessary preliminary to such endocytosis in
the case of polypeptides of the fixed extracellular matrices such as cartilage. These matrices
present the substrates in a compact non-diffusible form, and this limitation has to be
overcome before substantial degradation can occur. In addition, extracellular degradation of
diffusible proteins by limited proteolysis can occur, though it is usually restricted by the large
extracellular concentrations of proteinase-inhibitors. We have recently studied the influences
of free radicals on the generation of fragments from cartilage proteoglycan and their influence
on the proteinase-proteinase inhibitor balance.
In addition we have indicated that significant protein fragmentation may result in diabetes from
radicals generated by autoxidation of extracellular glucose.
Our earlier studies4 on free radical attack on intact discs of nasal cartilage showed that
defined radical fluxes (induced by gamma-radiolysis) could release macromolecules
(biosynthetically labelled by 35sulphate) from the discs. Molecular characterization of these
products revealed that virtually intact chondroitin sulphate was the primary product and implied
that the main cleavage reactions were taking place on the polypeptide core, releasing
oligopeptides attached to chondroitin sulphate side chains, which were themselves almost
undegraded unless gross radical fluxes were used. Significant release of intact
glycosaminoglycan could be obtained with doses of radicals corresponding to those that can
be produced by a few million macrophages in a few hours, in other words, corresponding to
biologically plausible doses, especially in inflammation. The limited degradation products of
free radical attack on proteoglycans were characterized in more detail recently using purified
proteoglycan monomer and intact proteoglycans as substrates. The data (Naish-Byfield and
Dean, unpublished) confirmed that selective attack on the polypeptide core is a major event. A
clear contrast in the nature of products released by chemical elimination reactions
(glycosaminoglycan alone) and by radical attack (glycosaminoglycan attached to oligopeptide)
was demonstrated.
Such fragments of connective tissue may possibly be generated in inflammatory conditions by
the action of radical-generating cells such as macrophages. In the extracellular fluid they might
then be subject to enzymic proteolysis. It has been suggested frequently that free proteinases
may occur widely in these inflammatory circumstances because extracellular inhibitors such as
alpha-1-proteinase inhibitor (a 1PI) are selectively inactivated by free radicals, leaving free
proteinase activity. However, we (Dean, Nick and Schnebli, unpublished) found that free
radicals generated from transition metals with hydrogen peroxide have roughly the same
capacity to inactivate three proteinase inhibitors (a 1PI, secretory leukocyte proteinase
inhibitor and eglin) as they do a relevant target enzyme (neutrophil elastase) when all are used
at concentrations appropriate to the in vivo condition (around 5 M). Since many extracellular
proteins probably have detectable quantities of transition metals loosely bound (e.g., copper
on histidine residues) and since hydrogen peroxide is the dismutation product of the primary
radical generated by triggered leukocytes, this radical generating system is probably relevant
(Table 1). On the other hand, some peroxy radicals may be more selective in inactivating a
1PI (by virtue of its active site methionine, which is very susceptible to oxidation) than the
other inhibitors and enzymes. Whether appropriate peroxy radicals occur in the extracellular
fluid at appropriate places and times is rather debatable. So the suggestions that emphysema
and other conditions in which extracellular proteolytic activity comes to exceed extracellular
proteinase inhibitors may result from free radical affront are therefore insecure, though it is
clear that localized environments may contain active proteinases.
As another extracellular event that may mark protein for complete intracellular proteolysis, we
have studied the action of autoxidizing sugars on some soluble proteins. Partly consequent on
radical generation, proteins are glycosylated. We now report5 that protein fragmentation takes
place, with bovine serum albumin as target protein, using glucose and glyceraldehyde
autoxidizing for one to eight days. This may cause accelerated catabolism of some proteins in
poorly controlled diabetics.
The general point has been raised indirectly above that radical damage to proteins may be
important in causing inactivation of protein function. If such non-functional proteins are to be
removed, then it may be expected that some feature of the radical modification will lead to
recognition of the protein by cellular degradative machinery. In the case of the extracellular
released fragments, this recognition is probably based usually on the adsorptive endocytosis
of the materials: this can result probably from the unfolding of the protein moiety and the
relatively increased exposure of hydrophobic areas, though other more subtle changes may
also be important.
In the case of intracellular proteins, radical-mediated damage to proteins may also be
important in establishing basal rates of catabolism of intracellular proteins. The consequent
residue modification, fragmentation with some associated new N-termini, and unfolding may
all help to 'signal' that a damaged protein is more available for catabolism by a variety of
routes. For instance, by cytoplasmic mechanisms involving ubiquitin conjugation or by
lysosomal routes involving exposure of hydrophobic surfaces on the damaged proteins, which
facilitate their uptake into the site of ultimate catabolism. We have demonstrated that several
conditions of elevated radical flux lead to an increased rate of proteolysis of bulk long half-life
proteins in cultured cells6 and of mitochondrially synthesized proteins in isolated
mitochondria.7 A greater acceleration of intracellular protein degradation after radical attack
can be observed in erythrocytes.8 The roles of the several routes for intracellular catabolism of
radical modified proteins are not established yet, though the main relevant possibilities are
summarized in Table 2.
A striking feature of studies of effects on radical fluxes on cell catabolism6 is that while low
doses of radical flux may cause accelerated catabolism, which can be construed as a
detoxifying protective antioxidant function, higher doses often simply lyse the cells. We9 have
investigated this to some extent in relation to macrophage-mediated lysis of T. brucei. We
noted an interesting difference in sensitivity to lysis by radicals generated from hydrogen
peroxide between bloodstream and procyclic forms, which to some extent could be abolished
by removal of the glycoprotein coat of the bloodstream forms. Surprisingly, this coat seemed to
be conferring increased sensitivity to radical Lysis; this again indicates the possible
importance of protein damage (as opposed to damage to other target molecules). Table 3
summarizes some evidence that macrophages can lyse T. brucei by means of their triggered
radical production: the process can be inhibited by antioxidant enzymes that remove hydrogen
peroxide (i.e., by catalase, or catalase with superoxide dismutase, but not by superoxide
dismutase alone). It is interesting that the addition of metal is not needed in this system: it is
provided by the medium. The failure of trolox (an amphiphilic water soluble analogue of
tocopherol, vitamin E, the main lipid soluble chain-breaking antioxidant) to prevent cytolysis
indicates that lipid peroxidation may not be critical in its mechanism.
We are investigating more closely the mechanisms involved in cytolysis of nucleated human
macrophage cell lines by radicals generated from hydrogen peroxide and transition metals.10
We use a simple medium consisting of Hanks' Balanced salts solution, so that the addition of
metal is unnecessary. Our concern is to establish whether protein or lipid damage, or both, are
crucial early events committing cells to Lysis during such radical attack. We demonstrated that
in the case of our cell lines, an event predictive (during radical attack) of Lysis and occurring
earlier than any of those presently in the literature, is membrane depolarization. This occurs
within a few minutes, while depletion of ATP and GSH is rather slow, and, indeed, not very
extensive. Lysis follows the membrane depolarization events with a lag of the order of 1 hour.
We argued that changes in membrane potential could reflect either lipid or protein damage.
Using a very sensitive fluorimetric assay of lipid damage, we were able to detect lipid damage
(as production of hydroperoxides) over a short period comparable with that of depolarization.
However, we could completely abolish this lipid peroxidation (by the addition of antioxidants
such as butylated hydroxytoluene) without affecting depolarization or subsequent Lysis
significantly. In this respect the cells seemed to behave rather like the trypanosomes
mentioned above. Therefore, amongst possible cell membrane targets, proteins seem to be
the most likely site of primary damage leading to Lysis. In agreement with the comments
above on functional inactivation of proteins, we have shown that the activity of certain ion
pumping proteins in the cell membrane, notably the Na/K-AtPase, is depressed over an
appropriate time scale. It seems that proteins may be critical targets in cytolysis by radicals.
Thus protein damage by radicals is critical in many biological processes. This damage may
lead to functional inactivation, but usually the inactivated proteins are probably degraded, so
that proteolysis forms a secondary defence. However, when the target proteins are critical for
rapid homeostatic mechanisms (as in the case of transport proteins) or when the proteolytic
defence and/or other antioxidant defences are overwhelmed, toxic events may ensue. These
are probably important in many chronic pathologies such as artherosclerosis (where damage
to LDL may be critical) and chronic inflammatory diseases (where connective tissue
catabolism probably involves some radical-mediated damage). The toxic events may even be
so disastrous as rapidly to lyse cells.
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Table 1. Some important Free radicals and related molecules in oxygenated biological
systems
Radical Source/site Comments
Superoxide
radicals (O2)
Electron transport chains (intracellular and in
plasma membranes of some leukocytes, such
as macrophages)
Not a very reactive entity; gives rise to
H2O2 by spontaneous and catalyzed
dismutation
Peroxyl
radicals (RO2)
Lipids, sugars and proteins that may be
relatively stable
Selective in reactivity; generate
hydroperoxides
Alkoxyl radicals
(RO)
Lipids, other macromolecules, reactions of and
from peroxy radicals
More reactive than peroxyl radicals in
many contexts
Hydroxyl
radicals (OH)
From some reactions of quinones and from
reaction of transition metals with H202 (the
Fenton reaction)
Highly reactive; rather unselective in
action
H2O2 From dismutation of superoxide radicals and
from some oxidase reactions
Together with transition metals,
generates hydroxyl radicals; diffusible
through membranes
Hydroperoxides On lipids and proteins Can be fragmented by transition metals
(ROOH) to give alkoxyl and peroxyl radicals
Table 2. Possible mechanism for enhanced protein degradation after radical damage
After limited radical attack
polypeptide-histidine-polypeptide
¯
polypeptide + aspartate-polypeptide
|
(enzymatic addition of N-terminal basic amino acid)
¯
(lysine or arginine)-aspartate-polypetide
|
recognition by the ubiquitin-dependent proteolytic system (present in most cellular compartments)
¯
enzymatic-proteolysis
After extensive radical attack
1) unfolding of proteins makes them:
a) more susceptible to proteinases
b) more hydrophobic, and therefore more likely to enter lysosomes from the cytoplasm, or endosomes
(and hence later lysosomes) from the extracellular fluid
2) Radical attack fragments proteins, and hence in the case of fixed proteins of extracellular matrices
makes them diffusible and more accessible for endocytosis and degradation by cells such as
macrophages
Source: The basis for the ideas above are summarized in Dean, 1987, FEBS Lett.
220: 278-282; and Wolff et, al., 1986, TIBS 11: 27-31.
Table 3. Lysis of bloodstream forms of Trypanosoma brucei by the macrophage
oxidative burst
Conditions % specific lysis by macrophages
Untriggered PMA-triggered
Control 0.3 (0.3) 60.3 (1.4)
(a) + catalase (2000 U/ml) 0.0 (0.5) 00.1 (0.9)
(b) + superoxide dismutase (300 U/ml) 1.0 (0.9) 58.0 (2.2)
(c) + catalase and superoxide dismutase (as above) 0.2 (0.6) 00.8 (1.1)
trolox (1mM) 2.1(0.6) 56.1(5.1)
Bloodstream trypanosomes (biosynthetically labelled in their protein with leucine)
were co-cultured with macrophages (from 7 day infected mice) at a 10:1
macrophage:trypanosome cell ratio for 2 hours. The medium was M 199 plus
2.5% rat serum. Phorbol myristate acetate (PMA) was at 50 ng/ml. Results are
means (with s.d. in brackets, for n = 3). From ref. 9.
  
  
The Cross-Reacting Determinant of the Variable Surface
Glycoprotein of Metacyclic Trypanosoma congolense
W.R. FISH, D.J. GRAB and J.D. LONSDALE-ECCLES
International Laboratory for Research on Animal Diseases
P O Box 30709, Nairobi, Kenya
References
The International Laboratory for Research on Animal Diseases was set up to address the
problems of important animal diseases that affect livestock production in Africa, with its initial
targets being trypanosomiasis and East Coast fever. The major emphasis of ILRAD's
programme is in immunological approaches to the control of these two diseases. However, in
order for such an approach to be successful, it is necessary that a parasite antigen, or
antigens, be found that are accessible to antibody attack in vivo. In the case of African
trypanosomes, the major surface proteins, which are called variable surface glycoproteins
(VSGs), elicit a substantial immune response. However, these parasites ensure the successful
continuation of succeeding waves of parasitaemia by changing their surface VSGs in a
process called antigenic variation.¹
Although the surface coats of the African trypanosomes undergo continuous waves of change
during the course of an infection, the different VSGs all contain similar structures at the
carboxy-terminal (C-terminal) end of the molecule. This moiety is believed to function as an
anchor by which the VSG is attached to the surface membrane of the parasite.2 This putative
anchor has been shown to comprise a complex glycosylphosphatidylinositol (GPI) moiety. Also
found in the C-terminal portion of the VSG is an immunologically cross-reactive determinant
(CRD).3 Antibodies directed against the CRD epitopes react with VSGs from different species
of African trypanosomes, as well as a variety of proteins from many lower and higher
eukaryotes.2 Galactose, glucosamine, inositol 1,2-cyclic phosphate, and 1,2-
dimyristoylglycerol (1,2-DMG) have all been shown to influence the binding of anti-CRD
antibodies.4,5 Interestingly, however, in the case of African trypanosomes, this cross-reactivity
was initially believed to be observable only in VSGs released from the surface of the parasite*
by the action of a GPI-specific phospholipase-C (GPI-PLC).5,6 GPI-PLC acts by cleaving the
1,2-DMG from the GPI moiety and results in the formation of sVSG (a soluble form VSG),
which, when analysed by sodium dodecylsulphatepolyacrilamide electrophoresis (SDS-
PAGE),6 has a slightly higher apparent molecular mass (Mr) than does the GPI-containing,
membrane form VSG (mfVSG). The GPI-PLC activity is reported to be activated by thiol-
reducing reagents and inhibited by a variety of metal ions and detergents.7,8,9,10 However, in
some cases the effect of these reagents has not been distinguished from a possible effect of
the reagent upon the substrate rather than the enzyme itself. Clearly, this is of significant
importance in the understanding of the process involved in the exposure of the CRD and
release of the VSG from its membrane anchor. We have studied this using bloodstream and
procyclic forms of several species of African trypanosomes and, in more detail, bloodstream
forms and metacyclic forms of T. congolense. (The metacyclic forms are the infective forms of
the parasite that are transmitted by the tsetse fly when it takes a blood meal from a
mammalian host.) Like the bloodstream forms, the metacyclic forms have a surface coat that
undergoes antigenic variation. The procyclic forms are culture-adapted forms that resemble
the parasites that are found in the midgut of the tsetse fly; they have no surface coat and
show no binding of anti-CRD antibodies.
(* Strictly speaking this may not be the case since, by using
immunoelectronmicroscopy, anti-CRD reactivity can be observed in fixed
parasites. The reactivity is observed both on the surface of the parasite and in
internal organelles such as the endocytotic network and trans-Golgi
apparatus.12,13 However, because the anti-CRD antibodies do not recognize the
CRD epitope in healthy, living trypanosomes, the CRD is unlikely to be useful as a
potential antigen for vaccination purposes.)
Bloodstream forms of T. congolense, when analysed by SDS-PAGE and western blotting
techniques using affinity purified anti-CRD reactive antibody (IgG), gave a single reactive band
with an Mr of approximately 55,000. In contrast, metacyclic forms of the parasites gave
several more or less discrete bands in the Mr range between 49,000 and 57,000. In the latter
case we were surprised to observe several phenomena that did not accord with the dogma of
increased CRD exposure (i.e., increased anti-CRD antibody binding to VSG) with the mfVSG
to sVSG transition.
We observed that the metacyclic forms of T. congolense have, as expected, a CRD epitope
on their VSGs. However, the 1,2-DMG does not need to be removed from these VSGs in
order to cause increased binding of the anti-CRD antibodies to VSG. Furthermore, the
exposure of the CRD is exquisitely sensitive to the method of sample preparation. For
example, in contrast to reduced samples, sonicated samples that were not reduced with
dithiothreitol showed no reactivity with the anti-CRD antibody. A variety of metal ions or
detergents were tested for their effects on the exposure of the CRD. The results varied
according to the reagent added and whether or not the reagent was added before or after
sonication. Different results were also obtained when samples were prepared by the freezing
and thawing of hypotonic lysates rather than by sonication.
While our results do not necessarily negate previous conclusions regarding the relationship
between the exposure of CRD and the removal of 1,2-DMG, they clearly show that the
exposure of CRD does not necessarily mean that the 1,2-DMG has been removed, as has
been suggested by some workers.5,11 Indeed, these workers suggested that the exposure of
CRD could be used as an assay for the release of the myristate anchor by the GPI-PLC.
Furthermore, our results show that the pathway to the exposure of the CRD is clearly a
complex one that can be halted at various intermediate steps by appropriate handling of the
samples and that the reduction of disulphide bonds plays an important and, perhaps, crucial
role in these events. An unravelling of these "unfolding" steps may help us to elucidate the
various steps involved in the synthesis, packaging, transport and breakdown of the molecules
during the intracellular processing of VSG.
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Food or digestive vacuoles (DVs) in Paramecium have been the subject of investigations for
more than a century. Because of their large size and rapid formation, these DVs can be
readily studied using light microscopic techniques.1 In fact, phagosomal acidification was first
observed in this cell type as early as 1893.2 However, not until the last ten to fifteen years
have we come to appreciate the true complexity of the phagosome-lysosome system in this
cell. Notwithstanding these complexities, there are major advantages of using this cell as a
model to study the control of intracellular digestion. In Paramecium the duration of the
digestive cycle is relatively short, and the digestive processes are sufficiently synchronous
and separated in time to permit perturbation of individual processes in situ and dissection of
these processes via a pulse-chase protocol. Thus, by following a number of parameters such
as vacuolar pH, vacuole size, acid phosphatase activity and thin-section and freeze-fracture
morphology we have been able to distinguish at least four digestive processes that occur
during a digestive cycle.3 These four processes can each be subdivided into at least four
steps as outlined in Table 1.
These processes are facilitated in the vacuoles by the sequential addition and/or retrieval of at
least three separate morphologically and functionally distinct pools of membrane-bound
vesicles. This results in the formation of four morphologically distinct stages of the vacuole,
DV-I to DV-IV, with each stage having its own characteristics.4 The discoidal vesicles provide
membranes for vacuole formation. The acidosomes are responsible for DV acidification, which
kills the ingested microorganisms, denaturing their proteins and preparing the vacuoles for
lysosomal fusion. The lysosomes contain a complement of acid hydrolases capable of
degrading most of the ingested macromolecules. The degraded products are transported from
the vacuole to the cytosol to be used for the cell's growth. Finally, following defecation of the
undigestible vacuolar contents from the DV-IV at the cytoproct, the spent DV-IV membranes
are retrieved and the resultant vesicles are transported along microtubular ribbons back to the
oral region where they are reused in forming new DVs.3
Having obtained a relatively complete picture of the number of processes and steps involved
in the digestive cycle, we have now turned our attention to the study of the regulation of these
processes, in particular to whether these processes have to take place in a sequential order
and how each step or process affects subsequent ones. We used (1) a pulse-chase protocol
together with exposing these labelled cells before the onset of each of actin filaments, (2)
ionophores that dissipate pH gradients, (3) weak bases that elevate vacuolar and vesicular
pH and (4) trifluoperazine, a calmodulin antagonist. These cells were then analysed using acid
phosphatase cytochemistry, monoclonal antibodies specific for different membrane pools, and
lysosome morphometry, as well as the acidification and degradation assays developed for
these purposes. Thus, while the above perturbants may exert additional inhibitory effects on
cellular processes not measured in this study, the totality of the experimental data appears to
support the idea that the digestive processes behave as a chain reaction where each event
exerts some control over the subsequent digestive steps. In this report we attempt to provide
a brief summary of our findings on the regulatory mechanisms of the phagosome-lysosome
system. The results are divided into three sections, each describing the effects of one of the
first three digestive processes on the subsequent process or processes.
Results
DV formation
Vacuole formation is the first process in a digestive cycle and obviously is also the first, and
perhaps the most crucial, regulatory process in a digestive cycle. When DV formation is
blocked, all subsequent processes are eliminated. However, when DV formation and the
subsequent processes are allowed to proceed normally, we find that the formation rate
determines, to a large extent, the defecation rate.5 This conclusion is derived from studying
the formation rate when cells were pulsed continuously with latex beads. During such a
continuous pulse, the accumulation of labelled DVs could be divided into two periods: an initial
period of linear but rapid increase in DV number followed by a second period after the mean
number of labelled DVs/cell had reached a plateau that was maintained for the remainder of
the pulse (Figure 1). The presence of this plateau indicates that either Paramecium is quickly
saturated with DVs after feeding so that no new DVs are formed and no labelled DVs are
ingested, or that the rates of formation and defecation are equal. To distinguish between these
two possibilities, cells were pulsed with fluorescent beads for one hour and divided into two
portions. One portion of the cells was kept in the initial pulse, which showed no net change in
DV numbers for the remainder of the pulse, and the second portion was washed briefly to
remove the fluorescent beads and fed again with a second label of nonfluorescent beads. In
the latter group, the loss of the older fluorescent DVs was linear at a rate identical to their
original formation rate during the beginning of the first pulse. The rate of DVs formation after
exposure to the second label was also linear and rapid, but when exposed to the larger bead
size used in this experiment, the DVs/cell value plateaued at a higher steady level. Since new
DVs are continuously being formed while old DVs are continuously being defecated, to attain
a steady level of labelled DVs, the defecation rate has to equal the DV formation rate. Not only
are the rates of formation and defecation equal, but we also find that the defecation rate
appears to be governed by the formation rate. This is confirmed by comparing the formation
and defecation rates when cells were pulsed with decreasing bead concentrations. Under
these conditions, the DV formation rates were lowered and lower plateau levels of labelled
DVs were obtained. For each bead concentration, the defecation rate was reduced to the
same extent as the formation rate (Figure 2). These findings suggest that (1) the formation
process is the key step in regulating digestion and (2) the defecation rate is governed by the
formation rate.
DV acidification effects of blocking acidosome-DV fusion on vacuolar acidifications as
well as the lysosome fusion-digestion and defecation processes
As a nascent DV grows in size, acidosomes6,7 bind specifically to its surface. These
acidosomes, which are located mostly in the cytopharynx area, are irregularly shaped electron
translucent vesicles. They are acid phosphatase negative7 and have a distinctive freeze-
fracture morphology8 and deep-etched appearance (unpublished observation). Microfilaments
are found in regions where acidosomes bind to the nascent DV and to the very young DV.
These microfilaments apparently play an important role in the acidosome-DV fusion, since
perturbation by cytochalasin B (CB) results in a block in acidosome DV fusion.7,9
When acidosome-DV fusion was blocked by CB, DV acidification as well as the subsequent
third10 and fourth processes of the digestive cycle became severely affected. Acidification of
DVs, the pH was measured with indicactor-dye-stained yeast cells, was almost abolished.7
Lysosome-DV binding, as determined by measuring the number of bound lysosomes per m m
of cross-sectioned DV-membrane profile (Figure 3), and lysosome-DV fusion, as determined
by the appearance of phagolysosomal membrane antigens in the DV membrane (Figure 4)
and acid phosphatase in the lumen, were greatly reduced (Figure 5). In our numerous pulse-
chase studies we have rarely, if ever, observed lysosomes bound to the newly formed DVs in
unperturbed cells, but numerous lysosomes accumulate around the normally acidified DV-II.
This resulting lysosome layer bound to the DV-II often becomes highly conspicuous.7 When
cells were exposed to 0.3 mM CB, lysosome binding to DVs was practically eliminated; only
one 20-min-old DV in the treated cells had associated lysosomes; 1.4 lysosomes/m m of DV-
membrane profile. The other eight DVs had none or just a few scattered lysosomes
associated with their membranes10 (Figure 3).
To measure the lysosome-DV fusion rate, we used two monoclonal antibodies specific for the
phagolysosomal (DV-III) membrane10,11 (Figure 4) jointly with acid phosphatase cytochemistry
(Figure 5). In control cells chased after a 3-min pulse in latex beads, the DV-III membrane
antigens were not expressed on young DVs. As these DVs aged, they showed increasing
binding to these antibodies so that all 20-min-old DVs were positive. The lysosome-DV fusion
rates for both control experiments were 5.1%/min as calculated from the linear portion of the
curve (Figure 4). In CB-treated cells only 20% of the labelled DVs expressed the
phagolysosomal membrane antigens by 20 min. although this had increased to 40% by 45
min. making the lysosome-DV fusion rate only 1.3%/min. This represented a 75% inhibition
when compared with the control rate. This inhibition was readily reversible; the removal of CB
by washing resulted in normal rates of fusion after a lag of about 15 min. When cells with 3-
min-old DVs in which acidification was nearing completion but the lysosome fusion step had
not yet begun were exposed to CB, CB did not inhibit the fusion rates but did reduce the
maximal extent of fusion to 78% of that in the control cells (Figure 4).
Using acid phosphatase cytochemistry12,13 as a lysosome-DV fusion assay, results obtained
from four separate experiments were all similar to those obtained with monoclonal antibodies
(Figure 5). When acidosome-DV fusion was blocked by CB, less than 5% of the labelled 15-
min-old DVs were acid phosphatase positive. With prolonged exposure to CB, only 15% of the
labelled DVs became positive, giving a lysosome-DV fusion rate (0.65%/min) of less than 8%
of the control rate. Again, the inhibitory effect of CB was readily reversible; 40% of the DVs
became acid phosphatase positive 20 min after a wash, as compared with 50% in the control
(Figure 5). Proteolysis of phagocytosed FITC-albumin in CB-treated cells was also reduced to
a similar amount (unpublished results). As regards the fourth process, DVs in CB-labelled DVs
in untreated cells were not ingested for at least 45 min. whereas labelled DVs in untreated
cells could be defecated any time after 20 minutes.14
These results demonstrate that when acidosome-DV fusion is blocked, all subsequent
processes are essentially blocked: vacuoles will not be acidified and will not acquire the
lysosomal membrane nor the lysosomal acid phosphatase. Finally, proteolysis is essentially
prevented and vacuole defecation is greatly delayed.
Effects of inhibition of vacuolar acidification on the lysosome fusion-digestion and
defecation processes
15
NH4Cl has been shown to raise the pH of the endocytic compartments.  We have used yeast
labelled with fluorescein isothiocyanate to show that the vacuolar pH was elevated from 3 to
about 5.8 in the presence of 30 mM NH4Cl (unpublished). Though vacuolar acidification was
inhibited, this concentration of NH4Cl had no observable inhibitory effect on acidosome-DV
fusion. The net effect of this pH elevation that we observed is an inhibition of lysosome-DV
fusion. When measured by the Gomori method,13 lysosome-DV fusion was seen to be
inhibited by 40% (Figure 6) and proteolysis of phagocytosed FIT-albumin was inhibited by
72% (Figure 7,) with about half of this latter inhibition being attributable to the effects of NH4Cl
on proteolysis itself independent of its effects on vacuolar acidification and lysosome-DV
fusion.16 Under this treatment the defecation process was also slowed down (unpublished
results).
Lysosome fusion-digestion, lysosome-DV fusion
The extent of lysosome-DV fusion will indicate the percentage of DVs converted to
phagolysosomes, thus regulating the efficiency of proteolysis. However, it appears that once
the acidosomes fuse with the DVs, lysosomes are able to recognize and bind to these DVs.10
Thus, when cells were exposed to either NH4Cl, monensin or FCCP after the acidification
process had commenced, little inhibition of lysosome-DV fusion per se was noted.
Lysosomal proteolysis
When cells were pulsed with undigestible materials such as latex beads in axenic medium, the
duration of the processing period was 28 min and t½ for defecation was 37 min. However,
when cells were pulsed with beads and digestible material such as albumin, vacuolar
acidification and lysosome-DV fusion were normal but the retrieval of acid phosphatase was
delayed (Figure 8), and the duration of the processing period was extended to 43 min and t½
for defecation was 60 min (Figure 9).17 These results show that the fourth process of
defecation is influenced by the duration and efficiency of proteolysis, both of which are
influenced by the phagocytosed materials contained within the DVs.
Summary
These results show that in Paramecium a chain of events takes place whereby each event
exerts some control over the subsequent digestive processes. Thus, when DV formation is
blocked, the acidification, lysosome fusion-digestion end defecation processes will not take
place. When acidosome-DV fusion is blocked by CB, vacuolar acidification fails to occur.
Under the last condition, lysosome-DV binding and fusion as well as proteolysis are inhibited
by 90% and the DVs will not begin to be defecated for at least 50 min. whereas labelled DVs
from untreated cells start to be defecated after 20 min. When the decrease in vacuolar pH is
inhibited by NH4Cl inhibiting acidosome-DV fusion, the secondary effect is a much lower
reduction in the lysosome-DV fusion rate than when acidosome-DV fusion is prevented. As
any reduction in the rate of lysosome-DV fusion will result in a slower rate of phagosomes
being converted to phagolysosomes, proteolysis in these cells was found to be reduced. When
the rate of proteolysis is reduced and its completion delayed, retrieval of lysosomal membrane
and enzyme will be delayed, which will result in an extension of the digestive period and/or a
slower rate of defecation. This results in defecation commencing at a later time. Thus, the
overall effect is that the time required to complete a vacuole cycle is dependent on a number
of factors operating in a sequential manner on the vacuole. When one of these factors is
compromised, the resulting effects will be propagated along the chain of steps. This leads to
an extended life of the vacuole as well as a decreased membrane recycling rate.
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Table 1. The phagosome-lysosome system in Paramecium
Four processes DV age (min) Membrane structure pH
Formation and release of DVs
a. old DV membranes recycle back to cytopharynx 0-6 discoidal vesicle 7
b. particles captured by oral and somatic cilia    
c. discoidal vesicles fuse with cytopharynx
d. a newly formed DV is released (DV-I)
Acidification-condensation
a. acidosomes bind to the forming DV
b. acidosomes fuse with DV-I 4-10 acidosome 3
c. DV condenses, fission of membrane tubules
d. vacuolar pH drops from 7 to 3 (DV-II)
Lysosome fusion-digestion
a. lysosomes bind to acidified DV-II
b. lysosomes fuse with DV-II, forming a DV-III 8-20 lysosomes 3-7
c. proteolysis and DV pH returns to 7
d. lyso. membrane & acid phosphatase retrieved
Defecation
a. lyso. membrane and enzyme retrieval completed
b. egestion-competent DV-IV moves to cytoproct >20 ? ?
c. DV and plasma membrane fuse at cytoproct
d. retrieval of spent DV membrane
Figure 1. Cells were pulsed continuously with fluorescent beads of 0.06 m m ( ) or
washed with axenic medium for 3 min after 60 min of pulse (top arrow). Immediately
after the wash (bottom arrow), cells were pulsed with 0.3 m m non-fluorescent beads
and were scored for both fluorescent ( ) and non-fluorescent ( ) bead-labelled DVs.
Figure 2. Cells were pulsed with varying concentrations of fluorescent beads of 0.26 m
m in diameter for two hours and were fixed at various times during the pulse. After
washing, fluorescent DVs in  ³ 100 cells were scored for each time point. For cells
pulsed with the lowest two concentrations of beads, lucifer yellow was added to aid in
the visualization of the labelled DVs.
Figure 3. Binding of lysosomes to the DVs in DV-age- and acidification-dependent.
Because lysosomes in Paramecium contain a distinctive glycocalyx in their luminal
surface and characteristic paracrystalline inclusions, they can be recognized without
acid phosphatase cytochemistry. Micrographs used to determine the number of
lysosomes per m m length of cross-sectioned DV-membrane profile were randomly
selected. In untreated cells, values shown by the closed circles represent the exact DV
age, whereas the open circles represent the mean of DV age in cells that were pulsed
for 3 min. Cells treated with CB ( , 0.3 mM) were not chased to remove excess latex
beads. Each value represents measurements obtained from 1 to 10 micrographs of
various magnifications.
Figure4. Effects of CB on the rate of lysosome-DV fusion. To mark the age of the DVs,
cells were pulsed with nonfluorescent latex beads for 3 min and chased in fresh axenic
medium. Cells were fixed in 4% formalin in phosphate-buffered saline and acetone
permeabilized before being incubated in either of the two phagolysosome membrane-
specific monoclonal antibodies (189D1G12 and 320E7, as represented by the open and
closed symbols, respectively), followed by the FITC-labelled second antibody. For each
time, labelled DVs in ³ 100 cells were scored for positive fluorescence and an average
value for the percentage of fluorescence-positive DVs/cell was thus obtained. CB (0.3
mM) was added to cells with 15-s-old ( , ) or 3-min-old ( , ) vacuoles. To test for
reversibility of the CB effects, aliquots of cells (exposed to CB when their DVs were 15-
s-old) were washed (arrow) after 15 min of CB exposure (n,o). Control cells ( , ) were
exposed to the same amount of DMSO (0.2% v/v) as the experimental cells but not to
CB.
Figure 5. Effects of CB on acid phosphatase activity in labelled vacuoles. Cells, pulsed
with latex beads and India ink and chased in fresh axenic medium, were air dried on
albuminized slides and fixed for acid phosphatase localization by light microscopy
according to the hexazotized rosaniline method of Barka and Anderson.12 CB (0.3 mM)
was added to cells after a 15 s prepulse with latex beads ( ). Aliquots of cells exposed
to CB when their DVs were 15 s old were washed after 15 min (arrow) of CB exposure
(o). Control cells ( ) were exposed to the same amount of DMSO (0.2% v/v) as the
experimental cells but not to CB. Each value represents the average of 4 experiments.
Figure 6. Effects of NH4Cl on the rate of lysosome-DV fusion when vacuolar
acidification was inhibited. Cells were pulsed with small fluorescent beads for 3 min
and then chased. NH4Cl (30 mM) was added to cells containing 0-min-old DVs ( ). Cells
with 3-min-old DVs ( ) were also exposed to this weak base for the purpose of
differentiating their effects on lysosome-DV fusion independent of the DV acidification
process, which was well along at this vacuole age. Vacuoles in control cells ( ) were
not exposed to NH4Cl. Cells were fixed in 5% formalin in 0.05 M cacodylate buffer at pH
7.2, washed in acetate buffer at pH 5.0, and incubated in the Gomori medium13 at 37 °C
for 10 min. For each time, 200 fluorescent DVs were each evaluated for acid
phosphatase activity.
Figure 7. Effects of NH4Cl (30 mM) on the rate of FITC-albumin proteolysis. With (n) or
without ( ) this weak base, cells were pulsed with a mixture of latex beads and FITC-
albumin from 0 to 3 min and chased. Cells were also treated with NH4Cl at 6 min ( ); at
this age NH4Cl at 30 mM has been shown to exert no inhibitory effect10 on the
lysosome-DV fusion rate. For each time, TCA-soluble fluorescence is expressed in
arbitrary units/mg protein.
Figure 8. The rate of acid phosphatase retrieval depends on the contents of the
vacuoles. Cells were pulsed with fluorescent latex beads with ( ) or without ( )
albumin for 3 min and were chased in axenic medium. For each time, 75-225 fluorescent
DVs were evaluated for this enzyme activity.
Figure 9. The duration of the processing period (which is defined as the period of time
when the DVs are not defecation competent) and the rate Of defecation are dependent
on the contents of the vacuoles. Cells were pulsed with latex beads with ( ) or without
( ) albumin for 3 min and were chased in axenic medium. Labelled vacuoles were
scored for the determination of the processing period and the rate of defecation as
described previously.16
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Intracellular proteins are continually being synthesized and degraded back to amino acids.
One important function of intracellular proteolysis is to eliminate from the cell polypeptides with
highly abnormal conformations as may result from mutations, biosynthetic errors and
postsynthetic damage. In recent years much progress has been made in our understanding of
how such abnormal proteins are recognized and selectively eliminated. Such studies have led
to the discovery of new proteolytic systems with unanticipated properties, which are reviewed
in this article.
One important feature of protein degradation in all cells and even within organelles, such as
mitochondria or chloroplasts, is that this process requires metabolic energy. On
thermodynamic grounds, peptide-bond hydrolysis should be a spontaneous process and not
require ATP. Our laboratory has therefore focused on understanding this ATP requirement
because it represented an important clue to discovering the responsible degradative system,
and because it suggested the existence of novel biochemical mechanisms. This research led
to the discovery of a new soluble proteolytic pathway in mammalian and bacterial cells, as well
as in mitochondria, which requires ATP hydrolysis for function. Our knowledge of this pathway
is most advanced in Escherichia coli, which were first shown to contain a new type of enzyme,
an ATP-dependent protease. The best studied such enzyme is protease La from E. coli;
however, as discussed below, similar enzymes appear to be widespread. For example, a
similar ATP-dependent protease has been demonstrated in the matrix of mammalian
mitochondria, and an ATP-requiring protease complex that acts independently of ubiquitin has
recently been demonstrated in the cytosol of mammalian cells. Also, in the cytosol of
eukaryotic cells, there exists a very large protease complex (1.5 kDa) that specifically
degrades proteins conjugated to ubiquitin; it also requires ATP hydrolysis to function.
Protease La
In E. coli the energy requirement for protein breakdown results in large part from the
involvement of the ATP-dependent protease La. This enzyme is encoded by the lon gene and
has been shown to catalyze initial steps in the selective breakdown of proteins with highly
abnormal conformations and of certain normal proteins that are also rapidly degraded.
Protease La is an ATPase as well as a protease, and these two functions are tightly coupled.
In fact, for every peptide bond hydrolyzed in proteins, the enzyme consumes two ATP
molecules. In other words, protease La consumes almost as much energy in cleaving peptide
bonds as the cell uses to form them.
One important property of protease La is its precise regulation and its activation by protein
substrates. The binding of a protein substrate to the protease leads to a marked activation of
the enzyme's capacity to degrade peptide bonds, as shown with exogenous model peptides.
This effect is seen only with protein substrates, such as denatured proteins, which interact with
a regulatory region outside the active site and thereby cause allosteric activation. Native
proteins are not hydrolyzed and do not activate the protease. This mechanism probably helps
ensure that the protease does not exist in an active form in the cytosol, causing cell damage,
but it becomes active only when it binds to a potential substrate (e.g., an unfolded
polypeptide).
Substrates also influence the activity of this enzyme through a novel ATP-ADP exchange
mechanism. The tetrameric enzyme binds up to four molecules of either ATP or ADP, but it
has an even higher affinity for ADP, which is a potent inhibitor of proteolysis. Protein
substrates, such as denatured albumin, both stimulate the binding of ATP analogs to the
protease and also induce the release of the ADP molecules bound to the enzyme. By contrast,
native proteins that are not degraded do not have these effects. Thus, in vivo, ADP molecules
are normally bound to the protease and inhibit its function, until a potential substrate interacts
with protease La. This step causes release of the bound ADP, promotes ATP binding and
enhances proteolytic activity. These unusual properties presumably have evolved to prevent
inappropriate or excessive degradation of normal cell constituents.
In the past year, the complete sequence of the lon gene, which encodes protease La, has
been determined by the dideoxy method. The enzyme contains consensus sequences found in
several other ATP-binding proteins. However, no two sequences homologous to the catalytic
sites of any other proteases were found in this enzyme. Thus, protease La seems to represent
the first of a new class of proteolytic enzymes.
The Heat-Shock Response and Protein Breakdown
The cellular content of protease La is also carefully regulated at the transcriptional level. Our
studies, and those of Neidhardt, indicated that the lon gene is a heat-shock gene, i.e., one of
the cellular genes that is induced at high temperatures and a variety of other stressful
environments. We have shown induction of protease La in other conditions where cells
generate large amounts of abnormal proteins, e.g., after incorporation of amino acid analogs
or after expression of cloned foreign proteins in the bacteria. Under such conditions, the
increased production of protease La seems to help prevent the accumulation of the abnormal
proteins by enhancing the cell's capacity to degrade such polypeptides. Accordingly, the rates
of protein breakdown and the level of protease La are reduced in E. coli mutants (htpR
strains), which have a defect in the expression of heat-shock genes. Also, when wild-type
cells are incubated at high temperatures (42 °C) or when they synthesize large amounts of
incomplete or missense proteins at low temperatures, the cellular content of protease La
increases 2 to 4 fold. Concomitantly, there is an induction of the other heat-shock genes in the
bacteria. The promoter region of the lon gene contains a sequence homologous to that in
promoter regions of other heat-shock proteins. In eukaryotic cells the generation of large
amounts of abnormal proteins also appears to initiate the heat-shock response.
For example, microinjection of denatured proteins into frog oocytes elicits expression of heat-
shock genes. Furthermore, ubiquitin, a critical component of the ATP-dependent degradative
system in eukaryotic cells, is a major heat-shock protein.
Other ATP-Hydrolyzing Proteases
In addition to protease La, E. coli has been found to contain another ATP-Mg-dependent
endoprotease named protease Ti. This enzyme (Mr = 340,000) is composed of two
components, both of which are required for proteolysis, but have distinct functions. One
component, A (subunit Mr = 80,000), is a labile ATPase that is stabilized by ATP. The other
component, P (subunit Mr = 20,000), is a heat-shock polypeptide containing a latent
proteolytic site that can be labelled with diisopropyl-3 fluorophosphate. These subunits show
no proteolytic activity unless they are reconstituted. The ATPase activity of the reconstituted
enzyme is activated 2 to 4 fold by protein substrates. Thus, protease Ti shares many unusual
properties with protease La, such as coupled ATP and protein hydrolysis and protein-activated
ATPase. However, these functions in Ti are associated with distinct subunits that modify each
other's activities. Since these findings are very recent ones, it is still unknown whether similar
enzymes exist in other cell types.
A very similar enzyme to protease La has been found in the mitochondria from rat liver. The
mitochondrial matrix contains an ATP-dependent pathway capable of completely hydrolyzing
abnormal organelle proteins to amino acids. Furthermore, the mitochondrial ATP-hydrolyzing
endoprotease functions independently of ubiquitin, like protease La. This enzyme is very large
(550 kDa) and degrades proteins in an ATP-dependent fashion, rather than resembling the
main proteolytic system in the eukaryotic cytosol. The mitochondrial enzyme even has a
similar specificity for peptides as does protease La, and its ATPase activity is activated by
protein substrates.
The Proteolytic Complexes in Mammalian Cells
Eukaryotic cells contain a 650 kDa (19S) multifunctional complex with multiple endoproteolytic
activities. This structure is composed of 9-12 subunits of 23-34 kDa and hydrolyzes basic,
hydrophobic and acidic peptide substrates as well as proteins. It has been called by many
names (e.g., the multicatalytic protease, macropain, LAMP), but we recently suggested the
name "proteasome" to reflect its proteolytic activity and its identity with the cylindrical particle
known as the "prosome" and present in the eukaryotic nucleus and cytosol. Prior studies had
noted a small activation of this enzyme by ATP. Recently, using rapid chromatographic
procedures and glycerol as a stabilizing agent, we isolated from skeletal muscle and liver a
form of this enzyme that displays a large ATP stimulation. Hydrolysis of peptide substrates
was stimulated up to 9 fold by ATP and of casein 4 to 6 fold. Neither ADP nor AMP had any
effect, nor do nonhydrolyzable ATP analogs. This effect of ATP was very labile, and was lost
with storage. The ATP-stimulated and independent "proteasomes" closely resemble each
other (e.g., in apparent molecular weight, subunit composition and immunological reactivity).
This enzyme does not require ubiquitin for activity, and thus it may be responsible for the ATP-
stimulated hydrolysis of proteins that cannot be conjugated to ubiquitin (e.g., ones that lack
free amino groups). Although its precise role in intracellular protein breakdown is still
uncertain, this enzyme is clearly the major proteolytic activity in the cytosol of mammalian cells
at neutral pH.
The elegant studies of A. Hershko, A. Ciechanover and co-workers have shown that the ATP-
dependent pathway in mammalian cells requires the heat-stable polypeptide, ubiquitin. In this
process, protein substrates undergo conjugation to ubiquitin by a multistep process requiring
ATP. This modification marks them for rapid degradation. Our laboratory and that of
Rechsteiner have identified a very large (1.5 kDa, 26S) enzyme complex within the cytosol
that specifically hydrolyzes these conjugated proteins. The ubiquitin-conjugate-degrading
enzyme (UCDEN) and the proteasome differ in many respects, including size, subunit
composition and requirement for ATP. However, these enzymes seem to co-purify and to
function in concert during ubiquitin-dependent proteolysis, and we have found that monoclonal
antibodies against the proteasome block the ubiquitin-dependent pathway. Although the
structural relationships between these two large enzyme complexes remain to be elucidated, it
seems most likely that the proteasome functions as a subunit of the larger (26S) conjugate-
degrading complex.
Prospects
Appreciable progress has been made in our understanding of protein breakdown in bacteria
and mammalian cells, but many important questions are still unresolved. Greater knowledge
about protein turnover and the heat-shock response in parasitic organisms is highly desirable.
Many similarities, and important differences, may be discovered through such studies of
protozoa. For example, it has been shown that the gene for ubiquitin in trypanosomes is
induced by heat shock, but it is organized in a very different fashion from that in mammals,
since it contains up to 50 transcripts of ubiquitin in linear array. The significance of this
interesting difference is unclear, probably because virtually nothing is known about protein
breakdown, the role of ubiquitin and the heat-shock response in these microorganisms.
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African trypanosomes, the causative agent of "nagana" in livestock and sleeping sickness in
man, are protozoan parasites that are cyclically transmitted by tsetse flies (Glossina spp.).
They have a 12-15 nm thick coat of a variable surface glycoprotein (VSG) covering the entire
surface of the organism.¹ The generation of a new population of trypanosomes with a different
surface coat has been shown to be the result of a clone-specific change in the expression of a
particular VSG gene.2,3 It is clear that the ability of the parasite to alter its VSG2 has
hampered the development of a conventional vaccine against trypanosomiasis. Therefore, a
clearer understanding of the biochemistry of the VSG may suggest alternative targets for
immunological intervention.
The VSGs from T. brucei are proteins known to be attached to the plasma membrane via a
glycosyl-phosphatidylinositol (GPI) anchor.4 In addition, the presence of the GPI anchor is
probably responsible for the immunological cross-reactivity observed between different
VSGs.2,4,5 It has been postulated that the VSG is selectively released in vivo from the plasma
membrane of the trypanosome as a result of the removal of the dimyristol-glycerol domain
from the phosphatidylinositol via an endogenous phospholipase-C (PLC).6,7,8 The form
containing the entire GPI anchor is commonly referred to as the membrane form of VSG
(mfVSG) while the form lacking the dimyristolglycerol moiety is known as the soluble form of
VSG (sVSG). Using subcellular fractions, we have that the VSG-specific PLC resided in the
membrane of the flagellar pocket.9 However, we could not exclude the possibility that the
mfVSG phospholipase-C activity could be in other membrane enclosed compartments: coated
vesicles, endosomes, or other prelysosomal compartments. Internal localization of the mfVSG-
PLC has also been postulated by others.4 The present report is an attempt to address this
problem further.
Methods
Trypanosoma brucei clone MITat 1.52 was grown in lethally irradiated rats (600 rad) and the
organisms isolated from the infected blood using isopynic Percoll gradients followed by DEAE-
cellulose chromatography supplemented with nucleosides.9 The cells were washed twice in
ice cold SHKE (250 mM sucrose, 50 mM HEPES, 25 mM KCl, 1 mM EDTA, pH 7.4), and a
membrane fraction prepared by the method of Grab et al..9 The fraction with the highest
specific activity for mfVSG phospholipase-C (which banded on top of 14.4% Percoll; Fraction
V) was then applied onto a 12.5-42.5% SHKE gradient and centrifuged (4 °C) for 16 hours in
an SW-41 rotor. The gradient was collected and the fractions analysed for total protein,10
mfVSG-PLC,9 and adenyl cyclase.11 In one experiment the cells were resuspended in RPMI-
1640 medium (108/ml) supplemented with 100 m m hypoxanthine and BSA (10 mg/ml) and
incubated at 37 °C for 30 minutes before fractionation. The BSA content was determined by
conventional liquid phase RIA using rabbit anti-BSA serum (Miles-Yeda, Ltd.) and 125I-BSA.
Results and Discussion
Data from several experiments showed that the mfVSG-PLC activity resided in two membrane
fractions with densities of 1.13 and 1.14 gm/ml respectively (Figure 1), with equally highly
specific activity in each. However, most of the enzyme was in the 1.14 gm/ml peak. Adenyl
cyclase, a putative flagellar pocket membrane marker12, was found in high specific amounts in
the 1.13 density fraction as well as in two broadly banding fractions with average densities of
1.11 (flagellar pocket membranes?13) and 1.09 gm/ml, with the bulk of the total activity
residing in the lighter fractions (Figure 2). To clarify whether any of the mfVSG-PLC containing
fractions could be of intracellular origin, the trypanosomes in one experiment were
preincubated with BSA to load the endocytic compartments of the parasite. The 1.13 density
fraction contained the highest specific amount of BSA (Figure 3).
Although preliminary, the data suggest that the 1.13 density fraction may be of endosomal
origin resulting from the fusion of a relatively higher density mfVSG-PLC containing fraction (d
= 1.14) with a lighter membrane component (density less than 1.12) of possible flagellar
pocket origin. The intracellular localization of the mfVSG-PLC is also suspected by Bülow et
al.14 The data and interpretation, although attractive, are still far from complete. One should
be able to ascertain this by incubating the trypanosomes under conditions were BSA or
horseradish peroxidase is known to load only the flagellar pocket region and other internal
organelles. In addition, other fractionation methods using other physical parameters are being
exploited: e.g., free-flow electrophoresis.
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Figure 1. Sucrose density gradient analysis of Fraction V. The relative  specific activity
(RSA) and relative total activity (RTA) for mfVSG phospholipase-C(mfVSG-PLC) in
various fractions are shown.
Figure 2. Sucrose density gradient analysis of Fraction V. RSA and RTA for adenyl
cyclase activity.
Figure 3. The relative specific content for BSA.
  
  
Understanding Human Lysosomal Diseases: A Review
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Our present knowledge about the biogenesis and function of lysosomes would never have been
established without the presentation of a variety of lysosomal disorders by nature's diversity.
Research about lysosomes provides an excellent example of cooperation between medical and
biological sciences. Medicine cannot make any progress without basic science, but the
advancement of basic science also depends on clinical observations and questions. It has been
estimated that 1 in 100 children has a monogenic disorder. Metabolic diseases amount to only
about 10 to 20% of the monogenic disorders and almost exclusively follow an autosomal-
recessive or X-linked inheritance.
About 250 inherited metabolic diseases are known today and more than 30 have been identified
as lysosomal diseases, which thereby represent the largest organelle-specific group. About 70
metabolic diseases affect the central nervous system. Of the 250 diseases, only about 20% have
a treatment protocol. With regard to the frequency of the particular disorders, we can expect 1 to 2
children in 1,000 to suffer from an inborn error metabolism.
Lysosomes degrade almost any type of physiological macromolecule (Table 1). A storage disease
will result either from a missing degradation step or from defective release of the degradation
product.
Lysosomal storage diseases can be classified into three groups, shown in Table 2. The most
frequent by far is the absence of an enzyme needed for degradation. This lack of enzyme activity
can be caused by mutations leading to absence of the protein or to defective enzyme protein, or
by defects of activators needed for the degradation of some sphingolipids, or by defects of
protective stabilizing proteins or peptide sequences. The largest group of lysosomal disorders are
the deficiences of hydrolases involved in the degradation of heteroglycans, presenting as
mucopolysaccharidoses, sphingolipidoses, glycoproteinoses and mucolipidosis I and IV.
The second type of lysosomal disease results from defective synthesis of the specific
carbohydrate recognition marker as shown in mucolipidosis II and III. Research about these
disorders has increased basic knowledge about the carbohydrate recognition marker.
The third group is likely to comprise transport defects through the lysosomal membrane. Examples
in man are cystine storage in cystinosis and N-acetylneuraminic acid storage in Salla disease.
There still remain diseases which from morphologic observations are likely caused by a lysosomal
dysfunction but for which the biochemical defect has not been established yet. The different forms
of the large group of ceroidlipofuscinosis and the Chediak-Higashi syndrome are among these
diseases.
The importance of genetic lysosomal diseases in the understanding of lysosomal biogenesis and
function is outlined in Table 3. Steps in the formation of lysosomal enzymes, some of them
facultative (+/-), are listed in this table and examples for genetic defects are given.
How can inborn errors of metabolism been treated? Table 4 summarizes the therapeutic
strategies that have been used to treat inborn errors of metabolism. Only three treatment methods
are of potential use for lysosomal diseases. Removal of toxic material is the rational for the
treatment of cystinosis with cysteamine. When treatment is started early, the progress of the
disease can be stopped. Cystinosis and Fabry's disease are diseases for which renal
transplantation may be considered in the event of renal failure. Enzyme replacement might be a
technique especially interesting for the treatment of lysosomal diseases, because the lysosomal
enzymes exhibit a carbohydrate recognition marker for which receptors are expressed also on the
cell surface pathway to the desired destination, the lysosome. However, practical realization of this
concept is difficult, as summarized in Table 5.
Despite these difficulties, there have been many efforts to apply enzyme replacement for the
treatment of human lysosomal diseases. All the earlier trials with discontinuous treatment have
been unsatisfactory, because either the enzyme concentration was low, such as in plasma, or the
side effects were not acceptable, such as after repeated buffy coat transfusions, or simply
because of the technical problems to be overcome to gain the amount of enzyme needed for
treatment. But the use of enzyme preparations for intravenous application is still being further
developed. Molecular genetics allow the biosynthesis of large amounts of the missing enzymes.
They can be modified to neoglycoproteins by adding carbohydrates, which can direct the enzymes
to targeted organs. Another promising technique is to form more stable hydrolase-albumin
complexes linked to antibodies that are directed to surface antigens of the targeted organ.
However, continuous enzyme replacement from transplanted organs seems to be more feasible.
Bone marrow transplantation might be a viable treatment method for some lysosomal diseases. It
has been shown that after bone marrow transplantation, a previously missing enzyme activity can
be detected in organs such as the liver, spleen and kidneys. But for all diseases with CNS
involvement, the blood-brain barrier seems to limit this approach. It is presently under discussion if
this is completely true, because microglia cells, which comprise 5% of the brain cells, may be
derived from bone marrow stem cells. If this proves correct, a very early bone marrow
transplantation might even benefit those with lysosomal diseases with CNS involvement.
However, in the diseases listed in Table 6, bone marrow transplantation already has been
attempted as an experimental, sometimes desperate, trial. The presentation of data and the
discussion of the results is very controversial and a definite recommendation cannot be given.
The strategy for the detection of a lysosomal storage disorder is outlined in Table 7. The cell
fractionation technique we primarily use is free-flow electrophoresis. This technique enables us to
purify lysosomes from almost any type of tissue culture cells, including lysosomal storage disorder
cells with altered physical properties of lysosomes. It seems that free-flow electrophoresis is the
method of choice for the isolation of lysosomes, especially from storage disease cells.
Many aspects of lysosomal diseases are still poorly understood (Table 8). There remain a great
number of questions. One of these questions is: what makes the different phenoytypic
expressions of the same enzyme defect? For instance, the same enzyme, alpha-iduronidase, is
defective in two different diseases, the mucopolysaccharidoses type Hurler and Scheie-both with
similar skeletal symptoms, but the first with severe brain damage, the second without any. It is
most likely that the explanation of such differences will come from molecular genetics. An
important question is why and how a lysosomal storage process causes a disease; this question
will be answered by biochemists and biologists. These are related problems. The first concerns
the specificity of a disease caused by a certain storage product. What we need is more insight
into the biochemical sequelae damaging cells and organs and leading to a disease. The other
unsolved questions are what happens to the stored material: what is its final destination, how does
it get there, does it affect endocytosis, is it undergoing exocytosis, does it affect the function of
other cells or organelles? These questions can be answered only by continuous research and
collaboration among biochemists, cell biologists, geneticists and clinicians.
Table 1. Digestive function of lysosomes
Table 2. Human lysosomal disorders
A: Defective enzyme activity
(missing or defective protein, defects of activator or protective protein)
- Mucopolysaccharidoses
- Sphingolipidoses
- Glycoproteinoses
- Mucolipidoses I and IV
- Glycogenosis type 2
- Acid lipase deficiency
B: Enzyme misplacement
- Mucolipidoses II and III
C: Transport defects
- Cystinosis
- Sialic acid storage diseases
D: Unknown
- Ceroidlipofuscinoses
- Chediak-Higashi syndrome
Table 3. Biogenesis of lysosomal enzymes
Table 4. Therapeutic approaches to inborn errors of metabolism
1. Dietary restriction of substrate
2. Replacement of missing product
3. Removal of toxic storage material
4. Activation of enzyme activity
5. Replacement of missing enzyme
6. Replacement of destroyed organ
Table 5. Enzyme replacement for the treatment of lysosomal disorders - methods and
difficulties
Methods
A: Discontinuous Therapy
1. Plasma infusion
2. Leucocyte transfusion (buffy coat)
3. Purified enzymes from urine, plasma, spleen and placenta
B: Continuous Therapy
1. Organ transplantation
2. Bone marrow transplantation
Difficulties
- continuous supply of enzyme necessary
- ligand properties of enzyme versus receptor specificity of target organ
- one enzyme form may not reach all tissues affected
- blood-brain barrier?
Table 6. Bone marrow transplantation in human lysosomal diseases
Mucopolysaccharidoses Sphingolipidoses
MPS I (Hurler)* Metachromatic Leukodystrophy*
MPS II (Hunter) M. Niemann-Pick*
MPS IIIA, B (Sanfilippo) M. Krabbe*
MPS IV (Morquio) M. Gaucher*
MPS VI (Maroteaux-Lamy)*
*Animal model available.
Table 7. Strategy for the detection of lysosomal storage diseases
Genetic transmission of a disease recognized (frequently associated with organomegally, +/- CNS
damage)
blood smear: lymphocyte vacuoles
tissue biopsy: intracellular storage vacuoles (e.g., liver, kidney, nerve tissue, bone marrow)
Analysis of storage tissue: Identification of lysosomes:
- histological differentiation by staining
procedures
- EM-cytochemistry
- isolation and chemical analysis of storage
material
- immunocytochemistry
- cell fractionation with co-purification of lysosomes/storage
material
Table 8. Open questions about lysosomal disorders
1. Different phenotypic expressions of the same defect (e.g., Huler/Scheie)
2. Relation of storage product to clinical expression
a) specificity of cell or organ alteration by a particular storage product (e.g., cystine, sialic acid)
b) the fate of undigested material:
- is the endocytic pathway affected?
- is exocytosis involved?
- is the cooperation of lysosomes with other cell compartments disturbed?
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The technique of introducing exogenous DNA into living cells, known as transfection, is a
commonly used and very important approach in molecular biology. A number of methods have
been developed to achieve this, 1-12 but none of them can likely be used in vivo studies. In this
paper we would like to introduce a pH-sensitive immunoliposome delivery system that can
efficiently deliver such macromolecules in vivo in a target-specific manner.
Mechanism of delivery
Immunoliposomes are lipid vesicles coated with antibodies that have been attached with
hydrophobic anchors.13 These surface antibodies direct the specific interaction of liposomes
with antigen-expressing cells. Previous studies revealed that the bound vesicles are taken up
by cells through a receptor-mediated endocytotic process.14 To prevent liposomes and their
contents from being delivered to the lysosomes for degradation, pH-sensitive
immunoliposomes are developed to enhance a prelysosomal discharge of the liposome
contents into the cellular cytoplasm.
It was found for the first time in this laboratory that liposomes composed of unsaturated
phosphatidylethanolamine and a weakly acidic amphiphile, such as fatty acid, become
destabilized and fusion-competent when the pH of the medium is reduced to below 6.5.15 If
these types of liposomes are endocytosed into endosomes that have a pH range of 5 to
6.5,16,17 they will release their contents into cell cytoplasm by fusing with the endosome
membrane from within and/or rupturing the endosome membrane.18 The prelysosomal
discharge of the liposome contents significantly enhances the cytoplasmic delivery efficiency
of the liposome for anti-tumor drugs,19 toxin20 and DNA.18,21
Delivery of plasmid DNA in vitro
In our model target system, monoclonal antibodies, anti-H2Kk, are used to direct liposomes to
either mouse Ltk or RDM-4 cells that express the murine major histocompatability antigen H-
2Kk on the cell surface. Plasmid pPCTK-6A - containing the herpes simplex virus thymidine
kinase (tk) gene under control of a cAMP regulatory element, which is located at 5' upstream
of the rat phosphoenolpyruvate carboxykinase (PEPCK) gene - were encapsulated into:
1. pH-sensitive immunoliposomes composed of dioleoyl phosphatidylethanolamine
P (DOPE):cholesterol: oleic acid (4:4:2), and
2. pH-sensitive immunoliposomes composed of dioleoyl phosphatidylcholine
(DOPC):cholesterol: oleic acid (4:4:2).
Both types of liposomes were able to deliver the plasmid to target cells as assayed by
expression of the gene product (Table 1).22 But the amount of thymidine kinase activity in cells
transfected by pH-insensitive immunoliposomes was eight times less than that transfected by
pH-sensitive ones. Plasmid DNA entrapped in the pH-sensitive liposomes that bear no
antibody also transform the cell phenotype less efficiently. Thus, both pH-sensitivity and
liposomal antibody are important for efficient delivery. About 50% of the Ltk cells treated with
the pH-sensitive immunoliposomes incorporated H-thymidine into the cellular DNA.
The long-term transformation efficiency of Ltk- cells by pH-sensitive immunoliposomes was
also examined and compared with that by traditional calcium-phosphate precipitation method.
We arbitrarily defined the "long-term transformation efficiency" as the proportion of treated
cells that can undergo at least three cell divisions within 12 days in a selection medium.
Therefore, a value of 5.5% was obtained for pH-sensitive immunoliposome method, whereas
a much lower efficiency, 6 × 10-4, was obtained for the latter technique.23
Delivery of plasmid DNA in vivo
To further demonstrate the utility of the pH-sensitive immunoliposome delivery system, a nude
mouse model was used to show the target specificity of the DNA delivery. We entrapped into
liposomes a plasmid, pBB 0.6, carrying E. coli chloramphenicolacety-1 transferase (CAT)
gene under control of PEPCK promoter. The target RDM-4 lymphoma cells bearing H-2Kk
antigen were grown as ascites tumor in Balb/c nude mice. A 3H-lipid marker was used to
monitor the distribution of liposomes. Several treatments were performed, including:
1) Mice bearing RDM-4 lymphoma cells in peritoneal cavity and injected i.p. with
pH-sensitive immunoliposomes containing the plasmid DNA
2) As in 1 except that liposomes are pH-insensitive composition
3) As in 1 except that liposomes are antibody-free, and
4) As in 1 except mice bearing no tumor cells
3H distribution in different organs revealed that without the presence of either tumor cells in
the mice or antibody on the liposome, the majority of the liposomes were taken up by the
spleen, regardless of the lipid composition of the liposomes. Moreover, liposomal antibody was
important for targeting; twice the amount of antibody-bearing liposomes was bound to RDM-4
cells compared with the antibody-free liposomes.21
The importance of liposomal antibody and pH-sensitivity for optimal delivery was further
confirmed by expression of the CAT gene. CAT activity of RDM-4 cells from mice treated with
pH-sensitive immunoliposomes was 6-fold higher than that with antibody-free liposomes. Up
to 25-fold increase of CAT activity in the tumor cells was observed when mice were treated
with pH-sensitive immunoliposomes instead of pH-sensitive immunoliposomes. Surprisingly,
no significant amount of gene product was detected in other organs of the treated mice.21 The
organ distribution of the CAT activity in mice treated with the pH-sensitive immunoliposomes
containing the plasmid DNA is shown in Figure 1.22 It was evident that the expression of the
CAT gene in tumor cells was cAMP-dependent.
Conclusions
The pH-sensitive immunoliposomes are able to deliver macromolecules specifically to the
cytoplasm of the target cell. The working mechanism of this system is summarized in Figure
2.23 The DNA delivery potential of the liposome has been demonstrated both in a tissue
culture system and in an animal model. Future work will further develop the liposome system
for cancer and viral chemotherapy, vaccine and gene therapy.
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Table 1. Effect of liposome composition and targeting ant body on the thymidine kinase
activity of Ltk cells
Lipid composition Antibody Activity of tk (cpm/mg protein)a
DOPC:chol:OAb
(4:4:2)
+ 9.7 ± 3.6
DOPE:chol:OAc
(4:4:2)
+ 76.8 ± 28.7
DOPE:chol:OAc
(4:4:2)
- 11.7± 6.8
a mean s.d. of 30 measurements.
b pH-insensitive composition.
c pH-sensitive composition.
Figure 1. CAT activity in ascites cells and organs of nude mice injected with pH-
sensitive immunoliposome containing the plasmid pBB0.6. Mice were also injected with
(open bars) or without (hatched bars) a mixture of 8-Br-cAMP and methyl-isobutyl-
xanthine to turn on the expression of the CAT gene.
Figure 2. Schematic presentation of the interaction of immunoliposomes with the target
cells. The liposomes bind to cell membrane by interaction between antigens ( ) and
antibodies (*). 1,2 First, liposomes appear in the endosomes (4) via endocytic pathway.
Some of the endocytic liposomes may be transported into lysosomes6 which results in
degradation of the liposomal DNA. Most of the pH-sensitive liposomes in the acidic
endosomal compartments may fuse with endosomes that result in the delivery of DNA
into cytoplasm.5 Alternatively, disruption of the endosomal membrane may also deliver
the DNA into cytoplasm.7 The DNA delivered into cytoplasm may be transported into
the nucleus by the "nuclear membrane binding protein(s)" or the "DNA-binding
protein(s)". The exogenous DNA in the nucleus is eventually integrated into the
chromosome8 that results in the expression of gene products.9,10
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Prior to secretion, secreted proteins are found in cytoplasmic secretory vesicles in eukaryotic
cells. Secretion of protein almost universally involves fusion of the secretory vesicle to the
plasma membrane. Although the mechanism of protein secretion appears to be the same in all
eukaryotes, there is considerable variation in whether or not secretory vesicles accumulate in
the cytoplasm, in how the secretion rate is regulated and where secretion occurs in the cell.
Cells such as lymphocytes store very little assembled secretory protein in their cytoplasm,
while cells such as exocrine cells and mammary epithelial cells (Table 1) store secreted
proteins in large secretory vesicles that characteristically have electron dense cover.1,2 The
rate of secretory vesicle fusion may be affected by no known stimulus, as in the case of
lymphocytes or mammary epithelial cells, or it may be regulated by an intracellular second
messenger, as is the case for endocrine, exocrine and neuronal cells, for example. Finally, the
sites of secretory vesicle fusion may be restricted. As can be seen from Table 1, secretion can
be apical, basolateral or non-polarized. Regulated secretion is found only in cells that have
storage vesicles, consistent with a model in which regulated secretory cells store their newly
synthesized secreted products until an appropriate extracellular signal triggers phasic release.
Newly synthesized membrane proteins reach the cell surface in transport vesicles. Because
such transport vesicles have an internal volume, they will contain all types of newly
synthesized secretory protein unless an exclusion mechanism operates. Conversely, storage
secretory vesicle membranes will carry membrane proteins to the surface, unless there is a
membrane protein exclusion mechanism. To test whether membrane proteins were excluded
from secretory granules, we purified secretory granules from the mouse pituitary cell line, AtT-
20, and showed that they lacked a newly synthesized membrane protein, gp70.3 We
concluded that plasma membrane proteins were excluded from secretory granules and exited
the cell by a different exocytotic pathway. This pathway we named the constitutive pathway, to
distinguish it from the exocytotic pathway for release of storage granule contents, which had
previously been called regulated secretion The constitutive pathway was defined initially as the
pathway that plasma membrane proteins take to the surface of cells. Externalization of
membrane proteins was found to be stimulus-independent, whereas externalization by the
regulated pathway was stimulus-dependent. Since some basal secretion can take place from
the regulated pathway even in the absence of a stimulus, constitutive secretion is not the same
as stimulus-independent secretion in our usage. Others equate the two, and so include in
constitutive secretion stimulus-independent release from secretory granules.4 We prefer to
retain a definition of pathways that is based on partitioning newly synthesized proteins.
In the pituitary cell line, AtT-20, both membrane proteins and secreted proteins can be
excluded from the secretory granule.5 The extracellular protein, laminin, appears to be one of
the secreted proteins not in secretory granules.6 The simplest model that fits currently
available data is that the secreted proteins that are excluded from the secretory granule exit
the cell by the constitutive pathway taken by excluded membrane proteins. Direct proof of this
model is lacking. There may be more than one pathway for constitutive secretion; fusion of
immature granules could occur on the regulated pathway.4,7
We have explored how different proteins are transported to the cell surface by transfecting
DNA encoding secretory proteins into secretory cells. We discovered that proteins fell into two
categories, those transported like ACTH, by the regulated pathway, and those transported like
laminin, by the constitutive pathway. The data for two such proteins - trypsinogen and the
kappa light chains of immunoglobulin - are given in Table 2 and compared with the secretion
of ACTH, monitored by radio-immunoassay. There is a slowly turning-over pool for both ACTH
and trypsinogen, which can be diminished by stimulation. In contrast, there is no pool with an
unusually long half-time for the kappa chains, nor is the size of the pool affected by
stimulation. The secretion rate of trypsinogen and ACTH is increased four to six times by a
stimulus, while kappa secretion rates are unaffected.
We have attempted to look at what features of trypsinogen cause it to enter the regulated
pathway using in vitro mutagenesis. Data on three mutant trypsinogens are compared with a
wild type in Table 3. The sorting index for the wild type calculated in this experiment is 0.10.8
One of the mutants, TB08, has approximately the same sorting index, while two (TB09 and
TB10) appear to be sorted more effectively than the wild type. Increases of sorting efficiency
on mutagenesis have also been reported for defective insulin.9
Sorting of proteoglycans into secretory granules
We have compared the sorting of a free oligosaccharide chain to protein sorting. Dense core
secretory granules contain a sulphated proteoglycan of the chondroitin sulphate type.5,10 The
sorting of free glycosaminoglycan (GAG) side chains, unattached to polypeptide chains, can
be determined directly by labelling cells with 35S-sulphate in the presence of the GAG chain
initiator, umbelliferyl xyloside.10 When we apply our conventional sorting assay to the
partitioning of free GAG chains between the pathways, we get a surprising result (Figure 1),
namely that the sorting of trypsinogen and GAG chains are indistinguishable. It is unlikely that
a protein and a carbohydrate can be recognized by identical sorting machinery. We are
considering the following alternative explanations. (1) The GAG chains are synthesized in the
secretory vesicles after sorting has occurred. If so, the remarkable similarity between the
sorting indices for proteins and GAG chains would then be fortuitous. (2) The sorting index
represents relative volume flow from the Golgi region to the two pathways, and constitutively
secreted proteins are excluded from the regulated pathway. (3) Proteins and GAG chains
condense together into a dense core in immature granules prior to sorting and are sorted
together.
In addition to GAG secretion, we have re-examined the sorting of an intravesicular chondroitin
sulfate proteoglycan that we had characterized earlier.10 Measuring the sorting index of this
proteoglycan by conventional techniques,8 we discovered that the sorting index was eight
times higher than that of trypsinogen. Such apparently efficient sorting is strongly reminiscent
of that of the hybrid protein created by deleting the C-peptide from proinsulin.9 There are at
least two possible interpretations of these findings, proteoglycan could be very efficiently
sorted, perhaps, for example, by forming the condensed core to which the hormones adsorb.
Alternatively, the proteoglycan that we measure could be generated largely or exclusively
within the secretory granule. This would give a misleading high sorting index. To incorporate
the data on the hybrid insulin molecule sorting into these models we would propose either that
the hybrid molecule, perhaps because of its inability to generate correct disulfide bonding,
condenses on a core matrix more readily.9 An alternative explanation is that the antigenicity of
the mutant proinsulin is generated only in the milieu of the secretory granule.
Conclusion
While there is no doubt some proteins are sorted into secretory granules and some are not,
the mechanism of sorting remains obscure. It certainly does not seem to be as simple as
targeting lysosomal enzymes to the lysosome. Mutations in proteins can increase their
efficiency of sorting into pathways. Increases in efficiency would be consistent with models of
sorting in which proteins need to come out of solution and condense to a solid matrix prior to
sorting, a model consistent with current data from electron microscopy.11,12 The probability of
coming out of solution to form a matrix could readily be enhanced by mutation of the three-
dimensional structure. Likewise, a core model could explain the co-sorting of free GAG chains
and proteins. Proteins excluded from the regulated pathway would be those excluded from the
forming core, although the accuracy of current data would also fit with lack of condensation,
but no exclusion from the core. Even if matrix formation underlies protein sorting in secretory
cells, the problem remains how selected membrane proteins, the integral membrane proteins
of the secretory granule, are segregated with the dense protein cores.
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Table 1. Secretion patterns in eukaryotes
Tissue Storage in secretory vesicles Regulated Polarity
Exocrine + + apical
Mast cell + + -
Endocrine + + basal (?)
Mammary epithelia + - (?) apical
Lymphocytes - - -
Liver - - basolateral
Storage of secretory vesicles is positive when secretory vesicles usually with characteristic
dense cores accumulate in the cytoplasm. Secretion is regulated when a known extracellular
signal increases or decreases the rate of secretory vesicle fusion. Polarity of secretion is
defined for epithelial cells. To what extent endocrine cells should be considered as polarized is
not clear at this time.
Table 2. Comparison of secretion properties in AtT-20 cells
ACTH1 TRYPSINOGEN2 KAPPA2
Half-time of storage pool (h) 18.0 ± 4.0 (3) 14.8 ± 1.7 (4) 1.8 ± 0.5 (3)
Released on stimulation (%h) 12.3 ± 1.3 (3) 17.1 ± 1.0 (4) -1.3 ± 2.0 (3)
Secretion rate (stimulated/rest) 5.6 ± 1.5 (3) 4.1 ± 1.5 (5) 0.9 ± 0.5 (3)
The releasable pool is considered to be the entire intracellular ACTH concentration measured
by radioimmune assay, or the amount that remains in the cell extract after an overnight label
with 35S-methionine, and a several-hour chase. The half-time is calculated from the rate of
release from the pool per hour. The amount released on stimulation is the fraction of the pool
released in one hour in the presence of a stimulus, less the fraction released in the absence of
a stimulus. The ratio of the secretion rate in the presence of the stimulus, in this case, 8-Br-
cAMP, to that in its absence is given. The figures in parentheses are the numbers of
measurements.
1 Measurements made by radioimmune assay.
2 Measurements made after a 15-hr label with 35S-amino acids followed by a 3 - to 6-hr
chase.
Table 3. Sorting efficiencies of trypsinogen mutants
Trypsinogen Wild type TB08 TB09 TB10
Sorting index - 70 - 79 145 - 149 243 - 245
Region deleted 0.10 0.08 0.20 0.21
The sorting indices were measured exactly as described by Moore & Kelly (1985) and
Burgess et al. (1987).
Figure 1. Comparison of chase kinetics for glycosaminoglycans and trypsinogen. The
data for trypsinogen were generated exactly as described earlier (Burgess et al., 1985)
in that cells were labelled with 35S-amino acids for 15 hr. The rate of release at the end
of the labelling period was determined by immunoprecipitation of labelled trypsinogen.
Similarly, the amount secreted during chase periods of 0 to 3 hr, 3 to 6 hr and 6 to 9 hr.
Also included is the increment in release rate between 6 and 9 hr, when 5 mM 8 Br-
cAMP was included in the chase medium. To label free GAG, the GAG chain initiator,
umbelliferyl xyloside, was added to the medium in the presence of 35S-sulphate, as
described previously (Burgess and Kelly, 1984). The secreted GAG chains, identified by
their characteristic "staircase" appearance on polyacrylamide gels, were quantified by
elusion from the gels.
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A resurgence of interest in proteolytic enzymes has occurred in recent years as a
consequence of the greater realization of the importance of proteases in the control of
intracellular metabolic processes.1 Their involvement is now known to extend beyond simple
protein digestion or the regulation of blood clotting and complement activation, and involves
such complex tasks as hormonal processing, intracellular protein transport and the regulation
of metabolic pathways. However, most work has concentrated on mammalian cells and only a
small amount has been done on microorganisms. For example, our knowledge of the
proteolytic enzymes of African trypanosomes is confined almost entirely to those found in the
endosomal/lysosomal system, namely, their acidic thiol-dependent proteases.2 In contrast,
little or nothing is known about the proteases that are involved in the subtle regulation of their
metabolic processes. In part this may be due to the presence of very high levels of lysosomal
cathepsin-like activity in the African trypanosomes, which tend to mask the presence of other
highly specific enzymes. Consequently, there is a need to find ways of circumventing the
blanketing effect of the trypanosomal lysosomal proteases.
In general, proteases are classified according to the mechanism of action of the enzymes.
This is frequently ascertained by employing specific inhibitors known to react with particular
amino acid residues within the enzymes. For example, trypsin and related enzymes are shown
to be serine proteases by their reaction and inhibition with diisopropylfluorophosphate (DFP), a
reagent that reacts almost exclusively with serine residues at the active sites of these
enzymes. Here we describe some of our observations on the uptake and hydrolysis of
fluorescently labelled materials by African trypanosomes as well as some effects of protease
inhibitors on these organisms.
Materials and Methods
Analysis of the thiol-dependent proteolytic activity of African trypanosomes, and of the serum
derived modulator of these proteases, was done by electrophoresis in fibrinogen containing
sodium dodecylsulphate polyacrylamide gels (Fbg-SDS-PAGE) as described previously.2,4
Detection of serine esterases was performed by incubating 3H DFP (Amersham, UK) with the
respective material as described by Scheiner and Quigley.5 The uptake of 3 m M 3H DFP by
Trypanosoma brucei6 was performed in pH 8.0 phosphate buffered saline glucose (PSG).
Uptake of rhodamine-lisamine-BSA (Molecular Probes Inc., Eugen, OR, USA) was performed
on an SLM Aminco 8000 spectrofluorometer (excitation, 560 nm; emission, 590 nm) using
6,7 
trypanosomes isolated and incubated (in PSG pH 7.4) in the presence of 50 m M
hypoxanthine.7 The hydrolysis of Z-Phe-Arg-NHMec was followed specrofluorometrically
(excitation, 380 nm; emission, 460 nm).
Results
Trypanosoma brucei incorporate 3H DFP into TCA precipitable material. The uptake is dose
and time dependent and conforms to a first rate order equation (Figure 1). The
chloromethylketones Ac-Ala-Ala-Ala-AlaCK, MeOSuc-ValCK, TPCK, or TLCK had a
statistically insignificant effect on the total uptake of 3H DFP by either trypanosomes or
trypanosome lysates. Analysis of the proteins labelled with 3H DFP, by SDS-PAGE and
fluorography, showed a doublet at 71 kDa, minor bands at 52 and 39 kDa and a band at 27
kDa. Only minor differences were observed between the control and TLCK or TPCK treated
samples. Curiously, the presence of TPCK slightly enhanced the labelling of the 39 kDa band.
A doublet of Mr approximately 70 kDa was labelled in living trypanosomes, the lower of which
was only weakly labelled in homogenates of the parasites.
Analysis by Fbg-SDS-PAGE clearly demonstrates the presence of thiol-dependent proteases
in African trypanosomes, which are apparently localized within their endosomal/lysosomal
system.2 We have observed and now isolated, a moiety from rat serum which has the capacity
to bind to and either stabilize or activate this lysosomal proteolytic activity. The molecule has a
similar Mr to serum albumin but, unlike serum albumin, it does not bind to amicon blue dye-A.
It also has properties similar to kininogens (pI 4.8) and is found in commercial preparations of
human high and low molecular weight kininogens, but again, antibody reactivity suggests
distinct identities of the molecules.
Characterization of the activating molecule is under way, but it is also necessary to ascertain
whether it is taken up by African trypanosomes. We are therefore studying endocytosis by
these parasites. Preliminary studies have been performed using Z-Phe-Arg-NHMec and
rhodamine-BSA. Providing the parasites are properly temperature equilibrated, they show an
almost immediate steady state hydrolysis of Z-Phe-Arg-NHMec. (If they are not temperature
equilibrated there is a lag phase of 1-3 min before a steady state is reached.) The hydrolysis
rate of Z-Phe-Arg-NHMec shows a non-linear increase upon increasing the temperature of the
reaction medium. The fluorescence of rhodamine-BSA in T. brucei is localized between the
nucleus and the flagellar pocket and its uptake is time, dose and temperature dependent.
Discussion
African trypanosomes contain acid2,8,9,10,11,12 and alkaline2,7,10,13,14 endopeptidase activities.
They may also contain cathepsin-D-like activity, although data to support this is weak at
present12 (J. Lonsdale-Eccles and G. Mpimbaza, unpublished observations). With respect to
the alkaline pH peptidolytic activity we have already shown that trypanosomes contain a DFP
and TLCK susceptible activity.2 We wished to see if there were additional serine peptidase
activities in the parasites and so tried the method of Scheiner and Quigley5 to explore this
possibility. Although we were able to incorporate DFP into discrete proteins, incubation with a
variety of chloromethylketones failed to prevent the incorporation of 3H DFP into these
molecules. In view of the fact that we have already seen a DFP and TLCK susceptible activity
in trypanosomes, it seems unlikely this observation may be the result of the specificity of the
enzymes being too tightly defined for the chloromethylketones concerned. It seems more likely
that the levels of TLCK and TPCK susceptible serine protease activity in the parasites may be
lower than those of the enzymes detected in the SDS gels. Thus, the observed 3H labelled
bands in Figure 2 are probably not proteases but rather serine esterases with, as yet, ill-
defined specificity. Pertinent to this is the observation that T. brucei contains at least two
particle-bound phospholipases which are differentially inhibited by DFP.15
While the situation with respect to serine proteases is still unclear, the situation with respect to
the thiol-dependent acid proteases, which we have termed trypanopains, is better defined.
One such enzyme has been isolated and purified from T. congolense.11 A similar activity has
been located in subcellular fractions containing lysosome-like organelles from T. brucei,2 and
in equivalent fractions from T. congolense (J. Lonsdale-Eccles and D. Grab, unpublished
observations). Their intralysosomal location would suggest that they play a role similar to that
played by the corresponding mammalian intralysosomal activities although this has not yet
been delineated. Nor is it clear what controls the activity of these enzymes. However, we have
observed that plasma contains a moiety that can bind to and apparently activate or stabilize
trypanopain activity when analysed by Fbg-SDS-PAGE.2,4 Curiously, preliminary experiments
using Z-Phe-Arg-NHMec showed no apparent enhancement of activity with this moiety. This
may mean that the binding of the serum moiety occurs at a regulatory site removed from the
active centre of the trypanopain, thereby causing allosteric activation in a manner similar to the
La protease. Alternatively, the moiety may stabilize the enzyme against autodegradation or
other inactivation processes that may occur during the Fbg-SDS-PAGE analysis.
Because a number of the physical properties of this moiety, such as its pI and Mr, resemble
those of low Mr kininogen, we explored this further. Commercial preparations of human
kininogens were tested and were found to contain this activity. However, antibody studies
suggest that the moiety is distinct from the high or low Mr kininogens. Thus the molecule may
be a molecule that is unrelated to kininogens but that which co-purifies with them.
Alternatively, it may be an immunologically distinct but related molecule. Other observations
suggest that it may be a variant of serum albumin. Although we have not yet identified the
molecule, we wish to ascertain whether it is taken up by trypanosomes and regulates their
proteolytic activity in vivo. In order to measure the endocytosis of this moiety, we need to set
up appropriate endocytotic assays. We have done this by using fluorescently labelled protein
that can be monitored quantitatively by spectrofluorometry and qualitatively by microscopy.
However, our observations have been complicated by the fact that the uptake of rhodamine-
BSA, and other molecules, by trypanosomes in vitro is not always reproducible (J. Lonsdale-
Eccles and P. Webster, unpublished observations). Definitive quantitative measurements of
endocytosis must therefore await the resolution of this difficulty. Nevertheless, rhodamine-BSA
is taken up in a time, temperature and dose dependent manner into a distinct region between
the nucleus and flagellar pocket in the area previously suggested to be that in which the
endocytotic network is located.16,17 Regardless of its identity, the molecule is a potential
candidate to regulate trypanopain activity in vivo and our current studies are aimed at
elucidating whether it plays such a role.
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Figure 1. Dose dependent uptake of DFP by T. brucei. The parasites (5 × 108) were
incubated in 1 mL PSG with various amounts of DFP (1.5 - 25 m L). After 45 min ice-cold
TCA was added to give a final concentration of 10% TCA. The precipitate was washed
twice with 500 m L 10% TCA and four times with ethanol. The samples were dried and
then resuspended in 250 m L SDS-gel sample buffer. 50 m L aliquots were subjected to
scintillation counting.
Figure 2. SDS-PAGE analysis of DFP-labelled proteins. Samples were prepared
essentially as described in Figure 1 except that the trypanosomes were pre-incubated
for 45 min in the presence and absence of 1 mM chloromethylketones. The samples
were subjected to SDS-PAGE, Coomasie brilliant blue staining, and fluorography. The
Coomasie stained gel (not shown) demonstrated an equal loading of all samples,
except for Lane 4, which had approximately half the amount of protein. Lanes 1-3, intact
trypanosomes; Lanes 4-7, trypanosomes lysates; Lanes 1-3, intact trypanosomes;
Lanes 4-7, trypanosome lysates.
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Mammalian cells have very efficient mechanisms for routing endocytosed molecules to various
cellular destinations following internalization. For example, many receptors are recycled back
to the cell surface while the ligands they carried into the cell are delivered to lysosomes and
degraded. We have studied the mechanisms for this sorting in cultured fibroblasts, primarily
Chinese hamster ovary (CHO) cells.1-6 In our studies we have emphasized the use of
quantitative fluorescence microscopy and digital image processing. This has provided a
powerful method for looking at endocytic processes in living cells.
Using fluorescein-labelled endocytic probes, we have measured the pH of various endocytic
compartments. We have found that endosomes maintain an acidic pH and that different types
of endosomes are regulated to different pH values.4,6 This acidification is required for several
of the processes associated with endocytosis, including release of several ligands from
receptors,7,8 dissociation of iron from transferrin,9,10,11 and penetration of some viruses and
toxins into the cytosol.12,13
More recently, we have developed two types of fluorescence assay for fusion of endocytic
vesicles. Both methods indicate that endosomes fuse actively for several minutes after
internalization. The fusion competence of the endosomes then falls off as the endosomes
mature. In this paper we describe a model that can account for many features of the sorting
which occurs following endocytosis. The model is based on our observations of endosome
acidification and fusion.
pH of endosomal compartments
The endosomal compartments in CHO cells are illustrated schematically in Figure 1. Since the
excitation of fluorescein is strongly pH dependent, the pH of endosomes can be determined by
delivering fluorescein-labelled probes to the appropriate compartment and measuring the
fluorescence.1 We have used a variety of fluorescent probes and incubation conditions to
obtain the pH values shown in Figure 1.
The early endosomes were labelled by very brief incubations with fluorescein dextran,
fluorescein-a 2-macroglobulin or fluorescein transferrin. At the very earliest times following
endocytosis, an average endosomal pH of approximately 6.5-6.8 was measured.3,4 After a few
minutes, fluorescein-a 2-macroglobulin accumulates in large endosomes, which are easily
resolved as distinct structures by fluorescence microscopy. These vesicles have an average
pH of approximately 5.5.4,6 After approximately 20 minutes, a 2-macroglobulin is found in
lysosomes that maintain a pH between 5.0 and 5.5 in CHO cells.6
Since transferrin remains associated with its receptor as it recycles,10,11 fluorescein-transferrin
can be used to measure the pH of endosomal compartments on the recycling pathway after
they have diverged from the pathway leading to lysosomes. In CHO cells, we have found that
the post-sorting recycling endosomes are heavily concentrated in the trans-Golgi region of the
cell. The pH of these para-Golgi recycling endosomes is approximately 6.5.6
From these measurements, we can establish that ligands and receptors are exposed to
different acidic pH values within different types of endosomes. This pattern of acidification has
several important consequences, which have been reviewed elsewhere.1 Many ligands such
as a 2-macroglobulin, low-density lipoproteins (LDL) and epidermal growth factor will
dissociate from their receptors at the mildly acidic pH, found in early endosomes. Other
ligands, notably lysosomal enzymes require a more acidic pH, like that found in large
endosomes, for complete dissociation.14,15 The iron that is carried into cells bound to
transferrin is released at pH values below 6.0.9 This suggests that iron is released within the
sorting endosome, since that is the lowest pH compartment on the recycling pathway. Many
viruses are also brought into the cell by receptor-mediated endocytosis and pass through the
same endocytic compartments.12 The compartment from which an enveloped virus penetrates
into the cytosol may be determined by the pH at which the virus coat proteins become capable
of fusing with target membranes.16,17 Only when the virus enters a sufficiently acidic
endosome will it be able to cross the membrane.
Vesicle fusion and separation on the endocytic pathway
It is clear that ligand-receptor dissociation within the cell is obligatory in those cases where
receptors are recycled as the ligand is degraded. As discussed above, the acidity of
endosomes is sufficient to cause the dissociation of ligands from receptors. However, at this
stage both molecules are still within the same compartment.18 The mechanisms for
segregating the ligands from receptors following dissociation have been unclear.
To observe how the process occurs in living cells, we have developed methods for studying
fusion and separation of vesicles in living cells. In one assay, endosomes are sequentially
loaded with fluorescein-labelled ligands, followed by anti-fluorescein antibodies, which quench
fluorescence. Endosome fusion is monitored by loss of fluorescence intensity.19 In a second
method, we use very sensitive image intensifiers and digital image analysis to measure the
fluorescence intensity of individual endosomes.
The picture that emerges from these studies may be summarized as follows (see Figure 2).
For several minutes after internalization, endosomes fuse actively. For non-recycling
components (e.g., LDL) this fusion results in a very large increase in the number of molecules
per endosome. Histograms of endosome intensities are shown in Figure 3. We estimate that
LDL per endosome increases approximately 40 fold within endosomes. In contrast, there is
only a small increase in the number of recycling components per endosome. For example, we
find that the transferrin per endosome increases about 2-3 fold. This indicates that transferrin
is being removed as LDL continues to accumulate. We have modeled this process as a
repeated series of fractionations, analogous to repeated distillation steps. If each cycle
removes a higher fraction of transferrin than LDL, then repetition of the cycle can result in very
efficient sorting of transferrin from LDL. Results of sample calculations are shown in Figure 4.
The values of F are the fraction of molecules removed from a sorting endosome at each
segregation step. For recycling molecules, F values near 0.2 would lead to 90% efficient
recycling within 40 cycles. The maximum accumulation would be 4 times the number of
molecules in an early endosome. This is close to our observed values for transferrin. For
ligands that are retained in endosomes, F values near 0.01 are more appropriate. In this case,
accumulation is nearly linear and only about 20% of the ligands would be recycled after 40
cycles. This is close to the observed properties for ligands such as LDL or a 2-macroglobulin.
After 5-10 minutes, the endosomes no longer fuse with incoming vesicles.19 This would
correspond to a time at which they begin to mature into lysosomes.
The geometry of the sorting endosome is well-suited for carrying out this type of fractionation.
Acid-releasable ligands are distributed throughout the volume, whereas recycling components
are distributed along the membrane surface. The tubular extensions of endosomes have a
high surface to volume ratio. Fusion and budding of these tubular extensions would provide a
simple mechanism for carrying out the repeated fractionations described in this model.
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Figure 1. The figure illustrates pathways taken by a 2M (a), diphtheria toxin (D),
transferrin (T) and its bound iron (f), and lysosomal enzymes bearing mannose 6-
phosphate (M). The receptors for a 2M (a R), transferrin (TR), and lysosomal enzymes
(MR) are also shown. After binding at the cell surface and concentration in coated pits,
these ligands are internalized into small vesicular and tubular "early endosomes". The
ligands and receptors move to larger, more vesicular endosomes. The large endosomes
include structures termed "endocytic vesicles", "receptosomes", "late endosomes" and
"multivesicular bodies". The "sorting endosome" is similar to the structure termed
CURL (compartment of uncoupling receptor and ligand) that was described by Geuze
and coworkers in hepatoma cells.12. The late, prelysosomal endosomes" are the last
organelle prior to lysosomes. Tf and the recycling receptors are resumed to the cell
surface via "recycling endosomes located near the Golgi complex.
Figure 2. Illustrative model of repeated fractionations. Early endosomes containing LDL
(L) and transferrin (T) fuse with sorting endosomes. In the model, the LDL distributes
according to the volume between the lumen and the tubular extensions. This figure
shows the distribution with 10% in the tubular extension (FL = 0.1). At the same time
50% of the transferrin is distributed into the tubular extensions (FT = 0.5). When the
tubular extensions pinch off transferrin and LDL are trapped in the lumen of the sorting
endosome or the recycling endosome. The figure shows that after three repetitions of
this cycle, 75% of the transferrin is recycled whereas 83% of the LDL remains in the
sorting endosome.
Figure 3. Histograms of endosome intensities. CHO cells, line TRVb1, were incubated
with Rhodamine transferrin or DiI-labelled LDL for 2 minutes or 20 minutes at 37 °C. The
brightness of individual endosomes was determined by digital image processing, and
histograms of the intensity within each range were prepared. It can be seen that the
amount of LDL per endosome increases approximately 40-fold while the transferrin
content increases only slightly. This would be predicted from the type of process
illustrated in Figure 2.
Figure 4. Ligand accumulations and recycling efficiency. The properties of sorting
systems similar to that shown in Figure 2 were calculated for different values of F, the
fraction of molecules contained in the tubular extension. Values of F near 0.2 produce a
rapid saturation of the ligand content per endosome (A), and recycling efficiency near
90% is achieved after 40 cycles of fusion and segregation (C). This type of behavior is
comparable to observations with transferrin. For F values near 0.02, large increases in
the ligand concentration per endosome occur (B) and little of the ligand is recycled (D).
This type of behaviour is seen with LDL.
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A major function of lysosomes is the autophagic turnover of cytoplasmic components,
including organelles and proteins.1,2 The precise mechanisms for the uptake of proteins are
not clearly identified, although there are indications that both microautophagy and
macroautophagy are involved.1,2 There is considerable but mainly circumstantial evidence that
reduced lysosomal membrane stability results in enhanced catabolic activity and vacuolar
fusion.3 In view, therefore, of the importance of the lysosomal system in turnover of
cytoplasmic components, and its involvement in many pathological responses, it is important
to establish the relationship between lysosomal stability and lysosomal function.
Structure-linked latency of lysosomal enzymes is a complex phenomenon involving several
factors, including membrane permeability and the internal associations of the hydrolases with
structural components.4 It is well established that many agents such as various disease
conditions, stress, hormones and drugs can induce destabilizing alterations in lysosomes,
resulting in reduced hydrolase latency.3,5 However, the relationship between altered
physiological states or pathological conditions and lower order events involving hydrolase
latency and protein catabolism is seldom clear, and it is often difficult to determine whether
functional changes in lysosomes are a cause or an effect of cellular dysfunction.3
In our attempts to test this relationship we have used predominantly cytochemical studies on
molluscan digestive cells from the hepatopancreas or digestive gland as a model system.
Many molluscan cell types are particularly rich in lysosomes, which are involved in processes
of digestion, excretion, immunity and autophagic mobilization of nutrient reserves.6 This
relative abundance of lysosomes and the obvious dependence of these cells on lysosomal
processes makes them suitable models for the investigation of functional relationships.
In this respect, singular attention has been paid to the digestive cells, which are in fact
multifunctional.6 These cells are involved in the pinocytotic uptake of food and its subsequent
digestion in secondary lysosomes.6 However, digestive cells also have a degree of functional
analogy with vertebrate liver cells (hepatocytes) in that they store glycogen and lipid, and are
the site of major physiological processes in the animal, including detoxication and excretion.6,7
As well as being of considerable metabolic significance, the digestive gland is a major
interface between the organism and its environment. Previous studies have clearly
demonstrated that the cells of this organ are highly responsive to toxic chemical pollutants.6,7
Most of these responses apparently involve both structural and functional alterations in
lysosomes, although it is probably artificial to discriminate between them. We have been
particularly interested in the identification of causal relationships in the responses of marine
molluscs to environmental stress and establishing a conceptual framework for the chain of
events from environmental stimulus to consequences for the organism. Our approach has
been to examine responses to stress and various drugs and xenobiotics at several levels of
biological organization, namely from the biochemical and subcellular to that of the whole
animal.
This report summarizes progress in this area, with particular emphasis on the cellular
consequences of experimentally induced alterations in lysosomes. In attempting to establish
functional links we have used experimental manipulation of digestive cells in order to
characterize their lysosomal and cellular reactions. In this context, H.K. Hawkins has
subdivided lysosomal reactions into three basic categories, namely, changes in membrane
permeability, in vacuolar fusion events and in lysosomal contents.3
Lysosomal reactions in molluscs fall into these three classes, which often may have
considerable overlap. We will now consider these reactions in more detail.
Changes in lysosomal stability are induced by a variety of in vivo experimental treatments of
mussels. These include elevated temperature, hypoxia, salinity increase, certain sex steroids
and lipophilic xenobiotics.6 All of these treatments result in a decrease in cytochemically
determined stability of lysosomes, based on hydrolase latency, and this has been confirmed
biochemically in selected experiments. These effects are believed to involve an increase in the
permeability of the lysosomal membrane because they are frequently reversible by cortisol
treatment, which is a recognized membrane stabilizer (Figure 1).8,9
Reductions in lysosomal stability in digestive cells have frequently been demonstrated to be
reversible during the course of adaptation to particular stimuli such as salinity increase; this
suggests that such changes may have an adaptive physiological role.10,11 The possible
consequences of destabilizing alterations in lysosomal membranes have been investigated in
a number of experimental conditions, for instance, treatment of mussels with 17 b -estradiol
results in a rapid destabilization of digestive cell lysosomes (Figure 1).9 This is accompanied
by an increase in the formation of tertiary lysosomes containing lipofuscin, which may be
indicative of augmented autophagy.9
Salinity increase also results in a rapid decrease in lysosomal stability and evidence of
enhanced autophagy.10,11,12 Mussels are known to osmoregulate intracellularly by increasing
the concentration of cytosolic free amino acids.10,11 These are probably generated by
enhanced protein degradation and this hypothesis is supported by evidence of increased
amino acid concentrations in fractionated lysosomes.11 The implication is that decreased
lysosomal stability is involved in the activation of lysosomes for the autophagic degradation of
cytoplasmic proteins.
More recent studies have used the polycyclic aromatic hydrocarbon (PAH) phenanthrene as a
model destabilizer of digestive cell lysosomes.13,14 Digestive cells have a relatively low
cytochrome P-450 content, resulting in a low rate of metabolism of PAHs and other lipophilic
drugs.7 The consequence is that PAHs accumulate in these cells and there is evidence that
the lysosomes are a major site for their sequestration.15 The response relationship between
tissue concentration of phenanthrene and lysosomal stability has been determined and this
has a sigmoidal form indicating an "all or nothing" type of response.13,14 This finding suggests
that at a particular threshold level of incorporation of phenanthrene into the lysosomes, there
is a "catastrophic" alteration in membrane organization involving permeability/fluidity changes
resulting in the reduced stability of latent b -N-acetylhexosaminidase and b -glucuronidase
(Figure 2).13,14 Concomitant determinations were made of the loss of 14C-label from pre-
labelled cytosolic proteins in the digestive gland cells over a concentration range of
phenanthrene.13 The results indicated that there was an increased loss of 14C-label only from
cells in which the lysosomes were destabilized (Figure 2).13 As the possibility of re-
incorporation of 14C-label due to protein synthesis had been minimized, this finding was
consistent with enhanced catabolism of cytosolic proteins. In fact, both lysosomal membrane
stability and concentration of 14C-label cytosolic protein were significantly correlated (r = 5, p =
0.001, two-tailed test).14
Other changes in lysosomes frequently accompany the measured decrease in stability. These
include increase fusion of vacuolar components, lysosomal swelling, increased neutral lipid
and lipofuscin content and increased numbers of tertiary lysosomes (Figure 3).6,7,12,16 These
changes are all consistent with the hypothesis of increased autophagy and catabolic activity
resulting from increased lysosomal fragility. Ultrastructural evidence of increased architectural
fragility of lysosomal membranes and enhanced fusion with other vesicular components lends
further support to this hypothesis.12 Furthermore, evidence of enhanced microautophagy and
leakage of hydrolase into the cytosol following treatment with PAHs has been tentatively
linked with reduction of membrane stability.12,17
Additional support for the hypothesis that enchanced catabolic activity is linked with lysosomal
fragility is provided by evidence of atrophic alterations in the digestive cells following
lysosomal destabilization.
In conclusion, we can say that although the evidence of increased protein catabolism
associated with lysosomal fragility is still correlational, there is considerable supportive
evidence that increased membrane fragility does in fact result in enhanced autophagy leading
to atrophy of the digestive cell.
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Figure 1. The effects of injections of sex steroids (100 m l 5 × 10-7 M) and cortisol (100
m l 10-2 M) on the labilisation period of lysosomal hexosaminidase after 2 h in Mytilus
edulis (mean ± SE).9
Figure 2A. The effect of phenanthrene concentration in seawater on specific activity of
14C-labelled cytosolic proteins (as % of control values) in the midgut gland (each point
is the mean ± SE of at least five replicate experiments).
Figure 2B. The effect of phenanthrene concentration in seawater on lysosomal stability
in digestive cells (each point is the mean ± SE of five replicate experiments, each
experimental treatment contained five animals). Exact probability values are given in
the figures where values differ significantly from those of the control. These are shown
vertically above the appropriate data points.13
Figure 3. Results of stereological analyses of lysosomes in the digestive cells of
mussels. Controls (C) and experimental (E) mussels exposed to water accommodated
fraction (PAH-rich, 30 ppb total hydrocarbon) of North Sea crude oil were sampled after
34 and 103 days. Bar height gives a point estimate of the relevant parameter; the
associated interval estimates are 95% CL/Ö 2.6
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Plasma membrane glycoproteins are transported to the cell surface by cellular pathways that
begin with the insertion of the nascent protein into the membrane of the rough endoplasmic
reticulum (RER) and proceed with the transport of the protein through the Golgi membranes to
the plasma membrane.1 During transport, glycoproteins are subjected to a variety of co- and
post-translational modifications. In addition, the nascent protein must fold properly for full
activity and possibly transport to the cell surface.2,3,4 One component of proper folding is the
formation of intra- and, sometimes, intermolecular disulphide bonds.5,6,7 Current evidence
suggests that disulphide bond formation is mediated by protein disulphide isomerase (PDI)
located in the lumen of the rough endoplasmic reticulum.5,7
The glycoproteins of simple enveloped viruses have been useful in the study of the transport,
modification and folding of plasma membrane glycoproteins. The HN protein of Newcastle
disease virus (NDV), a paramyxovirus, has been used here to explore the formation of
intermolecular disulphide bonds and the role this sort of post-translational modification plays in
the intracellular processing of a glycoprotein. The HN glycoprotein is a type 2 glycoprotein,8
that is, the protein has no cleavable signal sequence but rather a bifunctional hydrophobic
region near the amino terminus which serves as both a signal sequence and a membrane
anchor. The amino terminus of the protein is the cytoplasmic tail while the carboxy terminus is
transported across the membrane. It has been well documented that the HN glycoproteins of
some paramyxomviruses, including the AV strain of NDV, form disulphide linked homo-
oligomers.9 Indeed, as shown in Figure 1, virion associated HN protein is exclusively in the
form of disulphide linked oligomers. The monomeric form of HN protein seen in the presence
of reducing agent is absent when proteins are electrophoresed without reducing agent.
Without reduction of virion proteins, HN is resolved as a high molecular weight band near the
top of the gel (HNo). Evidence is presented here that the NDV HN disulphide linked oligomers
form in the late stages of residence in the RER. However, not all nascent HN protein forms of
oligomers and oligomer formation is not required for transport of the protein to the cell surface.
Indeed, evidence is presented that the level of oligomer formation depends upon the
concentration of the protein in cells.
Intermolecular disulphide bonds form intracellularly
To explore the formation of intermolecular disulphide bonds, infected cells were pulse labelled
(5 min) or pulse labelled and then chased with non-radioactive methionine in the presence of
cycloheximide. Proteins present in the cell extracts were resolved on polyacrylamide gels in
the presence or absence of reducing agent (Figure 2). We have previously found that the HN
protein is transported through the cell extremely slowly.10 Pulse labelled HN reaches the cell
surface with a t½ of 78 min. We also found that 100% of cell associated pulse-labelled HN
protein reaches the cell surface after approximately 2.5 hours of chase.10 Therefore, chase
times were extended to four hours. It is clear that the oligomer does not begin to appear until
15 min of chase and continues to increase in amount up to 2 to 3 hours of chase.
To determine the intracellular location of the formation of the oligomer, use was made of
inhibitors that block glycoprotein migration at various points in the cell. CCCP, an inhibitor of
oxidative phosphorylation, blocks any energy-requiring process such as migration of protein
from the RER.11 Figure 3A, lanes 5 and 6, shows that if CCCP is present during the non-
radioactive chase, the disulphide linked oligomer does not form. Monensin, a sodium
ionophore, is reported to interfere with the transport of most membrane glycoproteins by
preventing their exit from the medial Golgi membranes.12 Clearly, the HN oligomer forms in
the presence of monensin (Figure 3B, Lanes 6, 7 and 8).
These results argue that the formation of the disulphide-linked oligomer of the HN protein
occurs postranslationally prior to the exit from the medial Golgi membranes. The results with
CCCP suggest that the formation of the disulphide bonds either requires energy in the RER or
that the oligomer forms after the protein leaves the RER. It has been shown that when cells
are incubated at 15°C, glycoprotein transport from the RER is blocked.13 When pulse-labelled
NDV-infected cells are subjected to a nonradioactive chase at 15°C, the disulphide-linked
oligomer forms (not shown). Thus, it is likely that the formation of the HN oligomer is an
energy-requiring process that occurs in the RER, a finding consistent with the proposed
location of PDI in eucaryotic cells.15
Oligomer formation and intracellular transport
A key to the understanding of the intermolecular disulphide bond formation in intracellular
transport of the HN protein is the efficiency of this post-translational modification. If this
modification is required for intracellular transport of the protein, all HN protein that reaches the
cell surface should be in the form of disulphide-linked oligomers. It is clear from Figure 2 that
not all pulse labelled HN protein is found in oligomers after prolonged chase periods. This
finding was confirmed by immunoprecipitating the HN protein from these extracts with antibody
specific for the HN protein (see Figure 7). Thus, we asked if the monomeric form of the protein
can be found at the cell surface. We have previously devised an assay to isolate only cell
surface glycoproteins using polyclonal antisera directed against NDV proteins.10 We have also
adapted the assay for monoclonal antibody directed against the HN protein (Morrison and
McGinnes, in preparation). Using this assay, and isolating the cell surface HN protein under
non-reducing conditions, it is clear that a significant amount of cell surface HN is in the form of
monomers (Figure 4).
It is possible that monomeric forms of the HN protein are less efficiently incorporated into the
plasma membranes. To determine the kinetics of insertion into the cell surface of the two
forms of HN protein, cell surface molecules were isolated at various times after the onset of
the chase and resolved on gels. The amount of the two forms of the HN protein were
quantitated with a densitometer. Figure 5 shows that the kinetics of appearance at the cell
surface, as well as the release, of the monomer and the oligomer are very similar. Thus, the
monomeric form of the HN protein is transported to the cell surface at a rate similar to that of
the disulphide-linked form.
Expression of the HN protein using a retroviral vector
A cloned copy of the HN gene was expressed in chick cells to explore further the processing
of this protein. The expression vector used for these studies is a retrovirus14,15 derived from
Rous sarcoma virus. This virus is replication competent but with the sarc gene deleted. In the
place of the sarc gene is a C1a I site for insertion of foreign DNA. Insertion in one direction
allows for the expression of the sense version of the gene, while the opposite direction allows
for the transcription of antisense sequences. The cDNA of the HN gene was inserted into a
plasmid containing a DNA copy of the retrovirus and chick embryo fibroblasts were transfected
with the DNA. Since the virus is replication competent, transfected cells will release virus,
allowing for the spread of the infection throughout the entire culture. Thus all cells in the
culture receive the HN gene. Figure 6 shows that the cells transfected with the retrovirus
containing the sense version of the HN gene (RHN) express the HN protein, whereas cells
that received DNA with the HN gene inserted in the antisense direction (R antiHN) do not
contain the protein. The level of HN expression is approximately 5-10% that seen in NDV-
infected cells 6 to 8 hours after infection.
The HN protein expressed from the retrovirus vector is transported to the cell surface. To
assay for cell surface expression, two different assays were used. First, antibodies were used
to isolate specifically cell surface molecules as described above. RHN cells contain HN at the
cell surface while RSV or R antiHN cells are negative (not shown). A second assay for cell
surface expression of the HN protein takes advantage of the ability of the HN protein to attach
to red blood cells. Cells expressing HN on their surfaces will adsorb red blood cells.16,17 Table
1 shows a quantitation of haemadsorption using ND-infected cells. At various times after
infection, red blood cells are added to intact cells, incubated once, and unbound blood cells
washed away. Bound red blood cells are lysed and the amount of released haemoglobin
determined in order to quantitate the amount of red blood cell binding. There is negligible
binding early in infection, while binding increases with time, reflecting the presence of the HN
protein on infected cell surfaces. Similar assays were done with the RHN cells. Significant
binding of red blood cells (6 × 106) was observed while the antisense expressing cells were
negative.
A surprising result was that the ratio of the monomeric form and disulphide-linked oligomers
present in these HN expressing cells was quite different than that observed in infected cells
(Figure 7, compare top and middle panels). In this experiment, NDV infected cells contained
70% of the HN protein in the form of disulphide-linked oligomer, whereas the retrovirus-
infected cells contained 10% in the form of a disulphide-linked oligomer. In addition, the vast
majority of cell surface HN protein is in the form of a monomer (not shown). There are two
possible explanations for the reduced level of disulphide-linked oligomers in these cells. First,
it is possible that the presence of another viral protein in the infected cells promotes the
formation of disulphide-linked oligomers. A second possibility is suggested by the fact that the
level of HN protein expression from the retrovirus vector is lower than that in an actively
infected cell. Perhaps disulphide-linked oligomers form efficiently only after the HN proteins
reach a critical concentration in the cell.
Disulphide-linked oligomer formation early in infection
If it is the concentration of protein in a cell that promotes the formation of disulphide-linked
oligomers, then monomer formation should be favoured very early in an infected cell when the
concentration of viral proteins is relatively low. To test this possibility, infected cells were
subjected to a pulse chase at 3 to 5 hours post-infection, in contrast to the usual time of 5 to 7
hours post-infection. The ratio of monomers and disulphide-linked oligomers was determined.
Figure 7, bottom panel, shows a densitomer scan of the resulting auto-radiograph. At the early
time point, most of the HN protein is in the form of a monomer (75%). However, later in
infection, oligomer formation is favoured (Figure 7, top panel). This result argues that it is the
concentration of the protein that determines the ratio of the monomer and the disulphide-
linked oligomer.
Conclusions
One recently described post-translational modification of two viral glycoproteins, the influenza
haemagglutinin protein HA and the vesicular stomatitis virus glycoprotein G, is oligomerization
of the protein.2,3,4 The influenza haemagglutinin protein forms trimers and the vesicular
stomatitis virus glycoprotein forms dimers and trimers soon after synthesis in the rough
endoplasmic reticulum. Evidence has been presented that the formation of these homo-
oligomers is essential for transport of the glycoproteins out of the RER. Thus, an obvious
question is the universality of this requirement. It is clear from the results presented here that
formation of the disulphide-linked oligomer of the NDV HN protein is not a prerequisite for
transport from the RER. Significant amounts of the monomeric form of the protein can be
detected at the cell surface. In addition, the amount of disulphide-linked oligomer in cells
seems to depend upon the level of expression of the protein. Thus, the formation of oligomers
may not be a universal requirement for the intracellular processing of viral glycoproteins.
While not all HN protein forms disulphide-linked oligomers, virion associated protein is
exclusively in this form. Thus the fate of cell surface monomeric HN protein is of interest. It is
possible that monomeric forms incorporated into virions rapidly form oligomers during
budding. Alternatively, it is possible that monomers are not used in virion formation and may
be endocytosed and degraded. This latter possibility raises interesting considerations for viral
infections under conditions when gene expression is limited, such as persistent infections.
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Table 1. Haemadsorption of NDV-infected cells
NDV-infected cells
Time after infection (hrs) Red blood cells bound (×106)
0.0 0.0
1.5 0.0
3.0 0.0
4.5 0.3
6.0 2.0
8.0 4.0
10.0 5.5
12.0 9.5
Figure 1. Virion proteins electrophoresed in the presence (+) or absence (-) of b
mercaptoethanol.
Figure 2. Pulse-chase analysis of infected cells. Cells infected for 5 hours were pulse-
labelled with 35S methionine (P) for 5 min or pulse-labelled and then chased for various
times. Total cytoplasmic extracts were electrophoresed on 10% polyacrylamide gels.
The lanes from left to right are 0, 5, 10, 15, 60, 90, 120, 180 and 240 minutes
respectively.
Figure 3. CCP and monensin treated infected cells. Panel A: cells were pulse-labelled
for 5 min and then chased for 1 hr (Lanes 2 and 5) or 2 hrs (Lanes 3 and 6) in the
absence (Lanes 2 and 3) or presence of CCCP (Lanes 5 and 6) Panel B: Pulse-labelled
cell extracts are shown in Lanes 1-4. Pulse-chase extracts are shown in Lanes 5-8.
Increasing concentrations of monensin (10-7, 10-6, 10-5 M) were used (Lanes 2-4, 6-8).
Figure 4. Cell surface HN protein electrophoresed in the presence or absence of b
mercaptoethanol. Cell surface molecules were isolated from cells chased for 2.5 hours
as previously described.10 M, marker proteins.
Figure 5. The kinetics of appearance and release of cell surface HN monomers and
oligomers. Cells pulse-labelled for 5 min were chased for various lengths of time and
cell surface HN isolated and quantitated by densitometer scans of autoradiographs of
polyacrylamide gels.
Figure 6. Proteins immunoprecipitated from retrovirus-infected cell extracts with anti-
HN monoclonal antibody. R, retrovirus alone; RHN, retrovirus containing HN gene; R
anti-HN, retrovirus containing antisense HN gene. Electrophoresis was in the presence
of b mercaptoethanol.
Figure 7. HN protein in NDV-infected cell extracts and retrovirus-infected cell extracts.
Cells were pulse-labelled for 5 min and chased for 2 hrs. HN protein present in the
resulting cytoplasmic extracts was immunoprecipitated with monoclonal antibody
against HN protein. The figure shows densitometer scans of autoradiographs of
polyacrylamide gels of the immunoprecipitate. M, monomer; O, oligomer. Top panel:
NDV-infected cells chased from 5 to 7 hours post infection. Middle panel: retrovirus
containing the HN gene, 2 hour chase. Bottom panel: NDV-infected cells chased from 3
to 5 hours post-infection.
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Theileria parva, a tick-transmitted protozoan parasite, is the causative agent of theilerosis, an
often fatal lymphoproliferative disease of livestock in East and Central Africa. The related
parasites T. annulata and T. sergenti, cause similar diseases in the Middle East/India and the
Far East, respectively. Although T. parva sporozoites may enter a variety of bovine cell types,
they appear to be able to survive only in subpopulations of lymphocytes in which the parasite
differentiates into a multinucleate schizont.1 Theileria schizonts are unique among protozoan
parasites in that they induce lymphoblastogenesis and clonal expansion of quiescent target
cells. Regardless of pre-infection phenotype, the Theileria-infected cells acquire some surface
antigens characteristic of proliferating bovine T cells.14 Since such cells are immortalized and
can easily be propagated in vitro, exhibit cellular pleomorphism and appear to acquire a
variety of other alterations in surface phenotype,14 Theileria-infected cells have been
considered transformed. However, such terminology has been considered misleading since it
implied an oncogenic aetiology and since the infection is curable with administration of
appropriate antibiotics.
Protein kinase activation in Theileria-infected cells
Ample evidence has been presented to implicate phosphorylation/dephosphorylation in the
modulation of a large number of processes vital to the life of a cell. Among these are cellular
differentiation, signal transduction and cellular proliferation.2-9 Cells can proliferate in response
to external signals as well as to intracellular events. Membrane receptors for several
polypeptide hormones and growth factors have been shown to have endogenous tyrosine-
specific protein kinase activity.8-11 Upon receptor engagement by ligand, activation of the
receptor kinase occurs, which initiates a series of modifications of specific target molecules,
which are thought to constitute intracellular pathways for cellular growth (for review, see 8).
Under normal circumstances, when a signal for cell growth ceases, homeostatic regulation
ensures inactivation of important molecules or the reversion of their levels to those obtained at
quiescence. It is thus envisaged that uncontrolled cellular growth could occur if important
molecules regulating cellular proliferation are constitutively produced or if because of structural
alterations, such molecules cease to be responsive to physiological control.
The important roles played by protein kinases in growth of cells stimulated us to determine if
any differences existed between the activities of these enzymes in cloned bovine lymphocytes
before and after infection with Theileria sporozoites. Supernatant and particulate fractions3
(100,000 × g) prepared from IL-2 maintained, con A stimulated or normal peripheral blood
lymophocytes (PBL) were used as control for those from Theileria-infected cells. Most
enzymatic activity was in the 100,000 × g particular fractions and was capable of
phosphorylating both endogenous and exogenous substrates.
Analysis of target amino acids residues13 and kinase co-factor requirements showed that the
Theileria-associated kinase(s) were cyclic nucleotide independent, Ca++ calmodulin insensitive
and phosphorylated serine/threonine, rather than tyrosine, residues on endogenous protein
substrates. Among a large number of exogenous substrates examined, phosvitin, glycogen
synthase and a wide variety of casein variants were the best substrates.
The susceptibility of the Theileria-associated kinases to inhibition by glycosaminoglycans, 2,3-
bisphosphoglycerate, pyridoxal 5'-phosphate and to stimulation by polyamines suggests that
the dominant protein kinase activity in Theileria-infected cells is casein kinase II-like.6,7
Furthermore, employing anti-bovine casein kinase II antibody,5 we have shown that the
Theileria-infected cells have markedly increased amounts of casein kinase II antigen. Also the
enzymatic activity is susceptible to partial inhibition by this antibody. Interestingly enough, in
addition to a /a1 and b subunits of the bovine casein kinase II, 5,17,18 we also see strongly
reacting antigens in the Mr range of 15-20 kDa. The latter have only been seen so far in
Theileria-infected cells. The latter findings are in agreement with our finding a casein kinase II-
like enzymatic activity in purified Theileria-macroschizont preparations.19 Current efforts are
directed at structural and functional characterization of the parasite enzyme.
Conclusions
(1) Our findings of substantial increases of casein kinase II-like enzymatic activity, as well as
antigen, in Theileria-infected cells suggest a possible role for this enzyme in Theileria-induced
cellular proliferation. This suggestion is supported by recent findings showing:
(a) Brisk activation of casein kinase II in response to hormonal stimulation of cells
in vitro.17
(b) Elevation of casein kinase II activity and antigen in differentiating cells.18
(c) Significant structural homologies between casein kinase II from various
sources and the products of the cell cycle controlling genes in yeast and other
species.12,15,16
(2) Induction of uncontrolled cellular proliferation by an intracellular parasite may thus obviate
the need to invoke exogenous factors. The Theileria schizont may activate a pathway that the
cell engages in response to normal growth signals. Uncontrolled growth may thus occur if
Theileria drives the lymphocytes to constitutively produce normal growth signal-transducing
molecules or, alternatively, if Theileria-derived analogs of molecular constitutents of
intracellular pathways for growth may not be susceptible to modulation by host-cell elements.
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Fibrinogen is a large molecular weight (Mr 340,000) glycoprotein present in plasma. Its
primary function is in blood clotting; it is cleaved by thrombin, and is transformed to fibrin clots
and specifically binds to receptors on platelets and regulates their aggregation. Human plasma
fibrinogen is a dimer with each half-molecule composed of three different polypeptides; Aa (Mr
66,000, 610 amino acids.), Bb (Mr 54,000, 461 amino acids) and t (Mr 48,000, 411 amino
acids). The half-molecules of the dimer are held together by symmetrical disulphide bonds
between two Aa chains (at Aa -28) and two t chains (at t -8 and t -9). In addition, fibrinogen
contains a number of inter- and intrachain disulphide linkages. The 6 fibrinogen polypeptides
are held together by 29 disulphide bonds and the protein does not have free sulphydyl groups.
The fibrinogen chains contain several prosthetic groups. Both the Bb and t chain contain
asparagine-linked carbohydrates, ester-bound phosphate occurs in the Aa chain and tyrosine-
O-sulfates in the Bb chain. There are two non-allelic forms of the t chain. In the t chain the 4
carboxy-terminal amino acids of the t chain are replaced by 20 amino acids.1,2,3
The complete molecule appears by electron microscopy to form a trinodal structure linked by
slender rope-like strands. Studies in which both image processing of electron micrographs
and analysis of low resolution X-ray crystallography were used extends this picture. It is
thought that the central domain of fibrinogen contains the two amino-terminal portions of the
half-molecule and the two end domains are composed of the carboxy-termini of the Ba and t
chains. The carboxy-termini of the two larger Aa chains are believed to fold back to form an
additional central domain.4
The fibrinogen genes have been localized in the long arm of chromosome 4 and the three
fibrinogen genes are linked in the order of t,a,b with the Bb gene in the opposite orientation.
Complete DNA sequences of the human t and partial sequences of the human Bb gene and
rat Bb t genes are known. There is little similarity in the three genes. On stimulation of
fibrinogen synthesis, during an acute phase response, there is a coordinate increase in levels
of all three mRNAs and this is accompanied by changes in the transcription activity of each of
the three fibrinogen genes. This indicates that similar mechanisms regulate the activity of the
three fibrinogen genes.5
Fibrinogen is primarily synthesized by hepatocytes, but megakaryocytes are also capable of
producing small amounts of fibrinogen. The production of fibrinogen by hepatocytes is
probably controlled by humoral agents. One mechanism, which is attractive and has received
much experimental attention, is that some degradation products of fibrinogen and fibrin elicit
the formation of a small peptide (about 30,000 daltons) from monocytes and/or Kupffer cells,
which in turn stimulates hepatocytes to produce more fibrinogen.6,7 The stimulatory agent, first
termed hepatocyte stimulating factor, is probably identical to interferon b 2- B cell
differentiation factor 2.8
Thus, fibrinogen is a multi-chain protein held together by an intricate array of disulphide bonds
and the three chains are intertwined in a specific pattern giving fibrinogen its unique
properties, which allow it to circulate in the blood awaiting signals to perform its haemostatic
functions. How this complex multi-chain protein is assembled intracellularly and what regulates
its production and secretion are the questions which our studies aim to answer.
Early studies
The separate chains of bovine,9 dog10 and rat11 fibrinogen are synthesized by mRNA-
dependent membrane-free translation systems as larger ("signal") precursors. This, together
with molecular cloning of cDNA for the Aa, Bb and t chains of fibrinogen, showed that the
three chains are synthesized from separate mRNAs. In vivo studies in dogs indicated that the
dimeric molecule is quickly assembled in the rough endoplasmic reticulum (RER),12 but a time
course study of secretion of rabbit fibrinogen suggested that the three chains are not
immediately assembled prior to secretion. Newly secreted rabbit fibrinogen first contained
nascent radioactive Bb chains, followed later by Aa and t chains.13 Pulse-chase experiments
with Hep G2 cells confirmed that newly secreted fibrinogen contains higher specific
radioactivity in the Bb chain than in Aa and t chains, again suggesting that pools of Aa and t
chains exist intracellularly.14
Most of our knowledge of fibrinogen assembly relies on the results of experiments performed
with a human hepatocellular carcinoma, the Hep-G2 cell.15 Hep-G2 cells were pulse-labelled
with L-[35S] methionine and "chase" incubated with non-radioactive L-methionine. At various
times the cells and the incubation medium were separated and fibrinogen and fibrinogen-
related materials were isolated by immunoprecipitation with a polyclonal antibody that
recognizes intact fibrinogen as well as its component chains. Prior to immunoprecipitation the
cells were homogenized in the presence of 0.2 M iodo-acetamide to block free sulphydryl
groups and minimize further disulphide interactions. The fibrinogen compounds were
separated by SDS-PAGE and detected by autoradiography. In some experiments the
fibrinogen-related compounds were excised from the gel and reduced and re-electrophoresed
to determine the chain compositions and the specific radioactivity of the component chains.
Intracellular forms of fibrinogen
In non-reducing gels, eight fibrinogen-related radioactive bands were obtained. The estimated
molecular weight of these proteins, as deduced from their electrophoretic mobilities on SDS-
PAGE and the chain composition of each is given in Table 1.
These studies confirm the presence of excess Aa and t chains and demonstrates that most of
these "extra" Aa and t chains exist as Aa - t complexes. Free t chains are present, but very few
free Aa or Bb chains.
The mechanisms by which excess Aa and t chains accumulate within Hep-G2 cells are poorly
understood. Unequal synthesis of the three chains may contribute to these pools. We have
determined that the initial rates of synthesis of Bb chain is less than that of Aa and t chains.
This inbalance in the ratios of intracellular chains may also be due to small differences in the
degradation rates of the three chains.
Order of chain assembly
The sequence in which the three component chains of fibrinogen interact with each other to
form fibrinogen was determined by following (1) the order in which the radioactivity of pulse-
labelled forms of fibrinogen decrease during the "chase" incubation (Figure 1) and (2) the
radioactivities of each of the chains in the various fibrinogen-related compounds at the end of
the "pulse" period and at different "chase" times. An interpretation of the results is presented in
Figure 2, and for convenience we have divided the intracellular assembly of fibrinogen into 5
steps.
Step 1. Unequal synthesis of the three chains, and perhaps unequal rates of
degradation, leads to an accumulation of excess Aa and t chains. Aa and t chains
combine to form an Aa -t complex (band C) which accounts for the major
intracellular form of fibrinogen-related material. Hep-G2 cells also contain free t
chains. These act as intracellular "pool" forms of Aa and t chains.
Step 2. Fibrinogen assembly begins by the attachment of either Aa or t chains,
drawn from the pool, with nascent Bb chains. This occurs while the Bb chain is not
fully completed and is still attached to polysomes of the RER. For incomplete Bb
chains to react with Aa and t chains the incomplete Bb chains, has to be of
sufficient length to span the large ribosomal subunit and the width of the ER
membrane and to expose N-terminal cysteine residues to the luminal surface of
the ER. The earliest precursor forms of fibrinogen noted was "pulse" labelled
incomplete Bb of between 27,000 and 32,000 daltons, complexed to either non-
radioactive Aa or non-radioactive t chains. The size of the Bb polypeptide is
sufficient to meet the above criteria.
Step 3. On completion of Bb chain synthesis, the Bb -Aa and Bb -t complexes are
released into the luminal side of the ER and the remainder of the fibrinogen chain
assembly occurs in the lumen of the RER.
Step 4. t chain is added to the nascent Bb -Aa complex and Aa is added to the
nascent Bb -t, forming half-molecules of fibrinogen. The Aa and t chains are
obtained from the intracellular pools. Analysis of these precursor forms from early
"pulse-chase" periods show that they are composed of radioactive Bb and non-
radioactive Aa and t chains.
Step 5. The final step in fibrinogen chain assembly is the joining of two half-
molecules by the formation of symmetrical disulphide bonds between two Aa and
two t chains.
All of the above steps occur in the RER. Fibrinogen at this stage is not fully glycosylated and
has not yet attained its phosphate and sulphate moieties. These final touches are thought to
occur in the Golgi complex, prior to secretion.
Other processing steps are probably involved in the final production of fibrinogen, cDNA
cloning studies suggest that a precursor of Aa chain, with an extension at the carboxyl
terminus, is a likely primary translation product,17 but our procedures do not allow us to
distinguish between the secreted forms of Aa and the putative precursor.
That there is a pool of Aa and t chains and that Bb chains are directly inserted into fibrinogen
precursors suggest that synthesis of the Bb chain may be the limiting factor in fibrinogen
assembly.
Fibrinogen production may be easily regulated by modulating the rate of synthesis of the Bb
chain. However, stimulation of fibrinogen synthesis in rats by defibrination results in an
increase of all three fibrinogen mRNAs indicating control at the transcriptional level.
Stimulation of synthesis in rabbits does not change the relative specific radioactivities of the
component chains of secreted fibrinogen,13 indicating that increased fibrinogen synthesis does
not alter the sequence of fibrinogen chain assembly.
Enzymatic mechanism of chain assembly
An enzyme, a protein disulphide isomerase, is present on the inner surface of the ER
membrane and is particularly abundant in secretory tissues. This enzyme may catalyze both
intra- and interchain disulphide interactions and can rearrange disulphide bonds in an oxidized
protein and also the formation of native disulphide bonds in reduced proteins.18 Therefore
fibrinogen precursors may exist in either reduced or oxidized forms prior to further interactions
with other fibrinogen chains. Incubation of Hep-G2 cells with 14C-iodoacetamide detected only
substantial free sulphydyl groups in the Aa -t complex, with small amounts in the free t chain.
Ordered disulphide-bond formation of fibrinogen chains is not spontaneous and requires more
than added enzyme. Attempts at in vitro assembly, in the presence or absence of disulphide
isomerase, has led only to a haphazard assembly of chains. The chains probably also need to
be held in proper juxtaposition. In this regard, it should be noted that a protein in the RER,
termed IgG heavy chain binding protein (BiP), binds to nascent proteins that are incompletely
assembled or with malformed proteins.19,20 Immunoprecipitation of nascent fibrinogen also co-
precipitates a similar 78,000-dalton protein.
Secretion of nascent fibrinogen
Only fully assembled fibrinogen is secreted into the medium by Hep-2 cells. None of the
precursor forms of fibrinogen, the Aa -t complex or the free t chains, are secreted. Since free
Bb chains do not occur intracellularly, but are complexed to other chains even before they are
completed, we determined the fate of free Bb chains by transfecting a surrogate secretory cell
(COS-1) with a shuttle vector pBc12BI containing full-length Bb cDNA. The Bb chain was
expressed and not secreted.21 This suggests that the "signal" for secretion probably does not
occur on any individual chain but resides on the intact dimeric molecule.
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Table 1. Size and chain composition of intracellular fibrinogen precursors
Bands on SDS-PAGE Estimated Mr Chain composition
A 340,000 Aa, Bb, t
B 214,000 Aa, Bb, t
C 140,000 Aa, t
D 125,000 mixtures Bb, t and Bb, Aa
E 113,000 Aa, incomplete Bb
F 102,000 t, incomplete Bb
Aa 65,000 Aa
t 45,000 t
Table 2. Amount of endogenous fibrinogen-related protein detected by different
procedures
 % of total fibrinogen antigens
Pulse-label Steady-state label Western Blot
Fibrinogen 4 33 13
Band B (half-molecule) 10 8 0
Band C (Aa -t) 18 30 53
Band D(Bb -a and t) 15 0 0
Band E and F (incomplete + Aa or t) 12 0 0
Aa (free chain) 2 0 0
Bb (free chain) 3 0 0
t (free chain) 36 26 11
Hep-G2 cells were incubated with L-35S-methionine for either 3 mins (pulse-label) or 15 h
(steady state). The percentage of radioactivity in the various compounds was determined by
scanning the autoradiograms with a laser densitometer and calculating the intensity profiles.
Figure 1. Pulse-chase incubation of Hep G2 cells with L-[35S] methionine. On the left is
an autoradiogram of fibrinogen-related materials at the end of a 3 min pulse and on the
right, that at the end of a 20 min chase period.
Figure 2. Scheme for the assembly of fibrinogen.
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The development of synthetic protease inhibitors that function by affinity-labelling offers the
possibility of obtaining reagents that may be used with living systems to inactivate a target
protease by covalent combination. The perturbation in the system should give some indication
of the normal function of the protease. If the protease has a role in pathology, an effective
inhibitor may have therapeutic value. The type of reagent we study is generally a low
molecular weight peptide derivative. Irreversible combination with the target protease permits
the inhibitor to resist displacement by normal substrates which are generally high affinity or
present in relatively high concentration. In addition, the low molecular weight inhibitor may be
made highly radioactive, permitting an analysis of the system with identification of the
molecular target(s) and a correlation of the protein modification with some change in function.
As the selectivity of the reagents improves, this type of application should become more
common. It is already feasible with a number of proteases.
Use of protease specificity for inhibitor structure
Our work has dealt with two of the proteinase classes, the serine and cysteinyl proteinases.
(Metallo and aspartyl proteinases are insensitive to the types of reagents we study.) A
knowledge of target enzyme specificity is essential for devising proteinase inhibitors that act
by affinity labelling. Proteinases have an extended active centre that may combine with a
substrate sequence of six or more amino acids. A familiar example is provided by the trypsin
family of serine proteinases, which act on lysine and arginine residues. Individual members of
this family are responsive to amino acid residues preceding the lysine or arginine residue.
Thus, plasma kallikrein cleaves after a Phe-Arg-sequence in its natural substrate; factor Xa,
after a Gly-Arg sequence; and thrombin, after Pro-Arg.
Chloromethyl ketones containing these sequences acquire a relative specificity for the
corresponding protease (Table 1).1 Plasmin, in contrast, generally favours proteolysis at lysyl
residues. Advantage may also be taken of differing responses to a D-amino acid residue in P3
or to various side-chain extensions that utilize an additional, possibly unique binding capacity
in this region.2 In the case of serine proteinases, these reagents alkylate the active centre
histidine residue.
However, peptidyl chloromethyl ketones also inactivate cysteinyl proteinases and for some in
vivo applications may be too reactive. Nevertheless, it has been possible with D-Phe-Pro-
ArgCH2Cl, a rapid inactivator of thrombin, selectively to inactivate this protease within the
blood coagulation cascade by intravenous administration of the inhibitor.3
Peptidyl fluoromethyl ketones
Some attention has been given to the development of analogous fluoromethyl ketones due to
their diminished reactivity compared to chloromethyl ketones and the expectation that a
proximity effect produced within the enzyme inhibitor complex would nevertheless promote
covalent bond formation.4-7 This has essentially been demonstrated. Peptidyl fluoromethyl
ketones are quite rapid in inactivating cysteinyl proteinases whose specificity they satisfy, yet
are extremely inert to mercaptoethanol,6 a model for the abundant thiols found in biological
materials. With respect to serine proteinases, the alkylation rate is slower than that of
chloromethyl ketones, chiefly by 1-2 orders of magnitude (Table 2). This loss may well be
acceptable if the gain is increased specificity in vivo. However, the fluoromethyl ketones are
more difficult to obtain than the chloromethyl ketones.
Peptidyl diazomethyl ketones
A different type of a covalent bond forming group is the diazomethyl ketone. Peptides with this
C-terminal function are unexpectedly stable. Serine proteinases are generally indifferent,
whereas cysteine proteinases are typically very susceptible to members of this reagent class.
R = remainder of peptide without carboxyl
It is important at this point to comment on the specificity of cysteine proteinases known to us.
Papain, the plant proteinase, is the best studied protease of this family, and, as an increasing
number of mammalian proteinases are found to be homologous to it, a papain superfamily is
identifiable, including the lysosomal cathepsins B, H, and L8 and the cytoplasmic calcium-
activated neutral proteinases.9,10 There are other non-homologous cysteine proteinases of
microbial origin.
Table 3. Specificity determinants in the papain family
P3- P2- P1
-Phe-X- Cathepsin L, B
-Leu-Leu-X- Cathepsin L, Calpain
Members of the papain family appear to bind substrates by positioning hydrophobic side
chains in S2 and S3 of the active centre, therefore the nature of the side-chain of the residue
whose peptide bond is being hydrolyzed is relatively unimportant. A phenylalanine residue at
P2 has been shown to provide the basis of an effective series of reagents for inactivating
cathepsin B and cathepsin L in which the P1 residue, X, may be basic, hydrophobic, small or
large. Although the nature of the amino acid in P1 does not seem to be specificity determining,
it was found that cathepsin L tolerates certain bulky side chains better than cathepsin B in this
position and the exploration of this difference led to a considerable enhancement of selectivity.
For example, Cbz-Phe-Tyr(O-t-Bu)CHN2 at 10
-8 M inactivates cathepsin L with a t½ of 5.7
mins, a rate 2.5 × 104 greater than its action on cathepsin B.11
Cellular studies of the uptake and metabolic effect of peptidyl diazomethyl ketones have
shown-either a drop in protein turnover in the case of cathepsin B and L inactivators,12,13 a
drop in residual intracellular proteolytic activity14,15 or the restoration of an enzymatic activity
(aryl sulphatase). The latter was observed in the case of a lysosomal storage disease
involving an aberrant but still functional aryl sulphatase that was destroyed by catheptic
proteolysis.16
Similar considerations of specificity apply to the calcium-activated neutral protease, calpain,
found in two forms in the cytoplasm. This proteinase is attracted to hydrophobic amino acid
side chains that bind in the S2 and S3 subsites of the substrate-binding region of the active-
centre, as found by Sasaki et al.17 from examination of a variety of peptide substrates. A Leu-
Leu- sequence is particularly favoured. This led to the synthesis of small peptide inactivators
for calpain, such as Leu-Leu-TyrCH2Cl
18 and Cbz-Leu-LeuMetCHN2,
19 which rapidly
inactivate calpain in vitro. Because cathepsin L also has affinity for similar residues in P2 and
P3, these inhibitors also inactivate that protease.
19 However, cathepsin L inactivators
containing a phenylalanine in P2 have no effect on calpain; therefore, ambiguity can be
resolved with the use of two inhibitors at the present time. It may be that further work will
provide a specific calpain inactivator. It can be expected that such an inhibitor would have
wide application in cellular studies on the role of this protease.
Peptidylmethyl sulphonium salts
R = remainder of peptide without carboxyl
A third class of affinity-labelling inhibitors was modelled on S-adenosyl methionine as a
biological alkylating agent.20 Peptidylmethyl sulphonium salts are particularly effective for
inactivating cysteine proteinases and have the advantage of being accessible with amino acid
side chains such as arginine whose incorporation into other inhibitor types is chemically
difficult.21,22
In connection with protein trafficking, it may be of interest that inhibitors of this type have been
applied to the study of prohormone processing. Rat proinsulin is converted to insulin by two
endo-proteolytic steps and subsequent trimming. The activities have been separated from
insulin secretory granules of rat insulinoma tissue by Hutton and his colleagues23 as Ca++-
dependent proteases with a low pH-optimum. One of the proteolytic splits follows a Lys-Arg
sequence and the other an Arg-Arg- sequence. The activity responsible for the post Arg-Arg
cleavage is highly sensitive to inactivation by Ala-Arg-ArgCH2S
+ (CH3)2, but considerably less
(orders of magnitude) to Ala-Lys-ArgCH2S
+- (CH3)2. On the other hand, this reagent is more
effective in inactivating the enzyme cleaving after Lys-Arg, as expected. The nature of the
proteases involved is not yet certain, although this sensitivity is characteristic of cysteine
proteases perhaps other types have not yet been adequately examined.
Summary
We have described several classes of peptide derivatives that act as affinity labelling
inactivators of serine and cysteine proteinases. Some of these have been shown to enter cells
and inactivate the target protease as demonstrated by protein chemistry. In other cases
cellular processes have been blocked but the protease involved has not yet been identified.
Extension of these methods can be expected to shed further light on protein metabolism.
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Table 1. Inhibitor selectivity is a function of sequence (rates of inactivation 10-3 ×
kapp/[I] (M-l sec-1))
Inhibitor Plasma kallikrein Factor Xa Thrombin Plasmin
Pro-Phe-ArgCH2Cl 23.3 0.22 0.02 0.032
Ile-Glu-GIy-ArgCH2Cl 4.8 32.0 0.5 0.075
D-Phe-Pro-ArgCH2Cl 8.0 4.5 11500.0 0.67
D-Lys(Bz)-Phe-LysCH2Cl 0.005 0.23 47.0
Table 2. Comparisons of peptidyl chloromethyl and fluoromethyl ketones
pH Ki (m M) ki (s1) Ref
Cathepsin B
Cbz-Phe-PheCH2Cl 5.4 0.23 0.21 5
Cbz-Phe-PheCH2F 5.4 0.14 0.055
Thrombin
D-Phe-Pro-ArgCH2Cl 8.0 0.025 0.115 7
D-Phe-Pro-ArgCH2F 7.0 0.25 0.0015
Plasmin
Ala-Phe-LysCH2Cl 7.0 0.83 0.003 6
Ala-Phe-LysCH2F 7.0 5.0 0.00042
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One of the challenges of contemporary biology is to unravel how the molecular composition of
the different cellular compartments is generated and maintained during the cell cycle. In
animal cells most of the efforts have been directed towards the study of how newly
synthesized proteins are transported to their correct cellular destinations, whereas the lipids,
which make up the framework of the membranes in the cell, have been given much less
attention.
This paper will focus on a working hypothesis for the generation and maintenance of the
different protein and lipid compositions of the two cell surface domains in the polarized cells of
simple epithelia. The epithelia lining the body cavities are composed of a single layer of
polarized cells. The apical plasma membrane domains of the cells line the lumen of the cavity
and the basolateral cell surface faces the underlying extracellular matrix and the blood
supply.)1,2 Each cell in the layer is linked to its neighbours by intercellular junctions, including
the tight junctions that form the permeability barrier between the cells.3 The tight junctions also
define the boundary between the apical and the basolateral membrane domains. The sorting
of newly synthesized surface glycoproteins defined for the two plasma membrane domains
has been localized to the trans-Golgi network, the exit compartment of the Golgi complex.2,4,5
The sorting of newly synthesized lipids enroute for the epithelial cell surface also takes place
intracellularly in the Golgi complex,6 raising the possibility that protein and lipid sorting are
directly connected to each other. Our working hypothesis is that the transport machinery in the
trans-Golgi sorts lipids and proteins into common carrier vesicles for delivery to the correct cell
surface domain.
A number of studies indicate that the apical plasma membrane domain is enriched in
glycosphingolipids whereas the basolateral domain has a correspondingly higher
phosphatidylcholine content. The distribution of other phospholipids (such as
phosphatidylserine and phosphatidylethanolamine), as well as of cholesterol, is similar in the
two domains. The asymmetric distribution of lipids in the two surface domains appears to be
restricted to the exoplasmic leaflet,2 where their intermixing is prevented by the tight
junctions.7,8 The lipids in the cytoplasmic leaflet seem to diffuse freely between the two
domains. Therefore, it follows that glycosphingolipids are exposed on the external surface of
the apical membrane, whereas phosphatidylcholine would be exposed on the surface facing
the basolateral milieu. The lipids common to both domains such as phosphatidylserine and
phosphatidylethanolamine are primarily in the cytoplasmic leaflet. This predicted topology is
consistent with the available data on lipid asymmetry in plasma membrane, choline-containing
lipids and glycosphingolipids being generally exoplasmic and amino-containing phospholipids
being cytoplasmic.9-13
Apical membranes may have such an unusually high content of glycolipids due to the
stabilizing and protective function of these lipids.14,15,16 The apical membranes face the
hazards of the external environment. In some epithelial cell types such as those lining the gall
bladder and the bile duct, the apical surfaces even have to withstand solubilizing
concentrations of the bile salt detergents. Glycosphingolipids are uniquely suited for a
protective function because they can form intermolecular hydrogen bonds between the
glycosyl head groups, the amide and hydroxyls of the sphingosine base and of the hydroxy
fatty acid.14 To a lesser extent sphingomyelin also has this capacity to associate by
intermolecular hydrogen bonds due to its ceramide constituent. This extensive intermolecular
hydrogen bonding capacity is a characteristic feature that distinguishes sphingolipids from the
major lipid family in animal cells, the glycerolipids. These cannot form interlipid hydrogen
bonds between their diglyceride moieties. The ester and ether groups can function only as
hydrogen bond acceptors, not as donors.
The sorting event in the trans-Golgi network need not be specific in both the apical and the
basolateral directions. It is possible that only one direction is mediated by specific recognition
of molecules to be transported (the signal-mediated pathway) and that the other route includes
molecules in transit without specific signal recognition (the default pathway).17 For apical and
basolateral membrane proteins, no conclusive answer is available yet, although several
attempts have been made to localize the protein signals mediating sorting. One clue might be
the tight exclusion of basolateral proteins from the apical side in MDCK cells,18 whereas the
converse is not true.19,20 A small fraction of apical proteins are "missorted" to the basolateral
side, possibly because the basolateral route operates by default. Biosynthetic protein transport
from the Golgi to the fibroblast cell surface has been postulated to be a default pathway.21
The basolateral route could be the fibroblast homologue. Sorting in the apical direction would
be signal mediated, and be specific for simple epithelia. In more complicated epithelial tissues
such as liver, the situation is different. Each hepatocyte has several apical poles lining the bile
canaliculi. Bartles et al.22 have shown that apical proteins are not sorted in the trans-Golgi
network. There seems to be no apical route from the Golgi complex to the apical membrane in
hepatocytes. Instead, apical proteins are delivered to the basolateral membrane, from where
they are sorted to the apical side. The simplest interpretation of these findings is that the
basolateral transport vesicles (the postulated default pathway) carry both apical and
basolateral proteins. The apical sorting machinery seems to be lacking from the trans-Golgi
network in hepatocytes.
In MDCK cells, specificity in the apical direction might be aided by glyco-sphingolipid-protein
interactions. Sphingolipid clustering in the luminal (exoplasmic) leaflet of the trans-Golgi
network is postulated to form the budding site for an apical membrane vesicle.6,23 The self-
association could be mediated by interlipid hydrogen bonding. This asymmetric sphingolipid
microdomain is assumed to be the starting point for inclusion of associating apical proteins
that bind directly to the glycosphingolipids or indirectly via interactions to a trans membrane
sorting protein. Such a sorting protein should bind to both glycosphingolipids and to the apical
proteins. Moreover, this protein is assumed to have another function. Its cytosolic domain
interacts with a cytosolic protein coat to induce the curvature leading to vesiculation. According
to this model, exclusion of glycerolipids in the exoplasmic leaflet could result from their inability
to form interlipid hydrogen bonds with the sphingolipids. The basolateral transport vesicles are
predicted to form from membrane regions depleted of apical components and these should,
therefore, be enriched in phosphatidylcholine as a consequence of lipid asymmetry. The
asymmetry of the lipids facilitates the lateral separation of the apical and the basolateral
precursor domains in the trans-Golgi network. Sorting would, according to this view, be the
formation of microdomains mimicking the properties of the membranes of their destination.
This hypothesis makes several predictions that can be tested. First, there should be specific
interactions between glycosphingolipids and apical proteins or between glycosphingolipids and
the putative bridging protein. Second, for exclusion of phosphatidylcholine to occur, the luminal
leaflet of the membrane segment that forms the apical transport vesicle has to be almost
covered by sphingolipids. The sphingo- to phospholipid ratio of the apical transport vesicles
would depend on the size of the vesicle; the larger the vesicle, the nearer the ratio between
the surface areas of the luminal and the cytoplasmic leaflets will be to one. Furthermore, if
sphingolipid clustering in the trans-Golgi network were a prerequisite for apical delivery, then
presumably sphingolipid recycling between the apical membrane and the trans-Golgi would be
necessary to replenish the sphingolipids lost in 4 h vesiculation event. Also, the putative
sorting protein has to cycle between the apical membrane and the TGN to be able to perform
sorting. Sorting proceeds for hours in virus-infected MDCK cells which synthesize only virus
proteins and not host proteins.
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Receptor-mediated endocytosis is studied extensively in liver parenchymal cells.1,2 At the
sinusoidal, i.e., basolateral cell surface, different receptors and their ligands are trapped in
coated pits that pinch-off from the plasma membrane. The vesicles formed lose their clathrin
coat and coalesce into a system of anastomosing tubules and connected vesicles, the
endocytotic or endosomal compartment. We described this tubulo-vesicular system in relation
to the distribution of a receptor that is unique for liver cells, the asialoglycoprotein receptor
(ASGPR).3 This receptor binds galactose terminal glycoproteins, which after internalization are
mainly destined for lysosomal degradation. This fate awaits many exogenous products that
are taken up by adsorptive endocytosis. Endocytotic products accumulate in endosomal
vacuoles.4,3 While the vacuoles grow larger, they show increasing numbers of internal
vesicles. The vacuoles remain connected to tubular elements. In well-differentiated hepatic
parenchymal cells, the endosomal tubules have predominantly a peripheral location and are
particularly abundant in the basolateral cell corners. It is here that small endosomal vacuoles
seem to arise. In less polarized cells, such as the cultured hepatoma cell lines Hep-G2
(human) and H4S (rat), the endosomal elements occupy less characteristic positions in the
cells. In these cells the endosomal tubules and those of the trans-Golgi reticulum (TGR)5 are
easily mixed up when observed by electron microscopy (EM). Therefore, in
immunocytochemical studies endocytosed markers like cationized ferritin or specific ligands,
tagged to electron-dense markers for EM detection, are required to distinguish endosomes
from TGR. The elements of the TGR, on the other hand, can be recognized by marking
endogenous secretory proteins, such as albumin in liver cells.
Significant differences exist in the molecular composition of the plasma membrane and of the
lysosomal membrane. Intensive membrane remodelling along the prelysosomal route seems
the obvious way to maintain this difference in spite of a conspicuous membrane flow resulting
from the vectorial transport of exogenous material to lysosomes. The intermediate composition
of endosomes that we observed for several membrane proteins illustrates that such
membrane remodelling indeed takes place (Table 1). In several studies we investigated these
changes in the endosomal compartment by observing individual membrane proteins after
immunogold labelling in thin cryosections.
Immunocytochemistry showed that the membrane of coated pits is, to some extent, different
from the rest of the plasma membrane. Pits were enriched in ligand-receptor complexes. The
pits appeared to be non-selective for different receptors. The ASGPR occurred together with
the mannose 6-phosphate receptor (MPR), which recognizes the phosphomannosyl residues
on lysosomal enzymes. These two receptors also co-localized to coated pits with the receptor
for polymeric IgA (IgAR).6 Recently, careful analysis of endosomal elements in cell fractions
demonstrated that the transferrin receptor (TFR) system entered Hep-G2 cells together with
the ASGPR system.7 Hence, at least 8 different compounds (4 receptors + 4 ligands) enter the
same elements of the endosomes. Of only the ligands of ASGPR and MPR, the main
destination is the lysosomal compartment. TFR with ligand and ASGPR recycle to the cell
surface. The MPR is also known to be absent from lysosomes.8,9 The IgAR with covalently
linked ligand is directed to the bile capillary (apical) cell membrane, where it is cleaved from
the membrane and secreted. By comparing the distribution of these different molecules in
immunodouble-labelled sections, we studied the sites of selective removal of the ASGPR,
MPR and the IgAR-ligand complex in liver cells.
Within the peripheral endosomal tubular system we found microdomains enriched in IgAR and
ASGPR, indicating a very early sorting of the two receptor systems. This is in agreement with
results demonstrating that segregation of endocytosed IgA and ASGPR ligand occurs during
the very first minutes after uptake.1
We observed accumulation of ASGPR ligand in the endosome vacuoles, whereas ASGPR
was present mainly in the tubules.3 Therefore, we called this tubulo-vesicular compartment
CURL, i.e., compartment of uncoupling receptor and ligand.3 Recently, the distribution of
ASGPR in endosomes was studied in more detail.10 It was shown that the larger the
endosomal vacuoles were, the less ASGPR was present in their limiting membranes (Figures
1, 2). ASGPR seemed to accumulate in the tubules. It was proposed that the ASGPR and
ligand dissociate in the acidic environment inside the endosomal vacuoles11,12 and that the
receptor molecules then migrate laterally into the tubules. Since receptor negative vacuoles
are often seen in continuity with receptor enriched tubules (Figure 2), we propose an efficient
block occurs at the junction of tubules and vacuoles that prevents the receptor from moving
back into the vacuoles and the ligand from moving in the reverse direction.
Besides the sorting of IgAR and ASGPR in peripheral early endosomes, we studied the
intracellular pathways of two other membrane proteins in endosomes, which occurred
predominantly in the deeper (late) endosomes, namely the MPR and a 120-kD lysosomal
glycoprotein, LGP120.13 MPR enters the endosomes by coated vesicles together with ASGPR
at a concentration that is almost proportional to the concentration of both receptors at the
sinusoidal cell surface.6 Nevertheless, quantitation of the immunolabelling in Hep-G2 cells
demonstrated that MPR is 5 times more abundant in endosomes than ASGPR relative to their
densities at the plasma membrane (Table 1). Most likely this is due to two phenomena. First,
MPR is segregated at a later stage from the endosomes than ASGPR. This fits well with the
impression that late endosomal vacuoles (large vacuoles with many internal vesicles) were
still labelled for MPR. Second, there may occur an additional supply of more MPR molecules
to endosomes via another route than coated pits. A significant pool of cellular MPR is
localized in the TGR of Hep G29 and H4S cells (Figure 3). In the TGR the receptor and
lysosomal enzymes seem to accumulate in characteristic electron-dense, clathrin-coated buds
and vesicles. Similar vesicles are often observed adjacent to endosomal vacuoles. This
suggests a direct transport of MPR from TGR to endosomes, by-passing the plasma
membrane. In the endosomes, MPR is usually enriched in tubules attached to the vacuoles,
which indicates that MPR, like ASGPR, is recaptured from the lysosomal route by lateral
migration from the vacuoles into the tubules. This would finally lead to the absence of MPR
from lysosomes.
It was therefore of interest to compare the MPR distribution with that of the typical lysosomal
membrane protein LGP120, which we found at least as abundant in endosomes as in
lysosomes of H4S cells (Table 1). This is in agreement with observations of other cell types.14
LGP120 occurred in vacuoles, but not in tubules of endosomes. The cell surface was virtually
devoid of LGP120, whereas the Golgi complex and TGR showed less than 5% of the total
cellular LGP120 labelling.
We offered H4S cells cationized ferritin (CF) for 5,10,30 or 60 min prior to fixation, prepared
cryosections and studied the distribution of MPR and LGP120 by immunolocalization. At each
time interval we counted the number of CF containing vacuoles, (i.e., endosomal vacuoles and
lysosomes), labelled for MPR and LGP120 (Figure 4). The complete data are reported
elsewhere.15 Apparently, CF is taken up in a very short living category of vacuoles in which
neither MPR nor LGP120 was detectable. Then a rapidly growing fraction of the CF-positive
vacuoles became labelled for MPR, which peaks at 10 min. The increase of MPR labelling
during the first minutes is in agreement with the above and suggested additional direct
transport of this receptor from TGR to endosomes. Furthermore, the main removal of MPR
from the endosomal vacuoles seems to take place after 10 min, The ASGPR, on the other
hand, has been reported to be segregated from the degradative route within the first few
minutes after endocytosis.7 This is consistent with our impression that MPR, in contrast to
ASGPR, occurs in relatively late endosomal vacuoles. The LGP120+ fraction of CF=containing
vacuoles increases more slowly than those with MPR. Increasing percentages of 50, 80 and
90% of the MPR+ CF vacuoles were also labelled for LGP120 at 10, 30 and 60 min,
respectively (not shown in Figure 4). Conversely, the percentage of LGP120+ CF vesicles that
labelled also for MPR decreased according to 75, 50 and 30% at 10, 30 and 60 min,
respectively. Since MPR-/LGP120+ vesicles can probably be defined as lysosomal structures,
the latter figures give an impression of the rate of uptake of CF in lysosomes. After 1 h
approximately two thirds of the CF containing structures are lysosomes.
About half of the LGP120 labelling is located in the endosomal vacuoles (Table 1). Only a very
little LGP120 is found in the Golgi area, which is consistent with a proposed fast transport of
newly synthesized LGP120 to lysosomes.16 It also suggests that the protein does not recycle
in circuits in which Golgi elements or TGR participate, as is probably the case for ASGPR and
MPR.9,17,18 Therefore, the inflow of LGP120 into endosomes from the Golgi complex or TGR,
either via the cell surface or directly by vesicles, is probably less significant than for the other
receptor molecules that we described. Instead, the high concentration of LGP120 in the late
vacuoles, is likely to be a result of recycling molecules from the lysosomes back into the
endosomal vacuoles although there is no direct evidence for such a recycling route. Small
irregular membranous structures rich in LGP120 may function as intermediates. They are
found to contain approximately 10% of cellular LGP120 labelling. That with time an increasing
percentage of CF positive vesicles marked for MPR also contained LGP120 demonstrates that
the bulk of LGP120 enters the endosomes at a later stage than MPR. However, some
MPR+/LGP120+ vacuoles were reached by CF very soon after uptake. Therefore, it is likely
that LGP120 is added gradually along a relatively long stretch of the endocytotic route.
Our observations are summarized in Figure 5. For three receptors and a major lysosomal
membrane protein we describe the sites of entry into and segregation from endosomes in
hepatocytes. Our observations are in agreement with a gradual transformation of the
endosomal membrane from a plasma membrane-like composition immediately after
endocytosis into one that resembles more closely the lysosomal membrane.
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Table 1. Immunogold labelling in cryosections of hepatoma cell lines (Hep-G2 and H4S)
for ASGPR, MPR and LGP120 in plasma membrane (PM), endosomes (End) and
lysosomes (Lys).
HepG2 H4S(3)
ASGPR(1) MPR(2) MPR LGP120
a b a b a b a b
PM: 51 (39) 18 (9) 16 (10) 1 (1)
End: 48 (37) 82 (42) 84 (53) 58 (50)
Lys: 1 (1) - (-) - (-) 41 (36)
a: relative distribution of gold particles over the three compartments mentioned.
b: percentage of particles of total cellular labelling.
(1) (2)
From: Zijderveld-Bleekemolen et al., 1987. Schuurman, Slot, Bleekemolen and Geuze (in
preparation). (3)Geuze et al., in press.
Figures 1 and 2. Endosomal elements of rat liver cells, immunolabelled for
asialoglycoprotein receptor (ASGPR). Labelling is most prominent in tubules and small
vesicles (Figure 1). Large vesicles (Figure 2), containing internal vesicles, are not
labelled, even though they are connected to ASGPR positive tubules (arrowhead).
Figure 3. Mannose 6-phosphate receptor (MPR) immunolabelling of the Golgi area in a
Hep-G2 cell. Golgi cisternae (asterisks) are almost devoid of MPR but tubules and
dense vesicles (arrows) of the trans-Golgi reticulum (TGR) seem to contain the receptor
at relatively high concentrations. The dense vesicles are thought to pinch off from the
TGR and transport MPR directly to endosomal vacuoles, an example of which is
depicted (inset), double labelled for MPR (9 nm gold particles) and asialoglycoprotein
receptor (ASGPR) (6 nm gold particles). The strong ASGPR labelling characterizes this
example as an early vacuole.
Figure 4. Percentage of cationized ferritin (CF) containing vacuoles in H4S cells, in
which mannose 6-phosphate receptor (MPR) (MPR+), LGP120 (LGP120+) or none of
these molecules (MPR-/LGP120-) were detected by immunogold labelling after
incubating the cells for various periods with CF (Geuze et al., in press)
Figure 5. Impression of membrane remodelling in the endosomes of liver cells. The
arrows indicate at which level inflow and segregation of typical endosomal membrane
proteins occur.
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African trypanosomes are protozoan flagellates that are responsible for extensive disease in
humans and domestic animals across a large area of Africa. The success of trypanosomes lie
in their ability to avoid the host immune response by varying, both biochemically and
antigenically, the glycoprotein coat (variable surface glycoprotein, or VSG) covering the entire
cell surface during the course of infection in the mammalian host.1,2,3
It is believed that the surface glycoproteins of trypanosomes are too antigenically diverse to be
useful as a material for a vaccine.4 However, other antigenically sensitive sites vulnerable to
antibody attack may be revealed as the cell biology of the organism is studied. A process that
may serve as a target for antibody attack within trypanosomes is endocytosis.
Trypanosomes, like all living cells, require materials from their environment for continued
growth. Many molecules enter cells by endocytosis, either by fluid phase or by absorptive or
receptor-mediated endocytosis of selected molecules via clathrin-coated vesicles.5 African
trypanosomes in the bloodstream of infected animals take up various particulate and soluble
substances in vesicles morphologically similar to the clathrin-coated vesicles found in other
eukaryotic cells.6,7,8 These vesicles bud only from the membrane of the flagellar pocket, a
deep invagination of the plasma membrane where the flagellum leaves the cell, and discharge
their contents into an intracellular tubular system.6
Iron, essential to all cells, is supplied to mammalian cells primarily by a major serum protein
called transferrin, which, when iron loaded, will bind to receptors on the cell surface. The
receptor-ligand complexes are internalized by receptor-mediated endocytosis9 through
clathrin-coated pits and vesicles10,11,12 and are delivered to the endosome compartment of the
endoycytic pathway.11,l3,14 Here, the low pH environment14,15,16 triggers the dissociation of
iron from the transferrin17,18 and the iron is transported across the membrane. The iron-free or
apotransferrin-receptor complexes recycle to the cell surface, where, at neutral pH, the
apotransferrin dissociates from the receptor and the cycle is repeated.10,11,17,18
African trypanosomes also require iron for growth (R. Kaminsky, personal communication).
For these cells, however, the mechanisms by which iron is acquired are not understood. We
have shown that colloidal gold coupled to diferric tranferrin bind to the surface of
trypanosomes and are internalized by vesicles via the flagellar pocket.8 Uptake of VSG
molecules also occurs via the same vesicles.8 It has recently been demonstrated that
transferrin and low-density lipoproteins enter Trypanosoma brucei by receptor mediated
endocytosis.7 However, little is known about the nature of the parasite receptors, or the fate of
substances internalized by trypanosomes.
This report will investigate the fate of various endocytosed substances in African
trypanosomes.
All experiments were carried out on T. brucei populations isolated from infected rat blood, as
previously described.19
Transferrin binding
Trypanosomes were incubated with 125I diferric transferrin on ice. At the indicated times, free
ligand was washed away and the cell associated radioactivity was determined. Binding was
slow and took up to 3 h to reach a plateau. The binding was saturable and was competitively
inhibited by excess unlabelled differic transferrin. Binding of 125I apotransferrin was found to
be only 12% efficient when compared with differic transferrin binding.
Cell association of transferrin at 37 °C
Trypanosoma brucei incubated with either 125I diferric or 125I apotransferrin were placed on ice
and, at increasing time intervals, washed with cold medium to remove unbound label and
transferred to fresh tubes to determine the cell associated radioactivity.
At 37 °C diferric transferrin rapidly associated with the cell and reached a maximum of cell-
associated activity at 10 min after the onset of incubation at 37 °C. Subsequently, the cell
associated activity declined, suggesting that the protein was released from the cells.
Cell association of 59Fe-transferrin
To determine whether the iron associated with diferric transferrin remained cell-associated,
trypanosomes were incubated in 59Fe-transferrin. At increasing times the cells were washed
and the cell-associated radioactivity was determined. A steady, linear accumulation of cell-
associated radioactivity was seen over a 90 min period.
In the presence of ammonium chloride, the accumulation of radioactivity was initially inhibited,
but within 30 min the rate of ferric 59Fe uptake was equivalent to that in the untreated
samples. The results suggest that iron accumulates in trypanosomes after dissociating from
transferrin in an acidic compartment. In the conditions used for these experiments, the cells
rapidly acidify the medium and as a consequence NH3 is protonated, becomes less permanent
to membranes and loses its ability to neutralize intracellular acidic compartments.
Transferrin-gold binding and uptake
Trypanosomes were incubated on ice in medium containing transferrin coupled to colloidal
gold particles. By electron microscopy, the gold particles were seen to bind to the surface of
the trypanosomes. Occasionally gold particles were found in flagellar pockets, but most
pockets did not contain the marker.
When trypanosomes were warmed to 37°C in the presence of transferrin-gold, the gold
particles were found in the flagellar pocket, in pits on the flagellar pocket membrane and in
intracellular vesicles in close proximity to the flagellar pocket. After a 5-min incubation at 37°C,
the gold markers were found in intracellular structures with tubular profiles and large vesicular
and lysosome-like structures.
If trypanosomes, incubated in transferrin-gold, were reacted with a silver intensification
solution and viewed by light microscopy, a dark reaction product revealing the colloidal gold
was present in the region between the nucleus and the flagellar pocket, situated at the
posterior end of the cell. Reaction product was seldom found in the anterior part of the cell.
Uptake of bovine serum albumin and transferrin coupled to gold
When trypanosomes were incubated in medium containing transferrin coupled to colloidal gold
of one particle size and bovine serum albumin (BSA) coupled to gold of a different particle
size, both markers bound to the cell surface. Both markers entered the cell via the flagellar
pocket and in the same intracellular vesicles. No segregation of the two markers was seen in
any of the endocytotic organelles except that some vesicular structures contained only the
smaller gold particles, regardless of the coupled protein.
Binding and uptake of horseradish peroxidase (HRP)
Trypanosomes incubated on ice in medium containing HRP were seen to have horseradish
peroxidase (HRP) bound to the cell surface, after visualization with diamino-benzidene. The
flagellar pockets did not contain HRP. Upon warming to 37°C, the HRP entered the cells via
the flagellar pocket and after 5 min was found in many intracellular structures. Often tubular
structures near to the Golgi apparatus were filled with HRP, but there was no consistent
association of HRP with the Golgi.
Serial sections through trypanosomes containing endocytosed HRP produced a pseudo three-
dimensional view of the endocytotic organelles and revealed them to be a complex tubulo-
vesicular network.
Uptake of HRP and transferrin-gold
When transferrin-gold was included in the incubation medium with HRP, the two markers co-
localized in the flagellar pocket and in many intracellular organelles. Whereas the transferrin-
gold always co-localized with the HRP, the HRP was found in vesicles close to the flagellar
pocket and in many tubular and vesicular structures that did not contain transferrin-gold. Many
of these HRP-containing structures were connected to structures that contained the colloidal
gold marker.
A fractional volume analysis revealed that transferrin-gold containing structures constituted 2%
of the total cell volume, whereas the HRP-containing structures constituted 5% of the total cell
volume.
Conclusions
It appears that trypanosomes obtain iron from the blood that surrounds them in a way similar
to that used by the mammalian hosts. Receptors on the surface of trypanosomes specifically
bind diferric transferrin, and the receptor-ligand complexes enter the cell, where they meet an
acidic environment that causes the iron to dissociate from the transferrin. The eventual fate of
the internalized transferrin has not yet been determined.
Morphologically, using transferrin coupled to colloidal gold, it seems that trypanosomes
internalize transferrin through coated vesicles into a tubulo-vesicular compartment similar to
the endosome compartment of mammalian cells.20 The precise morphological details of the
endocytotic uptake of transferrin must await analysis using monomeric protein, as it is clear
the proteins coupled to colloidal gold may be directed to sites other than those reached by
uncoupled proteins.21,22,23
It is clear that the organelles involved with endocytosis are morphologically complex structures
when visualized by HRP and that colloidal gold particles enter only parts of the endocytic
pathway. Endocytosis by African trypanosomes is important for nutrient uptake and possibly
for processing of intracellular VSG. An understanding of the complex mechanisms involved
may reveal new ways to control trypanosomiasis.
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